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Abstract 
The internal environment of the central nervous system (CNS) is protected from its 
surrounding milieu by barriers, which selectively facilitate and restrict the entry of 
molecules in and out of the CNS. These barriers form early during development, 
however, their selectivity in the developing brain appears to be different from those that 
protect the adult brain. The reasons for the differences in the CNS barriers between 
young and adult animals are still unclear. The experiments in this thesis were performed 
in order to obtain morphological and physiological explanations for the changes in the 
transfer of lipid insoluble molecules into the CNS that occur during development. 
Quantitative studies with radioactive markers in parallel with experiments using a tracer 
that could be visualised were conducted in an attempt to correlate physiological uptake 
with the structural studies. A marsupial species, the grey short-tailed South-American 
opossum (Monodelphis domestica), was used in all experiments since it is born at an 
early stage of brain development, and thus is a more accessible model than any 
eutherian animal during a similar developmental period. The transfer of lipid insoluble 
molecules has previously not been studied at such early stages of brain development. 
All experiments were carried out in accordance with NHMRC guidelines and with the 
approval of the University of Tasmania Ethics Committee. Lipid insoluble radioactive 
markers were injected into opossum pups and blood, cerebrospinal fluid (CSF) and 
brain samples were collected to assess initial rate of uptake and steady-state 
CSF/plasma and brain/plasma ratios. These experiments showed that the steady-state 
ratios for small lipid insoluble molecules were high in early development compared to 
the adult and that they decreased during development due to a reduction in CNS barrier 
permeability with age. Possible routes by which lipid insoluble molecules enter the 
brain were investigated using a 3000 molecular weight biotin-dextran and visualising it 
under the light and electron microscope. This tracer allowed localisation of a small inert 
lipid insoluble molecule at the blood-CNS interfaces. Quantitative measurements of 
CSF uptake showed that the dextran penetrates across the brain barriers to an extent 
similar to other small lipid insoluble molecules and thus validates the dextran as a 
suitable tracer. Under the electron microscope, it appeared that cells of the blood-CSF 
interface at birth already exhibited tight-junctions, which are the fundamental structures 
of the brain barriers. These junctions seemed to impede the intercellular movement of 
the biotin-dextran. Uptake into cells at the blood-CSF interface and lack of extracellular 
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biotin-dextran in the brain suggest that in the immature brain the route of penetration 
from blood to brain may be predominantly via the CSF rather than directly across the 
cerebral vessels of the developing brain. 
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Chapter 1: General Introduction 
This thesis starts with a general introduction to the field in Chapter 1. Chapter 2 
describes experimental procedures that were common to a majority of the studies. 
Chapter 3 describes and evaluates the animal model that was used in the experiments of 
this thesis. Chapter 4 presents quantitative uptake studies of several small lipid 
insoluble molecules from the blood into the brain and CSF. Chapter 5 presents 
experiments with a small lipid insoluble dextran that was visualised in the brain under 
the light and electron microscope and Chapter 6 is a general discussion of all the results 
obtained. Part of the work in this thesis has been presented in Saunders et al. (1999c), 
Dziegielewska et al. (2001) and Ek et al. (2001). Copies of these publications are found 
in the back of this thesis. 
Brief historical background 
The earliest experiments that led to the concept of a barrier mechanism between blood 
and brain were made around the turn of the 19 th century (Ehrlich, 1885; Lewandowslcy, 
1900 as cited by Habgood, 1990; Goldmann, 1909). These experiments involved small 
molecules that could easily be visualised eg. potassium ferrocyanide or dyes (such as 
trypan blue) that, after systemic injection, coloured almost the whole body but left the 
CNS unstained. On the other hand, when the dyes where injected directly into the brain 
the neural tissue became widely stained (Goldmann, 1913). These experiments also 
demonstrate the caution that has to be taken when interpreting the results of tracer 
experiments. Many of the dyes that were used in these early experiments were later 
found to bind to plasma proteins (Tschirgi, 1950), thus while in the plasma most of the 
dyes probably existed as dye-protein complexes. However, when injected directly into 
the CSF the dyes possibly existed as free dye to a much larger extent due to the low 
protein concentration in CSF. At the same time it was also noted that bile and sodium 
ferrocyanide, which had little effect when delivered vascularly, could have dramatic 
effects when delivered directly into the CNS (Biedl and Kraus, 1898; Lewandowsky, 
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1900 as cited by Habgood, 1990). Goldmann and Lewandowsky interpreted these 
experiments as an existence of barrier systems that restricted the entry of these dyes 
between the blood and the brain, and Lewandowsky coined the term "bluthirnschranke" 
(blood-brain barrier); however, at that time this concept was not widely accepted. Basic 
dyes did have the ability to stain central nervous tissue whilst acidic dyes did not stain 
the brain after systemic administration. This lead to the incorrect assumption that it was 
the affinity for neural tissue, and not its capacity to reach the brain, which explained the 
dyes ability to stain the CNS (Ehrlich, 1887; King, 1939 as cited by Habgood, 1990). 
The most obvious sites for a CNS barrier were the brain blood vessels, which could 
have properties denying the entry of dyes into the brain. During this time, however, 
using light microscopy, it was not possible to find any difference between the capillaries 
in the CNS and those of other parts of the body (Goldmann, 1913; Broman, 1941). It 
was not until the introduction of electron microscopy in the 1960's, revealing 
specialised ultrastructural properties in the brain capillaries, that a physical barrier to 
blood solutes was identified (Reese and Karnovsky, 1967; Brightman and Reese, 1969) 
(see below for more details about these experiments). 
Ehrlich (1904) noted that in general the dyes staining the brain also stained adipose 
tissue. This was probably the first indication that lipid solubility plays a role in the 
ability of blood solutes to reach brain tissue. The use of lipid soluble narcotics, which 
had a rapid central action, supported this hypothesis (Krogh, 1946). When better 
analytical techniques, such as radioisotopes were introduced, the use of basic dyes could 
be abandoned and the range of compounds used in experiments increased. This also 
meant that it was possible to measure tracer levels of solutes in a quantitative way. With 
the use of these new techniques Davson (1955) published a series of comprehensive 
studies with a number of small molecules, electrolytes and non-electrolytes, and 
confirmed that lipid-solubility was a main determinant of penetration from blood to 
brain. These studies also showed that charged molecules such as cations and anions 
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penetrated from blood into the brain very slowly. 
The earliest experiments investigating possible barriers in the developing animal were 
carried out in the 1920's (Wislocki, 1920; Behnsen, 1927; Stern and Peyrot, 1927 as 
cited by MoIlgard and Saunders, 1986; Penta, 1932 as cited by Mollgard and Saunders, 
1986). These studies used similar dyes and small markers that were used in the early 
experiments demonstrating barrier mechanisms in the adult animal (see above). Nearly 
all these studies showed that these markers penetrated into the developing brain in 
contrast to the lack of staining in the adult brain. These studies therefore lead to the 
misconception that the barriers were poorly developed until late in development. 
However, as was pointed out by MoIlgard and Saunders (1986), these early experiments 
indicating barrier immaturity injected huge amounts of dye that probably affected the 
integrity of the fetal and embryonic barrier mechanisms. As became clear later (see 
references below) and is also shown in the experiments presented in this thesis, the 
developing brain is indeed protected by barriers that are present very early in 
development. 
Current concept of the brain barriers 
The term blood-brain barrier (BBB) is widely used as a collective term describing 
several barrier mechanisms in the CNS. However, scientists working in the field use the 
more exact definition of this term to define the restriction to the passage of molecules 
from the lumen of blood vessels inside the brain to the surrounding brain tissue (see 
Figure 1.1). In this thesis the term brain barriers will be used as a collective term for all 
barrier mechanisms regulating the penetration of blood solutes into the brain. The 
current concept of the brain barriers includes multiple systems that control the internal 
environment of the brain, both by restricting and by facilitating the entry of solutes 
(Saunders and Dziegielewska, 1997). These systems include outward transporting 
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systems, such as the P-glycoprotein and multi-drug resistant protein, which exclude 
molecules by active transport out of the endothelium (Borst and Schinkel, 1998). These 
specialised transporting systems within the barriers will be discussed separately later. 
The brain barriers can be divided into four principal interfaces: 1) the endothelium of 
the cerebral blood vessels (blood-brain barrier), 2) the epithelium of choroid plexus 
tissue in the brain ventricles (blood-CSF barrier), 3) the ependymal lining of the 
ventricles and the pia-glia limitans (CSF-brain barrier), 4) and the meningeal barrier (a 
second blood-CSF barrier). The structures associated with these barriers will be 
described in detail below, first in the mature and then in the developing CNS (see also 
Figure 1.1). 
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Figure 1.1 
The brain barriers in the developing and in adult animal. The central picture is a 
schematic diagram of the three main compartments in the central nervous 
system (CSF, brain and blood). These compartments are separated from each 
other by four separate barriers in the developing brain. 1) The blood-brain 
barrier, which is situated between the lumen of the blood vessels in the brain 
and the brain tissue itself. Arrow points to the location of tight-junctions between 
the endothelial cells that restricts the intercellular passage of molecules. 2) The 
blood-CSF barrier, which is situated between the lumen of the blood vessels in 
the choroid plexus and the cerebrospinal fluid (CSF). Arrows point to the 
position of the tight-junctions that impedes the paracellular passage of 
molecules in between the choroidal epithelial cells. 3) The CSF-brain barrier, 
which is situated at the ventricular surface and the pia-glia limitans, between the 
CSF and brain tissue. This has only been shown to be a functional barrier in the 
early developing brain (Fossan et al., 1985) where the neuroependymal cells 
form a pseudostratified layer and are connected to each other by strap-
junctions (arrowheads). 4) The meningeal barrier, which is situated between the 
CSF filled subarachnoid space (SAS) and the overlaying blood circulation. The 
cells in the outer surface of the arachnoid have tight-junctions that hinder the 
extracellular movement of molecules. The dura mater has fenestrated blood 
vessels whereas the blood vessels in the arachnoids and on the pial surface 
have functional barrier characteristics similar to the blood vessels inside the 
brain. Likewise to the ventricular CSF-brain interface, a functional barrier seems 
to exist on the outer pial surface of the brain (arrowheads) during early 
development but disappears later. 5) The mature ventricular surface is made up 
of a flat layer of ependymal cells. These ependymal cells are connected to each 
other by gap-junctions and lack tight-junctions so there is a free passage of 
molecules between the CSF and the extracellular fluid of the brain. 
Abbreviations: D — Dura mater, OA — Outer Arachnoid, SAS — Subarachnoid 
space. Modified from Saunders et al. (1999b), Habgood (1990) and Krisch et al. 
(1984). 
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Barriers in the adult brain 
I. Blood-brain barrier 
In blood capillaries in the brain, the cell membranes of endothelial cells come together 
at the luminal side to form zonulae occludentes. Zonulae occludentes refers to a region 
of the intercellular cleft where the opposing cell membranes fuse at multiple points to 
form tight-junctions that obliterate the intercellular space. In freeze-fracture it has been 
shown that these tight-junctions form a continuous fusion and completely encircle the 
endothelial cells (Connell and Mercer, 1974; Dermietzel, 1975a; Shivers et al., 1984). 
These tight-junctions are believed to form a physical barrier to compounds and thus 
forming the structural basis for the blood-brain barrier. That the barrier was situated 
between the endothelial cells was first shown by Karnovsky (1967) and in further 
studies by Brightman and Reese (1969), who injected horseradish peroxidase (HRP), a 
40 000 MW protein, into mice and visualised it under the electron microscope. HRP 
was confined to the lumen of the capillaries. It could penetrate the space in between the 
endothelial cells until it reached the tight-junction where it was stopped. An inverse 
image was found when HRP was introduced into the ventricles. HRP could penetrate 
brain tissue all the way to the endothelial cells, but was stopped in the interendothelial 
clefts. The tight-junctions of the endothelial cells have also been found to be 
impenetrable to other tracers such as cytochrome c (Milhorat et al., 1973; Milhorat et 
al., 1975), lanthanum (Brightman and Reese, 1969; Bouldin and Krigman, 1975), and 
microperoxidase (MP) (Reese et al., 1971). The latter molecule was later found to bind 
to plasma proteins so the barrier was to a MP-protein complex, which would be 
considerably larger than MP itself (Milton Brightman, personal communication). In 
contrast to the above-mentioned studies, Nag et al. (1982) found that lanthanum could 
penetrate the intercellular cleft in some cerebral arterioles but not in cerebral capillaries 
or venules. However, studies using lanthanum as a tracer has to be interpreted with 
caution because of its toxicity and also because of the differences in methods used in 
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experiments. For instance, Bouldin and Krigman (1975) perfused the brain with a 
lanthanum solution for 15 minutes in vivo before fixing the brain whereas Nag et al. 
(1982) first perfused the brain with an aldehyde solution and then with a lanthanum 
solution. The use in vivo has to be questioned since it is toxic (Milhorat et al., 1975), 
whereas the relevance of experiments in fixed tissue to in vivo penetration may be 
limited because it is not known whether channels and pores remain intact in the process 
of fixation. 
Another way to study the permeability of the blood vessel wall is by measurements of 
electrical resistance over the endothelium. An electrode inside the vessel produces a 
small current and the fall in voltage with distance to the current source is partially 
affected by the leakage of ions through the vessel wall (indirect measurement of ionic 
permeability). Studies with electrical resistance in blood vessels have revealed that the 
brain capillaries have the highest resistance recorded for any endothelium. For example, 
transmembrane resistance of 2000 f2cm 2 in capillaries on the surface of the brain in 
frogs compared to 20-30 Ocm2 in skeletal muscle endothelium (Crone and Olesen, 
1982; Crone, 1984). Because of technical problems, however, measurements have so far 
only been made in the pial vessels which are accessible from the outside of the brain. It 
is still debatable if these vessels are a good representative of the vessels found deeper 
inside the cortex (for review see Allt and Lawrenson, 1997). In addition to restricted 
paracellular pathways, the endothelial cells in the nervous tissue also have low 
pinocytotic activity (Brightman and Reese, 1969; Sedlakova et al., 1999). 
II. The blood-CSF barrier 
This barrier is situated between the blood vessels of the choroid plexus and the CSF. 
Choroid plexus tissue is found in the roof of each of the ventricles as an invagination of 
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the ventricular ependyma forming lobulated structures and is believed to be the main 
producer of CSF (Johanson, 1988). Unlike blood vessels in other parts of the brain, 
choroidal vessels seem to lack the continuous membrane-membrane fusion found in 
cerebral endothelial tight-junctions (van Deurs, 1979). The choroid plexus is one of the 
circumventricular organs (discussed later) and shows similar fenestrated vessels, i.e. the 
capillary membrane appears to be reduced at certain points and this characteristic has 
been associated with higher permeability (Peters et al., 1991) (see Figure 5.6). The 
vessels are surrounded by connective tissue and leptomeningeal cells that have loose, 
discontinuous tight-junctions which are believed not to have a significant barrier 
function (van Deurs, 1979). This has been confirmed with tracer molecules that easily 
diffuse past the cells to reach the basement membrane of the choroidal epithelial cells 
(cytochrome c study by Milhorat et al., 1975; HRP study by Becker et al., 1967 and 
Brightman, 1968; MP study by van Deurs, 1978). HRP and MP seem to cross the 
endothelium of the choroid plexus by both interendothelial passage and pinocytosis but 
which process is the more important is not known. Outside the blood vessels in the 
choroid plexus is a layer of connective tissue and overlaying this is a layer of epithelial 
cells resting on a basement membrane (see Figures 5.3-5.6). At the apical (CSF) side the 
epithelial cells are fused together to form zonulae occludentes thereby minimising the 
paracellular pathway (Brightman and Reese, 1969; Dermietzel and Schunke, 1975). The 
transitional ependymal cells in the borderline between choroidal epithelia and the 
ventricular ependyma also seem to possess tight-junctions at their apical side (Krisch, 
1986). It is these tight-junctions between epithelial cells that are believed to form the 
ultrastnictural basis of the blood-CSF barrier. This has been confirmed by tracer studies 
using HRP (Becker et al., 1967; Becker and Almazon, 1968; Brightman and Reese, 
1969; Krisch, 1986), MP (van Deurs, 1978) and cytochrome c (Milhorat et al., 1973; 
Milhorat et al., 1975). After administration into the blood, the tracers leaked out of the 
choroid plexus blood vessels into the interepithelial cleft, but the intercellular 
movement of tracers was stopped at the apical tight-junctions. The much smaller 
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lanthanum has been reported to be able to cross the epithelial tight-junctions of choroid 
plexus of rats and cats (Castel et al., 1974; Bouldin and Krigman, 1975). This would 
indicate that the tight-junctions in the choroidal epithelium are 'leakier' than those of 
the cerebral endothelium, which have been shown to be impermeable to lanthanum 
(Brightman and Reese, 1969; Bouldin and Krigman, 1975). However, as has been 
discussed above the suitability of lanthanum as an in vivo tracer has to be questioned 
since it is toxic. 
Most of the transcellular transport across the epithelial cells is believed to be from the 
basal to apical direction, by pinocytosis in vesicles and multivesicular bodies. This 
transport seems to be lower in the choroid plexus epithelial cells compared to other 
epithelia of the body (van Deurs et al., 1978; Peters et al., 1991). 
III. CSF-brain barrier 
Krogh (1946) proposed that the composition of the brain extracellular fluid (ECF) in the 
adult resembles very closely that of the CSF, the implication being that they are in open 
communication with each other. It is generally known that polysaccharides and proteins 
present in the CSF readily penetrate into the ECF (Johanson, 1993). The ventricles are 
lined with a single layer of ependymal cells, which lack tight-junctions and are joined to 
each other by gap-junctions (see Figure 1.1). Gap-junctions are believed not to serve as 
excluding structures but to form channels for exchange between adjacent cells. 
Hydrostatic and osmotic forces therefore determine the net flow of solutes between the 
CSF and brain ECF, and this interface is unlikely to pose a significant barrier in the 
adult (Johanson, 1993). Similarly to the ventricular ependyma, the outer pial surface of 
the adult brain does not seem to constitute an impediment for macromolecules to diffuse 
between the CSF of the subarachnoid space and brain tissue (Saunders et al., 1999a). 
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1111. The meningeal barrier 
The outer lining of the brain and the subarachnoid space are the least studied of the 
blood-brain interfaces despite the fact that they constitute a major interface between 
blood, CSF, and brain (Bohr and Merllgard, 1974). This interface can be considered as 
part of the blood-CSF barrier but because of its anatomical segregation it is normally 
regarded as a separate barrier. In this thesis the name meningeal barrier will be used but 
it is sometimes referred to as the outer blood-CSF barrier. The meninges consist of an 
outer thick dura, the arachnoid, and the pia mater that surrounds the whole CNS 
(Johanson, 1998). Because it is sometimes difficult to structurally distinguish between 
the pia and arachnoid, they are collectively known as the leptomeninges (Peters et al., 
1991). In between the arachnoid and the pia is the subarachnoid space, which is filled 
with CSF, collagen, and many blood vessels. In an adult human the subarachnoid space 
holds about 60% of the total CSF volume (Johanson, 1995). This is also where the 
arachnoid villi are situated which allow CSF to pass back into the blood of the venous 
sinuses by bulk flow. Some of the blood vessels in the dura are fenestrated, and cells at 
the inner surface of the dura facing the subdural space seem to lack tight-junctions and 
have been shown to be leaky to HRP; thus the dura is not believed to constitute a 
significant barrier (Nabeshima et al., 1975; Krisch et al., 1984; Balin et al., 1986). 
Instead, the outer layer of the arachnoid consists of leptomeningeal cells, which have 
tight-junctions in between them (Dermietzel, 1975b; Rascher and Wolburg, 1997). A 
barrier at this level would isolate the CSF in the subarachnoid space from the outer 
blood circulation. Studies with HRP have shown that this is stopped at the outer surface 
of the arachnoid, which is where the arachnoid cells are linked by tight-junctions 
(Nabeshima et al., 1975; Balin et al., 1986). However, Balin et al. (1986) reported 
species differences. Blood borne HRP was stopped at the arachnoid in rat and monkey, 
but could enter the subarachnoid space in mouse. Some authors have also shown that 
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there are species-dependent characteristics of the meninges including the presumed 
barrier layer of the arachnoid. Angelov and Vasilev (1988) reported that the electron 
dense band between the dura and the arachnoid membrane is less prominent in the cat 
compared to other species and also only observed occasional tight-junctions in the 
presumed barrier layer of the outer arachnoid. Further studies by Angelov (1990a) 
compared the structure of the dura-arachnoid layers in rats, rabbits, cats and humans. 
The author could not give a general description of the tissues because of the 
heterogeneity between the different species. For instance, in the rat the dura-arachnoid 
membranes comprised of four distinct layers whereas in the cat and especially in 
humans these layers were difficult to differentiate. The arachnoid itself seems to lack 
blood vessels but in the reticular tissue of the subarachnoid space there are numerous 
vessels which have endothelial cells fused together by tight-junctions (Nabeshima et al., 
1975). This constitutes an endothelial blood-CSF barrier. The blood vessels at the pial 
surface of the brain are also known to have tight-junctions and have been extensively 
used as an accessible place to study brain blood vessels in vivo (Crone and Olesen, 
1982; Butt et al., 1990). The meningeal barrier has also been shown to be impermeable 
to MP but possible transport systems have not been studied (Cserr and Bundegaard, 
1984). 
Barriers in the developing brain 
It was noted early on that the CSF in the developing brain had a higher concentration of 
protein than in the adult (Flexner, 1938). This was first interpreted as a simple reflection 
of less developed barriers, however, as the development of the brain barriers has been 
studied in more detail, a somewhat different picture has emerged (Johanson, 1989; 
Saunders, 1992). Instead of being immature it seems that the developing CNS, with its 
own requirement for growth, maintains a different environment from that of the adult 
CNS. Rather than being immature the barriers seem to be specialised during 
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development, including additional barriers, not present in the adult (Fossan et al., 1985). 
Since tight-junctions have been found to be the structural basis for the brain barriers, 
most studies have focused on the development of these in order to find correlations 
between changes in structure and permeability during development. When the literature 
is scrutinised it becomes apparent that most studies have not been successful in 
correlating changes in morphology with changes in permeability of the brain barriers 
during development. In addition there are contradictory results in defining the 
functional onset of the different brain barriers. Possible explanations for these 
contradictions are discussed below. 
I. The blood-brain barrier 
The origin of cerebral vessels in the developing brain is from the perineural plexus. This 
consists of fenestrated vessels that form a network around the outer surface of the entire 
neural tube and which sends long sprouts with abundant branches down to the 
ventricular zone of the neuroectoderm. It has been shown in the mouse that at around 
embryonic (E) day 10, these vessels lose their fenestrations and also that zonulae 
occludentes-like junctions appear between the endothelial cells (Bauer et al., 1993). In 
the rat, intraneural vessels have been reported to lose their fenestrations at around E 12- 
E13 but the perineural vessels retain their fenestrations longer until around E17 (Stewart 
and Hayakawa, 1994). Another study in the same species found fenestrated 
intraparenchymal vessels as late as E17 (Yoshida et al., 1988). During growth of the 
CNS, the cerebral blood vessels undergo several other characteristic changes. There is 
an increase in the density of brain capillaries (Caley and Maxwell, 1970; Stewart and 
Hayakawa, 1987), a decrease in the thickness of the endothelial wall (Stewart and 
Hayakawa, 1987; Simionescu et al., 1988), changes in the tight-junctional structure 
(Schulze and Firth, 1992; Stewart and Hayakawa, 1994; Kniesel et al., 1996) and a 
decrease in pinocytotic activity (Bauer et al., 1993; Xu and Ling, 1994), however, other 
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studies have shown low pinocytotic activity even in early development (Stewart and 
Hayakawa, 1987). The induction of brain vessels to form barrier characteristics early in 
development appears to come from the surrounding nervous tissue. This was shown by 
Stewart and Wiley (1981) who transplanted avascularised embryonic quail tissue into 
embryonic chicks. When brain tissue was transplanted into the coelomic cavity this 
promoted barrier distinctiveness in the invading host vessels. In contrast, when somites 
where grafted into the embryonic chick brain ventricle, the invading cells seemed to 
lack barrier characteristics. What the molecular signals are that stimulate the vessels 
invading CNS tissue to develop barrier characteristics is still not clear (Risau et al., 
1998). 
Some of the first studies of the immature CNS claimed that the tight-junctions in the 
cerebral endothelium were incomplete compared to the adult and this was thought to be 
the reason for dyes staining the brain (for references see Saunders, 1992). Improved 
fixation techniques for fetal tissue have, however, produced evidence contrary to this 
view and demonstrated complex tight-junctions present between the endothelial cells at 
early stages of brain development (Mollgard and Saunders, 1975; Xu and Ling, 1994). 
MollgArd and Saunders (1975) reported a high complexity of the endothelial tight-
junctions in human (10-13 weeks old) and sheep fetuses (E125) using freeze-fracture 
techniques. Xu and Ling (1994) found that in 1-day old rats the cerebral endothelial 
cells already exhibited tight-junctions with several contact points. There have been 
several other more recent studies on the structural development of junctions of brain 
endothelium in the rat. Schulze and Firth (1992) studied cerebral tight-junctions in thin-
sections using the goniometric tilting device and found changes in the 'narrow zone' 
(close contact between the cell membranes) relative to the entire length of the tight-
junction between developing and adult cortical vessels of rats. Embryos and postnatal 
rats showed high variability in this ratio and also prominent membrane separation 
whereas the adult tight-junctions appeared more uniform in structure. At various ages 
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between E 17 and postnatal (P) day 16, however, there was little systematic change in 
these features of the tight-junctions. Stewart and Hayakawa (1994) also studied 
developmental changes in cerebral endothelial tight-junctions using transmission 
electron microscopy and found no differences in either the length of the tight-junctions 
or the cleft index (proportion of unfused cell membrane) between embryos and adults. 
However, they did find a decrease in the proportion of junctions with expanded cleft 
with age. The authors suggested that these larger clefts might be the ultrastructural basis 
for the apparently more permeable vessels in embryos. Kniesel et al. (1996) made a 
freeze-fraction study of cerebral vessels in rats from E 13 to adulthood. They reported an 
increase in the complexity of the tight-junction network between E13 to P1, with the 
most significant increase between E18 and Pl, but found no further changes after birth. 
This finding did correlate well with changes in the transendothelial resistance in 
developing rat pial vessels during development (Butt et al., 1990). At P17 the pial 
vessels resistance was around 310 Ocm2 , which increased dramatically to 1130 C/cm 2at 
P21, but increased little further after birth (1490 Qcm2 at P28-P33). Butt et al. (1990) 
also studied the penetration of lanthanum in the pial vessels and found that these vessels 
appeared impermeable to the small particle lanthanum in vivo even in fetal animals. The 
observation that the tight-junctions stop the paracellular penetration of lanthanum in pial 
blood vessels at early stages of development was later also shown for vessels in the 
corpus callosum (Xu and Ling, 1994). Xu and Ling (1994) also investigated the transfer 
of ferritin, a large protein tracer (molecular weight 900 000 Da), in blood vessels of the 
corpus callosum and found that it was transported in vesicles at earlier stages of 
development (P1 and P7), but one week later (P14) this transfer mechanism could not 
be detected. The authors suggested that the main route by which exogenous material is 
transported across the cerebral endothelium is by trancytosis in pinocytotic vesicles, and 
that a reduction in this activity is responsible for the decrease in vessel permeability 
with age. There have also been morphological studies of endothelial tight-junctions 
combined with HRP experiments in mice (Stewart and Hayakawa, 1987) and chicks 
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(Delorme et al., 1970; Wakai and Hirokawa, 1978) during development. Stewart and 
Hayakawa (1987) reported a parallel decrease in the tight-junction index and 
permeability of HRP in mouse embryos, and suggested a "tightening" of the 
paracellular route is responsible for the decrease in permeability with age. However, the 
largest drop in permeability index occurred between EIS and P10 when there was little 
change in the tight-junctional cleft index. Moreover, when HRP was visualised under 
the electron microscope, they could find no evidence of a paracellular route even at the 
earliest age studied. Delorme et al. (1970) found that there was free passage of HRP out 
of the telencephalatic vessels up to E 10 in the chick but later in development the 
paracellular route for HRP seemed to be blocked as a result of the formation of tight-
junctions of mature appearance. This is somewhat in disagreement with a later study by 
Wakai and Hirokawa (1978) which reported that the blood-brain barrier to HRP is not 
fully developed until E15 in the chick. As pointed out by Wakai and Hirokawa (1978) 
the discrepancy between these two studies may be due to the differences in the amount 
of HRP injected. As will be discussed below, the study of Wakai and Hirokawa (1978) 
has to be questioned in relation to the rather high quantity of HRP that was injected into 
the chick embryos. It is not clear from the description by Delorme et al. (1970) what 
quantity and volumes were injected into the embryos. 
The two most popular explanations for the higher permeability across the developing 
brain endothelium have been a higher paracellular permeability or an augmented 
vesicular transport across these cells in development. Mollgard and Saunders (1975) 
suggested an alternative explanation in that the higher transfer of proteins during 
development could be due to transport in the endoplasmic reticulum of endothelial cells 
but did not further investigate these structures. As discussed later a similar transporting 
system has also been suggested to be developmentally regulated at the blood-CSF 
barrier interface. Lossinsky et al. (1986) found that both HRP and ferritin were stopped 
by the endothelial tight-junctions, but were found in tubulo-canalicular structures inside 
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the endothelial cells in neonatal mice. This transporting system was not found in adult 
mice suggesting that transport in these structures during development could be 
responsible for the apparent higher permeability of developing brain vessels. 
II. The blood-CSF barrier 
The blood-CSF barrier in the developing brain has probably been characterised better 
than any other of the blood-CNS interfaces. A primitive ventricular system is first 
formed when the neural tube is closed and fluid is trapped within the central canal. 
Interestingly this closure is associated with a subsequent increase in the intraventricular 
fluid pressure and coincides with an onset of brain enlargement. That the ventricular 
system might provide an essential driving force for normal brain expansion and 
morphogenesis was demonstrated by Desmond and Jacobson (1977) and Desmond 
(1985). These two studies showed that intubation of the embryonic ventricular system 
in the chick, that lowers the CSF pressure, resulted in less tissue volume in all parts of 
the CNS and only about 50% of the normal cell number in the brain. That the pressure 
and composition of the ventricular fluid is important for brain development raises 
interesting questions about developmentally regulated changes at both the blood-CSF 
barrier and the CSF-brain barrier, since these two barriers control the composition of 
this fluid. At the time of neural tube closure, the choroid plexus has not yet formed, so a 
blood-CSF barrier as such does not exist. Some other tissue presumably forms the fluid 
inside the expanding ventricular system, and this is believed to be the neural tissue itself 
(Catala, 1998). The choroidal epithelial cells arise from the neural tube whereas the 
more central structures of the choroid plexus form from the paraxial mesenchyme 
(Wilting and Christ, 1989). The different choroid plexuses appear in the order of 4th, 
lateral, and last the 3rd ventricular plexus in all mammalian species studied (Catala, 
1998). The 4th ventricular plexus appears at E13 in both rat and mouse, at E5-6 in 
chick, at E24 in sheep, and during week 7 in humans (Catala, 1998), so this is the first 
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time a proper blood-CSF barrier can be considered. An important point to note is that 
the choroid plexus is much larger relative to brain tissue in the developing than in the 
adult animal (Johanson, 1995). Therefore it is possible that the choroid plexus plays an 
important role in providing nutrition for the brain during development (Johanson, 
1999). 
Junctions between the epithelial cells of the choroid plexus, that resemble the zonulae 
occludentes in the brain endothelium, have been shown to be present very early during 
development in mice (Zaki, 1981), rats (Dermietzel et al., 1977), sheep (Mollgard and 
Saunders, 1975; Mollgard et al., 1979), rabbits (Tennyson and Appas, 1968), humans 
(Tennyson and Appas, 1968; Bohr and 1■40llgard, 1974), and chicks (Delorme, 1972 as 
cited by Mollgard and Saunders, 1986). Changes in epithelial tight-junction complexity 
during development have been studied in the rat by Tauc et al. (1984). They showed 
that as early as E 14 the junctions are structurally similar to those in the mature animal 
forming continuous belts around the epithelial cells. This study also investigated the 
localisation of HRP in the choroid plexus after intravenous injections. Similar to the 
adult choroidal vasculature, HRP easily leaked out of the vessels to reach the basolateral 
membrane of the epithelial cells and into the intercellular space but appeared to be 
stopped at the apical tight-junctions as early as E14. A similar study by Lu et al. (1993) 
showed that the tight-junctions of 1-day old rats impeded the intercellular flow of HRP 
and suggested that the transcellular route for HRP was in vesicles at this age. However, 
since only 1-day old rats were studied, no comparisons could be made with other 
developmental ages. Freeze-fracture studies on sheep embryos have shown that 
complex tight-junctions are present as early as the E30 (Mollgard and Saunders, 1975) 
and that the minimum number of strands and junctional depth of the tight-junctions only 
changed to a minor extent between E40 and E125 (Mollgard et al., 1976). Further 
studies in sheep fetuses by Mollgard et al. (1979) using an improved freeze-fracture 
technique also found no evidence for discontinuous strands or a change in the 
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proportion of complex strands between E30 and E125 (sheep are born around E150). 
The blood-CSF barrier of the chick has also been extensively studied during 
development. Wakai and Hirokawa (1981) reported that a proper functional barrier to 
HRP is established at E10. This study showed that HRP injected intravenously 
penetrated the tight-junctions of the choroidal epithelial cells freely until E8, was 
blocked by most junctions at E9, but was never found to penetrate the junctions at E10. 
Furthermore, HRP was never found to be transported in vesicles from blood into the 
CSF. A similar study by Bertossi et al. (1988) showed comparable results except that 
the timing of the apparent junction tightening was slightly later. At ER) HRP appeared 
to be stopped by most of the tight-junctions but a few still seemed to be leaky and at 
EIS HRP never penetrated the junctions. This study also found little vesicular transport 
of HRP in the blood-CSF direction, but after an intraventricular injection, HRP was 
taken up in vesicles and was actively endocytosed and degraded in the epithelial cells. 
They concluded that at EIS the barrier to protein is functionally and structurally very 
similar to the adult. As described below in more detail, the studies by Wakai and 
Hirokawa (1981) and Bertossi, et al. (1988) claiming a poorly developed barrier early in 
development can be questioned in regard to the physiological state of embryos as a 
result of the large volumes and high concentrations of solutions that were injected. 
The concentration of proteins in CSF reaches a peak early in development, thereafter it 
gradually decreases with age (Saunders and Dziegielewska, 1997). This generally 
occurs during fetal development in eutherian mammals reaching a total protein 
concentration that is 10-20 times the adult level. This has been interpreted by some 
(Adinolfi, 1985) as a reflection of immature barriers, but with further studies it has 
become clear that this is probably not the case (Dziegielewska et al., 1991; Habgood et 
al., 1992). If the reduced permeability of proteins with age were a reflection of tight-
junction development between the epithelial cells, the structure of the tight-junctions 
would be expected to change. The reported minor changes in tight-junction complexity 
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during development (Mollgard et al., 1976) are unlikely to account for the dramatic 
changes in permeability of proteins that have been reported (Dziegielewska et al., 
1980). When endogenous albumin, exogenous albumin from other species, and 
chemically modified derivates of albumin were injected into sheep fetuses, native 
protein reached the highest concentrations in the CSF. Similar studies in neonatal rats 
(Habgood et al., 1992) and opossums (Knott et al., 1997) found similar results. Thus a 
possible transporting system seemed to be able to distinguish between different kinds of 
albumin. It was also found that the greatest number of choroidal epithelial cells 
containing albumin coincided with the peak in CSF protein concentration in opossums 
(Knott et al., 1997). The authors suggested that the route for albumin is intracellular 
through the epithelial cells of the choroid plexus in a process that can distinguish 
between native and modified albumins. This selective transporting mechanism seems to 
only be present during early development since in the more mature brain there was no 
difference in the penetration between different species of albumin (Knott et al., 1997). 
Mollgard and Saunders (1977) investigated the tubulo-cisternal endoplasmic reticulum 
(TER) in the immature choroidal epithelial cells in sheep and found that this system had 
close contact with the cell membrane both at the basolateral and apical sides. In 
contrast, later in development the TER was separated from the cell membrane and the 
authors suggested the TER could constitute a transcellular pathway between blood and 
CSF for larger molecules such as albumin during early development. Later Balslev et al. 
(1997b) showed using EM immunocytochemistry that albumin can be found in the TER 
of the immature choroid plexus in sheep after administering it into the blood. They 
found no albumin passing the interepithelial cleft and proposed that the TER is the main 
route of transfer for albumin from blood into CSF in the immature animal. 
- 21 - 
Chapter 1: General Introduction 
III. The CSF-brain barrier 
Brightman and Reese (1969) showed that in adult animals, solutes such as HRP diffuse 
unhindered from the CSF into the extracellular fluid (ECF) of the brain. However, when 
Fossan et al. (1985) perfused HRP through the fetal sheep ventricles at E60 it did not 
penetrate into the brain but did so later in fetal development at E125. This restricted 
entry into the brain at early stages of development was suggested to be accounted for by 
novel type of junctions found between cells in the neuroependyma of the ventricular 
zone (Mollgard et al., 1987). These single strand junctions differed in their freeze-
fracture appearance from tight-junctions in that they produced wider ridges and E-face 
grooves filled with particles, and were orientated perpendicular to the CSF surface 
rather than in a circumferential belt. These junctions were believed to be an 
uncharacterised type of junction and not simply precursors of gap-junctions, and were 
named strap-junctions. These strap-junctions were only present in early stages of sheep 
brain development (eg. E20-E60), and later, as the neuroependyma is replaced by an 
ependyma with adult characteristics, the cells are connected with gap-junctions 
exhibiting the normal 20 nm intercellular cleft. This novel barrier was postulated by the 
authors to contribute to creating a high osmotic pressure gradient between the CSF 
(containing a high protein concentration) and the ECF of the brain (containing a low 
protein concentration). The physiological importance of this barrier has therefore been 
hypothesised to provide an essential force for normal brain growth and development 
(Mollgard et al., 1987). A similar CSF-brain barrier has been reported in the 
neuroependyma of a developing marsupial species, the Australian tamar wallaby 
(Dziegielewska et al., 1988). Ultrastructurally the neuroependymal cells had the same 
strap-junctions in between them as reported for sheep (Mollgard et al., 1987). When 
HRP was administered intravenously into the developing wallaby, it was found in the 
CSF but the strap-junctions in the neuroependyma appeared to stop HRP from 
penetrating from the CSF into the extra cellular fluid (ECF) of the brain. The 
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neuroependyma was not studied in later stages of development in the wallaby so 
whether the strap-junctions disappear later in development, similar to the sheep, is not 
known. 
Similarly to the interior barrier between CSF and brain, Fossan et al. (1985) found that 
the outer pial surface of the brain was less permeable to HRP in fetal sheep at E60 than 
later in gestation (E 125). This interface has also has also been shown to be impermeable 
to endogenous albumin at E60 in sheep (Balslev et al., 1997a). Fetal rats have been 
shown to have complex junctions (non tight-junctional type) between the glial end feet 
from around E14 and these were suggested to be a supplementary barrier for 
macromolecules between the subarachnoid space and the ECF of brain in early 
development (Balslev et al., 1997b). These junctions might be precursors of gap 
junctions, which in their fetal form exclude proteins from the ECF. 
IV. The meningeal barrier 
The origin of the mammalian meninges is still not clear. This is because dye and marker 
studies carried out in order to follow the destiny of specific cells has in mammals 
proven complicated, since the tissue is formed by several embryonic layers. However, 
the early differentiation of this tissue has been examined in birds and amphibians. In 
amphibians the dura has mostly a mesodermal origin whereas the leptomeninges are 
formed from the neural crest. In the chick, the spinal meninges have a mesodermal 
origin but the cephalic meninges seem to have a more complex origin in birds (Catala, 
1998). It is uncertain, however, if the composite structure of the mammalian meninges 
is similar to that of amphibians and birds (Catala, 1998), and they have been suggested 
to have both neuroectodermal and extra-neural origins (Weston, 1970; Angelov and 
Vasilev, 1989). 
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Balslev et al. (1997b) showed that the blood vessels in the pia and subarachnoid space 
are fenestrated early in development of the rat (E 12) but soon become non-fenestrated 
vessels exhibiting tight-junctions between endothelial cells (E14-E16). This observation 
is contradictory to a study by Stewart and Hayakawa (1994) who reported that pial 
vessels are fenestrated as late as E 17 in the rat. Only one study seems that have 
investigated the tight-junctions in the outer arachnoid membrane, that are thought to 
make up the external barrier to the CSF in the subarachnoid space, during development. 
Rascher and Wolburg (1997) quantitated the changes in the complexity of the tight-
junctional network between the arachnoid cells in rats and chickens during development 
using freeze-fracture techniques. The complexity index was calculated as the total 
length of the tight-junctional strand divided by the total number of branching points. 
They found a successive increase in arachnoid tight-junction complexity between El0 
and adulthood in chicks, whereas the complexity index decreased slightly between P2 
and adulthood in the rat. In the adults, the complexity index was approximately double 
in the chicks compared to that of the rat. However, as pointed out by the authors, there 
is a lack of permeability studies of this specific barrier during development, so 
structural changes cannot be compared with permeability studies in order to deduce 
whether they are of significance for the functional development of this barrier. 
Structural aspects of the brain barriers in comparison to permeability 
of lipid insoluble molecules during development 
Even though the exact timing of the maturation of the brain barriers is somewhat 
unclear, the structural basis for these barriers seems to be well established by birth in all 
eutherian mammals studied. In mouse and sheep, the first blood vessels that invade the 
brain seem to possess structural and functional barrier characteristics (Mollgard and 
Saunders, 1975; Bauer et al., 1993; Xu and Ling, 1994; Bauer et al., 1995). In the sheep, 
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the junctional morphology can be compared with proper quantitative permeability 
studies for a range of differently sized lipid insoluble markers. The steady-state 
concentrations of various lipid insoluble molecules have been shown to significantly 
decrease during development in sheep fetuses (Evans et al., 1974; Dziegielewska et al., 
1979). These studies showed that between the E60 and the E125 the steady-state 
CSF/plasma concentration for sucrose and inulin fell from 23% to 7% and 11% to 3%, 
respectively. As pointed out by the authors, this reduction in steady-state ratios could be 
explained by other factors than a decrease in barrier permeability, such as an increase in 
the CSF turnover. The continuous production of CSF flushes out solutes in the CSF and 
hinders them from equilibrating with the concentration in the blood; this effect has been 
named the CSF sink (Oldendorf and Davson, 1967; Davson and Segal, 1969) and an 
increase in CSF sink could account for the age-related decline in steady-state ratios. 
Evans et al. (1974) reported a large increase in the CSF secretion rate between E60 and 
adulthood in the sheep (2.8 to 118 pl/min). However, when the secretion rate is related 
to the total CSF volume (which also increases during development) and is calculated as 
a turnover rate of CSF per minute, this only increased from 0.62% at the E60 to 0.83% 
in the adult. Furthermore, by dividing the CSF turnover rate by the brain mass at each 
age, the CSF sink for the brain was estimated; this was shown to significantly decrease 
during development from 0.32% at E60 to 0.01% min' g l brain weight in the adult 
sheep. Evans (1974) therefore proposed that it seems unlikely that the decreases in 
steady-state ratios can be explained by an increase in CSF sink, but rather by a decrease 
in the intrinsic permeability of the brain barriers. Structural investigations of the fetal 
tight-junctions of both endothelial and epithelial cells have reported that they closely 
resemble those of the mature sheep (Mollgard and Saunders, 1975; Mollgard et al., 
1979). It therefore seems that there is a significant decrease in barrier permeability long 
after mature tight-junctions are present. Changes in permeability of lipid insoluble 
molecules have not been studied in the mouse so similar comparisons cannot be made. 
In the rat, the exact onset of the structural characteristics for the brain barriers is still 
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disputed, however, nearly all studies show that the barriers are structurally mature at 
birth (Kniesel et al., 1996). However, the steady-state concentration of small lipid 
insoluble molecules have been shown to decrease significantly after birth (Ferguson and 
Woodbury, 1969; Habgood et al., 1993) when the structure of the tight-junction has 
been reported to be indistinguishable from the adult rat (Kniesel et al., 1996). Ferguson 
and Woodbury (1969) explained the falling ratios with age by an increase in the CSF 
sink, but did not present experimental evidence for this statement. The CSF turnover 
rate in rats as summarised by Saunders (1992) showed that this remained rather stable 
between P3 and P21-P23, and that the sink effect on the brain decreased over the same 
developmental time. Furthermore, Habgood et al. (1993) argued that if there was an 
increase in CSF sink with age this would reduce the time to approach steady-state. 
However, since this did not change between P2 and adulthood this was ruled out as an 
explanation for the age related decrease in ratios. It therefore seems that the 
permeability changes to small lipid insoluble molecules during development in sheep 
and rats is not a reflection of either maturation of the tight-junctions or an increase in 
CSF sink, but by other factors that are still to be identified. 
Difficulties in correlating barrier morphology with its function during 
development 
Possible explanations for the difficulty of correlating physiological permeability of inert 
lipid insoluble molecules (or the penetration of tracers) with structural studies of the 
barriers during development are discussed below. There is an obvious lack of good 
quantitative physiological studies of barrier permeability during development. In rats 
(Ferguson and Woodbury, 1969; Habgood et al., 1993) and sheep (Dziegielewska et al., 
1979) the permeability to various sized lipid insoluble markers has been extensively 
investigated. However, these types of studies are lacking in other species such as the 
mouse and chick in which the ultrastructure of the barriers have been studied 
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comprehensively (Doolin and Birge, 1969; Zalci, 1981; Stewart and Hayakawa, 1987; 
Bauer et al., 1993; Rascher and Wolburg, 1997). In these species, the permeability has 
only been studied by histological visualisation of some proteins, including HRP, in 
brain tissue (Delorme et al., 1970; Wakai and Hirokawa, 1978; Lossinsky et al., 1986; 
Roncali et al., 1986; Stewart and Hayakawa, 1987; Bertossi et al., 1988). The lack of 
physiological permeability studies in several species has lead to the confusion in the 
field such that comparisons have been made across species, but it is uncertain if those 
kind of comparisons are appropriate. Added confusion has also been brought about by 
the fact that birth is not a comparative developmental stage across species but 
appropriate comparisons have to be based on knowledge about general and specific 
stages of brain development (Stonestreet et al., 1996). 
Ultrastructural studies of cells at the barrier interfaces can only examine a very small 
proportion of all the cells even though a large amount of work is undertaken. This is 
especially true for thin-section electron microscopy, whereas freeze-fracture studies can 
examine much larger areas of tissue at one time. Freeze-fracture is the only practical 
way to establish that tight-junctions are continuous all around the cell or if they have 
gaps at certain points. Just to follow one junction in serial thin-sections around the cell 
would involve an enormous amount of sectioning and examination. This has lead to the 
problem that ultrastructural studies of the endothelium have only been carried out in 
certain parts of the brain, or studies have focused on the endothelium from a particular 
type of blood vessel. However, when a permeability marker is injected into the blood, 
the brain barrier permeability determined will be related to the permeability of all blood 
vessels in the brain. The problem is to know whether the blood vessels that have been 
examined ultrastructurally are representative for all vessels. Because of technical 
problems it has sometimes only been possible to study vessels that are easy to access, 
such as the pial vessels on the surface of the brain. 
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When the ultrastructure of tissue is studied from different developmental ages, the 
choice of fixation technique can also affect the outcome. Most studies have tended to 
use the same fixation techniques for all ages, but this is not always appropriate since it 
does not give satisfactory preservation of tissue. For instance, most fetal tissue is small 
and fragile and it is therefore not always possible to fix by perfusion, whereas adult 
tissue often requires perfusion fixation in order to preserve tissue adequately. Fixation is 
an important consideration because it can affect cell volumes and thus the appearance of 
cell junctions. Another aspect of studies with fetal animals is that extra care has to be 
taken in order to minimise physiological interference during experiments. This is 
especially important when markers are injected systemically or intraventricularly. If the 
volume injected is not carefully considered in relation to the volume of the compartment 
that it is injected into, this can have disastrous effects on the fetus. Equally important is 
to consider the changes in osmotic balance that the injection solution might produce in 
the fetus. As pointed out by Saunders (1992) several developmental studies have 
injected HRP in such high concentrations that it would have increased the total protein 
concentration in the blood by up to 2-3 times. For example, Wakai and Hirokawa (1978, 
1981) injected HRP intravenously into chick embryos in a concentration of about 50-
100 mg/ml. The injection volume was one tenth of the total blood volume, which would 
have resulted in approximately doubling the protein concentration in the blood. Other 
examples are the studies by Roncali et al. (1986) and Bertossi et al. (1988) in which 
HRP was injected intracardially into chick embryos aged between El° and E21 in a 
concentration of 0.3 mg per gram body weight in 0.1-0.3 ml saline solutions. A chick 
embryo at E 10 weighs approximately 2 grams (based on weights given by Davis and 
Garrison, 1968 for a chick embryo at Hamburger and Hamilton stage 36) and can 
therefore be expected to have a blood volume of about 0.2 ml. Such an injection would 
increase the systemic volume by about 50% and the protein concentration by about 30% 
in an embryo at E 10 (plasma protein concentration is 7.1 mg/ml at El0 as reported by 
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Birge et al. (1974). Furthermore, in the same study HRP was also injected 
intraventricularly in the same concentration but in a slightly smaller volume (0.05-0.1 
m1). To the author's knowledge nobody has estimated the CSF volume in a 10-day old 
chick but it can be expected to be only a fraction of the total blood volume. It is 
therefore difficult to imagine that the brain barriers could remain intact after adding 
such a large volume of fluid into the ventricular system. Yet another example is the 
study by Angelov (1990b) in which 1 and 10 mg of HRP were injected into the 
arachnoid space of adult rats and cats, respectively. This amount can be estimated to be 
10 times the total protein content in the CSF and would thus have significantly changed 
the osmotic balance in the brain. 
The permeability of the brain barriers has been extensively studied by the penetration of 
markers which can be visualised in tissue after fixation. The ideal marker should be 
physiologically inert, homogenous in particle size and structure, immobilised in its real 
position by fixation, and directly or indirectly capable of being visualised at low 
concentrations in the electron microscope. It would also be very useful if it were 
available in different molecular sizes and easy to quantify. The first tracer used for 
electron microscopy was horseradish peroxidase (HRP, mw 40 000), and it is still 
widely used as a marker for barrier integrity. However, it is not known if it is a good 
representative of other large lipid insoluble molecules such as plasma proteins. It is also 
a disadvantage that it is an enzymatic reaction product that is electron dense enough to 
be visualised under the electron microscope rather than the actual protein. Thus there 
are likely to be problems of interpretation due to diffusion of the reaction product. Other 
larger tracers suitable for electron microscopy such as ferritin (mw 900 000) and 
cytochrome c (mw 12 000) have been used but there has been a lack of low molecular 
weight tracers. Lanthanum, a very small electron dense particle, has been used in fixed 
tissue, but because of toxicity it is not suitable in vivo. Small heme-peptides, called 
microperoxidases, were introduced in the early 1970's (Feder, 1971), but they were later 
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found to bind to plasma proteins. The use of low molecular markers is essential when 
investigating small intercellular channels or cellular compartments. With the recent 
introduction of several smaller lipid insoluble tracers (such as the biotin-dextrans), the 
in vivo penetration of such molecules can be investigated in order to find out the route 
of transfer that molecules take across the brain barriers and how this compares to that of 
larger molecules. 
Studies that have tried to find correlations between morphology and physiology have 
concentrated on the ultrastructure of the paracellular route, namely the tight-junctions, 
as the structural determinant of barrier permeability. Claude and Goodenough (1973) 
correlated the transepithelial resistance of epithelia from different parts of the body of 
various species with the tight-junctional morphology. High resistance epithelia, such as 
the urinary bladder, showed high strand numbers and junctional depth whereas low 
resistance epithelia, such as the proximal tubule, had few strands and had little 
junctional depth. From this study it therefore appears that the morphology of the tight-
junctions does determine the electrical 'tightness' of a cell layer. As discussed above, 
however, tight-junctional structure and brain barrier permeability of lipid insoluble 
molecules do not always correlate well in the developing animal. Moreover, Martinez-
Palomo and Erlij (1975) used a hypertonic solution in order to make the intestines of 
rabbits more permeable. This treatment resulted in an increase in the permeability of the 
intestines, however, they could not find any change in the tight-junctional network in 
freeze-fracture replicas. It therefore seems that other aspects to a high degree also 
determine the permeability of cell layers such as other cell-cell junctions, transcellular 
routes, or other, still un-characterised attributes. There is also the possibility that the 
resolution of freeze-fracturing and thin-section electron microscopy, used to study tight-
junctional structure is not high enough to see small molecular differences that may 
underlie developmental changes in cell junction permeability. The molecular structure 
of tight-junctions is still not clear. Several tight-junction associated proteins have been 
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identified including ZO-1, ZO-2, ZO-3, 7H6, several claudins, cingulin, and occludin 
(Kniesel and Wolburg, 2000). Most attention has been given to the transmembrane 
protein occludin and some studies have found correlations between occludin appearance 
in postnatal rat development and the maturation of the blood-brain barrier (Hirase et al., 
1997 as cited by Rubin and Staddon, 1999). Several mutant occludin epithelial cell lines 
and also mice with null mutations have been developed in order to elucidate the role of 
occludin as a tight-junctional protein. Mutant cell lines have provided evidence both for 
and against occludin as a crucial transmembrane protein of the tight-junctions (Saitou et 
al., 1998; Bamforth et al., 1999). Mice lacking the occludin gene developed abnormally 
with retardation of several organs, however, barrier morphology and function in the 
intestine appeared normal (Saitou et al., 2000). Because of these and other experiments 
it is now believed that occludin is not the pivotal tight-junctional protein but only one of 
several proteins that can form strand structures, and attention has been switched to the 
family of claudins (Goodenough, 1999). It is now known that the tight-junctions are not 
as static as was first believed and that the junctional proteins probably change during 
CNS disorder such as multiple sclerosis (Bolton et al., 1998). Recently it has been 
shown that tyrosine phosphorylation of the junctional proteins can dramatically change 
the permeability of endothelial and epithelial cell cultures, however, the results are 
contradictory (Rubin and Staddon, 1999; Takeda and Tsukita, 1995 as cited by Chen et 
al., 2000; Chen et al., 2000). Other factors that seem to be able to influence the structure 
and function of the tight-junctions are cAMP, Ca2+, and GTPase levels (Kniesel and 
Wolburg, 2000). Maybe the molecular assembly and modulation of the tight-junctions 
are critical for understanding the paracellular permeability changes of the barriers 
during development. 
The circumventricular organs 
As the name implies, these tissues are situated around the ventricles of the brain and 
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include area postrema, median eminence, neurohypophysis, the pineal gland, the 
choroid plexus, and the subfornical organ (Prescott and Brightman, 1998). They are 
characterised by a lack of a blood-brain barrier and seem more adapted for exchange of 
solutes since they have fenestrated blood vessels, increased capillary density, thinner 
endothelium and a high level of vesicular transport (Prescott and Brightman, 1998). All 
these organs are believed to act as portals into or out of the brain via a signalling system 
which often includes hormones. The penetration of solutes from the circumventricular 
organs (CVO) to other parts of the brain is somewhat unclear. However, the ependymal 
cells overlying the CVO seem to possess tight-junctions that have been shown to stop 
the transfer of HRP (Madsen and Mollgard, 1979; Prescott and Brightman, 1998). Thus 
it is unlikely that the CVO act as routes of entry for the brain as a whole. 
Characteristics of barrier selectivity 
Influence of lipid solubility and molecular size 
The main determinant of a molecule's ability to enter the CNS is its lipid solubility 
(Oldendorf, 1974; Levin, 1980). Lipid solubility is important since it determines how 
easily a molecule can pass through cell membranes and to what extent it can form 
electrostatic bonds with water molecules. Consequently, the more polar groups a 
compound contains, the greater number of bonds it can form with water molecules 
which will effectively retain the compound in the aqueous phase (blood). In order for a 
compound to leave the aqueous environment (blood) and enter into the non-polar 
environment of the cell membranes, it needs to break these electrostatic bonds with 
water molecules. Lipid-solubility of a substance can easily be determined in vitro, by its 
partitioning between a non-polar and a polar phase. The partition coefficient obtained 
between octanol and water (LogPoct) has been widely used as a predictor of in vivo brain 
barrier permeability (Rapoport and Levitan, 1974). However, LogP oct values have been 
found to be a fairly poor predictor of a molecule's in vivo steady-state concentration in 
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the CNS or brain barrier permeability. For instance, compounds with similar LogPoo 
values can, in vivo, vary by two to three orders of a magnitude in their permeability 
across the brain barriers (Levin, 1980). A possible reason why Log oct has not always 
been a good predictor of brain uptake may be that the partitioning coefficients are 
greatly affected by the experimental conditions under which they are measured. LogF'oct 
measurements are attempted to be made under conditions so that all molecules are in 
their neutral form. However, the conditions of these measurements may be very 
different from those in vivo. Temperature and pH will directly affect the proportion of a 
compound in ionised form and thus will affect the rate of uptake into the brain. 
It might be expected that smaller molecules would penetrate the brain barriers more 
easily than larger molecules, however, this does not always appear to be the case. When 
the uptake into CSF is measured of compounds with low and similar lipid-solubility, 
this have shown that there is a strong inverse correlation between molecular size and 
steady-state concentrations in the CSF (Felgenhauer, 1974). The rate of entry in to the 
CNS for these compounds appears to be determined by the diffusion coefficient and 
since this is inversely related to molecular size, smaller molecules penetrate faster. 
However, if a much wider range of compounds is examined there is no correlation 
between brain-barrier permeability and molecular size. This suggests that molecular size 
per se does not have a major influence on blood-brain barrier permeability compared 
with lipid solubility. Furthermore, if structurally related compounds are compared, it 
appears that increasing the size of a molecule can in fact both increase its lipid solubility 
and entry into the CNS (Habgood et al., 1999). For instance, adding extra non-polar 
methyl groups to the carbon chain of methyl alcohol (to make ethanol, propanol, 
butanol etc) will increase the size, however, each extra methyl group will also make the 
molecule more lipid soluble (Habgood et al., 2000). 
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Enzymatic barriers 
There are also specific brain barrier mechanisms that are capable of controlling the 
entry of substances that are lipid soluble and thus could be expected to have a high rate 
of entry into the brain. These barrier mechanisms include enzymes that degrade 
substances as they cross the barriers and transport systems that actively transport the 
molecules back into the circulation (see below). The degradation of neuroactive 
substances such as L-dopa and tryptophan (precursors of dopamine and serotonin) by 
decarboxylases prevents them from accumulating in the brain to large extent. In clinical 
treatment of Parkinson's syndrome, it is necessary to saturate these enzymatic systems 
and this can be accomplished by administering large doses or by co-administration of a 
decarboxylase inhibitor. There are also several peptidases and angiotensin-converting 
enzymes present in the brain endothelial cells (Johansson, 1997). 
Active transport out of brain 
The concentration of a molecule in the brain is affected by both its influx into and efflux 
out of the brain. Many essential molecules for normal brain function such as glucose 
and amino acids would have a very slow penetration into the brain if it was not for 
active transport into the brain. These systems will be discussed in more detail later on in 
this Chapter. There are also several compounds, such as the drugs vinblastine and 
cyclosporine A, that have been found to have much slower uptake into the brain than 
could be expected from their lipid-solubility. The explanation for this was first found in 
a family of multi-drug resistant phospho-glycoproteins (Pgp) found in the vasculature of 
the brain and later also in a multidrug resistant protein (MRP) which has been found in 
the choroid plexus. These proteins are believed to function as a defence of the CNS 
against certain lipid soluble molecules. They are often highly expressed in brain 
tumours leading to reduced drug accumulation, and are therefore responsible for the 
clinical ineffectiveness of several anti-tumour drugs (Borst and Schinkel, 1998). 
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Tumours can also build up resistance to certain drugs because the exposure of a drug 
may lead to increased expression of both Pgp and MRP. The mechanism by which these 
proteins exclude some drugs from the brain is still not clear but is known to be energy 
dependant. Pgp and MRP both are have membrane spanning domains and can transport 
drugs from the cytosol of the cell or from the cell membrane itself to the external 
(blood) side of the membrane. These two proteins only share about 15% amino acid 
homology and substrates for them vary a great deal (Lautier et al., 1996). One way to 
overcome Pgp related drug resistance is to co-administer a known substrate or an 
inhibitor of Pgp function, leading to an increase in drug delivery (Borst and Schinkel, 
1998). However, because of the lack of good substrates for MRP, this approach has not 
yet been effective against MRP dependant drug resistance (Lautier et al., 1996). 
The importance of studying the brain barriers 
The knowledge about brain barrier selectivity is vitally important for estimating the 
entry of centrally acting drugs into the CNS. Equally important is to be able to estimate 
the CNS uptake of peripherally acting drugs with neurotoxic side effects. Therefore, 
accurate modelling of a drug's entry into the CNS could be very useful in predicting the 
prospective therapeutic success of a drug. However, at present it does not seem that 
drug companies have appreciated the full potential of understanding brain barrier 
selectivity. According to Pardridge (1999) more than 95% of all drugs are denied access 
to the brain but less than 1% of drug development effort is committed to improving 
brain delivery. Instead, more than 99% of all the effort goes to the discovery of new 
drugs. This is especially extraordinary since drugs against CNS disorders are one of the 
fastest growing areas in therapeutics. Some strategies to improve drug delivery have 
involved the utilisation of endogenous transporting systems, osmotic opening of the 
brain barriers, and the lipidisation of drugs. These have all been successful to a limited 
extent but there is still a huge scope for improvement, and also an enormous potential 
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benefit for new more specific CNS targeting drugs. Since some of the barrier 
mechanisms in the developing brain appears to be different, it is possible that 
knowledge of barrier mechanisms of the immature brain will lead to the development of 
new drug targeting strategies for the brain. 
Many pollutants, food additives and drugs in the mother's blood circulation may be 
harmful to the fetus if they are able to cross the human placenta. In the human placenta, 
the mother and fetal blood are only separated by a single layer of transfer-limiting cells 
(syncytiotrophoblasts). Compared with many other mammals, the human placenta is 
more permeable to small lipid insoluble molecules (Bain et al., 1988; Schneider, 1991) 
and is also believed to be a rather weak barrier to most drugs (Audus, 1999). It is often a 
challenge for clinicians to prescribe drugs for pregnant women because there is very 
limited knowledge of how these drugs may affect the unborn child. In addition, women 
often use drugs before they realise they are pregnant, during the first crucial time of 
pregnancy when the organs develop (Gilstrap, 1997). The problem might be even more 
challenging when the pregnant mother suffers from a chronic medical disorder such as 
asthma, diabetes, hypertension or various cardiac diseases, and the intake of a certain 
drug cannot be avoided not to jeopardise the health of the mother (Rayburn and Lavin, 
1986). Even though the brain barriers seem to form early in development, as have been 
described above, the barrier mechanisms in the immature brain are different from the 
adult. Therefore is it not always possible to know how or to what extent foreign 
substances can access the developing brain. This is especially a concern since the 
developing CNS may be particularly sensitive to exogenous material. The knowledge 
about fetal CNS barrier function is not only important when trying to predict possible 
adverse effects of substances on the unborn child but could also be of interest for fetal 
drug therapy. With better understanding of drug uptake into the fetal circulation and 
drug penetration into the developing CNS, this could be a growing field of therapy. 
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Possible routes of entry for lipid insoluble molecules 
into the CNS 
Paracellular pathway 
In vessels outside the brain, lipid insoluble molecules are believed to be transferred 
across the endothelium by filtration through pores. These pores have been suggested to 
be the intercellular cleft between endothelial cells with a radius of 40-70 A. Karnovslcy 
(1967) showed that, at least for HRP, the endothelial cleft in heart and skeletal muscle is 
indeed a functional pathway across the endothelium. However, it has been difficult to 
explain how larger lipid insoluble molecules cross the endothelium since they would be 
too large for the normal interendothelial cleft. One hypothesis has been that they cross 
through pores which are considerably larger (200-300 A) but the structural basis for 
these larger pores is still not known. The reason these large pores have never been 
localised has been proposed to be that they are rare in the vasculature, or if ever found, 
may have been believed to be artefacts (Rippe and Haraldsson, 1987). In the brain, 
however, the paracellular route is severely restricted by the continuous tight-junctions 
between endothelial cells. As has been described above it seems likely that these 
effectively stop the penetration of most proteins from blood into brain. Whether smaller 
molecules can penetrate the tight-junctions has still not been established, but this has 
often been considered to be the case (Goodenough, 1999). 
Transcellular pathways 
I. Active transport 
Normal functioning of the brain requires a higher rate of delivery of certain compounds 
than can be achieved by passive transfer. For instance the brain is in constant need of D- 
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glucose, which is delivered by the blood as an energy source for all the cells. 
Transporters for D-glucose within the brain were first described in the middle of the 
1980s and today six functional transport proteins have been identified, all related 
structurally and with similar function but expressed differently in various tissue 
(Drewes, 1998). Other molecules that are dependant on active transport into the brain 
are amino acids, peptides and ions. Amino acids are transferred into the CNS by several 
transporting systems that do not seem to be specific for one amino acid but prefer amino 
acids of particular size and charge (Smith and Stoll, 1998). Ions are either positively or 
negatively charged and would therefore have very low brain barrier permeability if not 
transported into the brain actively. They are transported by ATPases or antiporters with 
different transporting mechanisms at the luminal and abluminal membrane both in the 
endothelial cells of the brain capillaries and in the epithelial cells of the choroid plexus 
(Frelin and Vigne, 1998; Speake et al., 2001). Whether the movement of a specific ion 
in/out of the barrier cells is important for transcellular transport, or the need for the 
endothelial and epithelial cells to keep an ion gradient between themselves and the 
surroundings, is difficult to determine. At least for the choroid plexus, which is known 
to play a major role in CSF secretion, the mechanism by which CSF is produced is 
dependant on the existence of an ion gradient between the epithelial cell and blood/CSF 
(Johanson, 1995). 
II. Vesicular transport 
The plasma membrane can invaginate at both the luminal and abluminal side giving off 
membrane coated spheres called vesicles that can travel across the cell in a process 
called trancytosis. In these vesicles any molecule can be engulfed as long it is smaller 
than the size of the vesicle. Under normal circumstances the vesicular transport in brain 
endothelia is low compared to other endothelia (Connell and Mercer, 1974; Stewart, 
2000), but has been shown to be higher during development (Xu and Ling, 1994). The 
transport in vesicles has been found to be polarised in both the choroidal epithelia and 
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brain endothelia with greater uptake from the luminal membrane (van Deurs et al., 
1978; Balin et al., 1986). How important vesicular transfer is in endothelia is still 
debatable but it is believed to be only important for larger lipid insoluble molecules, 
since the process is rather slow. Stewart (2000) only found a weak correlation between 
vesicular density and protein permeability in several endothelia throughout the body 
including the brain. The author suggested that protein transfer is more dependant on 
receptor-mediated trancytosis. Three different mechanisms of vesicular transcellular 
transport have been proposed (Nag, 1998). Firstly, the vesicles are suggested to bud at 
the luminal cell membrane, move across the cell and empty their contents at the 
opposite side of the cell by fusing with the abluminal cell membrane, or by a similar 
process in the reverse direction. The second hypothesis is that vesicles only move a 
short distance within the cell and then fuse with another vesicle mixing their interior 
contents and then separate again. Eventually a substance will reach the other side of the 
cell as observed by Clough and Michel (1981) with ferritin transport in frog 
endothelium. The third hypothesis is that a whole row of vesicles fuse together and 
thereby form an extracellular channel through the cell in which fluid can move in either 
direction. This has been demonstrated by Simionescu et al. (1975) in rat muscle 
capillaries and was also suggested by Clough and Michel (1981). To the author's 
knowledge such vesicular channels have never been observed within brain endothelium 
or choroid plexus epithelium. 
III. Transfer in other subcellular structures 
Mollgard and Saunders (1977) studied the choroid plexus of the immature sheep and 
reported that the endoplasmic reticulum (ER) during early fetal development is in close 
contact with both the basolateral and apical membranes of choroidal epithelial cells. The 
ER could directly be linked with the membrane via a tubulo-cisternal system or 
vesicles. It was suggested that this system could constitute a transcellular pathway, 
which seemed to be developmentally regulated since it was not present in late fetal 
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development. This pathway was later suggested to be the route by which albumin 
crosses the epithelial cells of the choroid plexus (Balslev et al., 1997a). The ER has also 
been suggested to transport protein in the endothelial cells of the brain (Mollgard and 
Saunders, 1975). This is in contrast to Balin and Broadwell (1988) who found HIRP in 
tubular structures in the epithelial cells after systemic administration but suggested that 
these structures are components of lysosomal or endosomal systems and are not 
involved in trancytosis of HRP. The authors opposed the view by Mollgard and 
Saunders (1975, 1977) that the ER could constitute a pathway through the choroidal 
epithelium or the cerebral endothelium. Similar tubular structures were proposed to 
form functional pathways through the brain barriers by Lossinslcy et al. (1983, 1986). 
These studies showed that in states of increased brain barrier permeability, HRP and 
ferritin were found in channel like structures in endothelial cells which the authors 
referred to as tubulo-canalicular structures. 
IIII. Absorptive-mediated transfer 
More recently it has been discovered that certain peptide sequences are rapidly 
internalised into cells. This phenomenon was first observed for transcription factors of 
the Drosophila (Derossi et al., 1998), but has also been found for protein domains of 
viruses (Schwarze et al., 1999). The mechanism of the internalisation of the peptide is 
not clear, but has been suggested to involve electrostatic attraction between positive 
amino acids in the peptide and negative lipid or sugar components in the cell membrane 
(Derossi et al., 1998). The membrane is thought to destabilise and produce inverted 
micelles so that the membrane lipids form a ring around the peptide that can travel 
across the membrane and release the peptide into the cytoplasm. The findings have led 
to the development of so-called Trojan peptides, which can deliver other peptides into 
the cell when they are linked to the Trojan peptide. For example, these peptides have 
been shown to increase the transport of the anticancer drug doxorubicin into the brain 
parenchyma (Rousselle et al., 2000). 
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A 	BCD 
Figure 1.2 
Schematic diagram representing possible pathways across endothelial (blood-
brain barrier) and epithelial cells (blood-CSF barrier) in the brain. A) Diffusion. 
Lipid soluble (non-polar) compounds can diffuse through cell membranes and 
enter the brain. B) Receptor-mediated trancytosis. Some larger proteins such 
as the iron transporter transferrin bind to specific receptors at the luminal side of 
the cell membrane and the protein-receptor complex is then endocytosed. C) 
Carrier-mediated trancytosis. The cell membrane at both the luminal and 
abluminal side contains transporters that facilitate the transport of molecules 
such as D-glucose, ions and amino acids. D) Adsorptive trancytosis. Certain 
small peptides with a positive moiety can interact with the negative cell 
membrane and is then internalised into the cell. E) Vesicular transport. Vesicles 
are produced by an invagination of the cell membrane and can contain large 
molecules. Vesicular transport has been suggested to work by either vesicles 
moving from one side the opposite side of the cell, or by shuffling of contents 
from one vesicle to the next inside the cell, or by several vesicles fusing and 
forming an extracellular channel through the cell. F) Paracellular route. Most of 
the intercellular cleft is wide enough to all through all but very large molecules; 
however, at the luminal side of the endothelial cells and at the abluminal side of 
epithelial cells a zonulae occludentes (zo) is present, which severely restrict this 
pathway. G) Channels in subcellular structures. Certain tubulo-canicular 
structures in endothelia, and endoplasmatic reticulum in epithelia have been 
proposed to form functional pathways through the cell. 
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Present study 
The present study was undertaken in order to understand the mechanisms of transfer for 
small lipid insoluble molecules across the brain barriers during development. This was 
investigated in an integrated approach which combined both quantitative physiological 
permeability studies and morphological tracer studies in the same species over a similar 
developmental period. This has the significant advantage over previous studies in that 
the results from both approaches are directly comparable. 
In the present experiments, the blood-CSF and blood-brain uptake in very young 
(postnatal day 6) to newly weaned (postnatal day 65) South-American opossums 
(Monodelphis domestica) were investigated for several small lipid insoluble 
compounds. This is the earliest stage of brain development that such studies have been 
carried out in any species. Just how the present study of the brain barriers compares 
with previous studies can be illustrated by comparing the age at which the choroid 
plexuses appear in other species with the opossum. In the rat, the 4th choroid plexus 
appears at E12, the lateral at E13-E14, and the 3rd at E16 (Chamberlain, 1973). In 
sheep, the choroid plexus appears in the 4th ventricle at E 18-21, in the lateral ventricles 
at E21-E24, and in the 3rd ventricle at E30-E36 (Jacobsen et al., 1983) (sheep are born 
around E150). The earliest age at which permeability studies with inulin and sucrose 
have been carried out in these species is E 18-P2 in rats (Ferguson and Woodbury, 1969; 
Habgood et al., 1993) and E40-E60 in fetal sheep (Evans et al., 1974; Dziegielewska et 
al., 1979; Cavanagh et al., 1983). In contrast, the South-American opossum is born with 
only rudimentary lateral ventricular choroid plexuses, no 3rd ventricular plexus, and 
only a small 4th ventricular choroid plexus (Dziegielewska et al., 2001). 
In parallel to these permeability studies, an attempt has been made to visualise the route 
for small lipid insoluble molecules from blood into the brain. Only electron microscopy 
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could give high enough resolution to define any such route at the cellular level and it 
was therefore necessary to use a tracer that was or could be made electron dense. For 
larger molecules, horseradish peroxidase (a 40 000 molecular weight soluble protein) 
has been extensively used as a marker (Graham and Karnovsky, 1966; Bouchaud and 
Bouvier, 1978; van Deurs et al., 1978; Balin et al., 1986; Sedlakova et al., 1999 and 
many others), but not until quite recently has a low molecular weight electron dense 
marker been available. Microperoxidase (MP) was introduced in the early 1970's 
(Feder, 1971) as a low molecular weight marker (molecular weight 1500-1900 Daltons) 
but it was later found to bind to plasma proteins (Milton Brightman, personal 
communication). This means that it cannot be used as a small tracer in the blood, 
however, its usage as a small tracer might be valid when administered directly into the 
CSF since the CSF contains low levels of proteins. Biotin-dextrans have successfully 
been used as axonal tracers because of their inertness and low lipid-solubility (for 
references see Kobbert et al., 2000). In the present study, a low molecular weight biotin-
dextran was used as an external tracer for small lipid insoluble molecules and was 
visualised both at the light and electron microscopic level. In addition, its penetration 
from blood to CSF was also measured in order to directly compare its CSF uptake with 
other small radiolabelled markers. Its penetration from blood into the CSF and brain 
was studied at comparable ages to the quantitative permeability studies using 
radiolabelled markers. 
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Aims 
There were two main aims of this thesis: 
• The first aim was to quantitate, in vivo, changes in the transfer of small lipid 
insoluble molecules from blood to brain and blood to cerebrospinal fluid (CSF) 
that occur during development, particularly at very early stages. 
• The second aim was to visualise the transfer route for such molecules into the 
developing brain. 
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Review of techniques used to study brain uptake 
There are a number of methods used to study the uptake of molecules from blood into 
the CNS. The most commonly used in vivo and in situ methods are described below and 
are also briefly discussed in relationship to their applicability to the present studies. 
There have also been several in vitro models developed, but since it is difficult to mimic 
what is occurring during development in vivo with an in vitro model, such models were 
ruled out in the current investigations. 
In in situ methods the uptake into brain is determined after arterial infusion of test 
substance in anaesthetised or in animals immediately after death (Begley, 1992). The 
perfusate normally contains one or several test substances and an impermeable 
molecule, and is infused by a motor driven syringe pump normally through the common 
carotid. The impermeable molecule is used to estimate vascular space. From this the 
amount of test substance still trapped inside blood vessels in the brain can be 
determined and is subtracted from brain samples in order to obtain true concentrations 
in brain tissue. The perfusion can last from a few seconds up to hours. The technique 
can determine the unidirectional uptake constant (Kin; usually expressed as gl g -1 
either by using single or multiple time points. Multiple time point analysis gives a more 
accurate estimate but a larger number of animals must be used. The advantage with this 
method is that the medium containing the test substance can be precisely controlled so 
problems with protein binding or competition with endogenous compounds do not exist. 
Since in situ brain perfusion is more technically challenging than other methods this 
was judged not suitable in the present experiments due to the very small size of the 
animals. 
The brain uptake index (BUI) is a simple and fast technique which calculates the uptake 
of test substance in relation to a reference molecule into one or both hemispheres after a 
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single arterial (normally carotid) bolus injection (Cornford, 1998). The injectate 
normally consists of a 14C labelled test substance, a 3H reference isotope and 113Lndium 
(binds to transferrin and is therefore impermeable in short-term experiments). A few 
seconds after the injection the animal is decapitated and the brain dissected out and 
prepared for scintillation counting. The 3H reference isotope eg. tritiated water is almost 
completely cleared from blood during a single pass through the brain. The brain uptake 
index is calculated as [Extractedtest substance — EXtraCtedindiumVEXtraCtedreference and the 
ratio given as a percentage. BUI is only appropriate for test substances that have a fast 
uptake into the brain and could therefore not be used in the present experiments 
involving slowly penetrating lipid insoluble markers. Furthermore, it would be 
extremely difficult to give intra-arterial injections into small pups. 
Analysing the uptake rate into the CNS after peripheral injections of test substance in 
awake animals is probably the most physiological technique available (Egleton and 
Davis, 1997). The technique is experimentally simple, but it is more difficult to interpret 
the data obtained. The injection solution is prepared in a similar way to the infusate in 
perfusion experiments with an impermeable marker to determine vascular space. Blood 
samples are collected throughout the experiment until the animal is killed and brain 
tissue obtained. The data can be either analysed as a single time point or multiple time 
points. In the former analysis brain samples are collected at one time point and in the 
latter at several time points. The advantage of this method is that the test substance's 
uptake into brain can be measured in awake animals that have been minimally 
manipulated. The uptake rate is determined under the influence of all components in the 
blood and the test substance is allowed to pass the vascular bed many times. However, it 
can sometimes be difficult to interpret the results just because the uptake rate 
determined is influenced by factors such as protein binding or metabolism. A 
combination of an in situ and an in vivo technique will give the best understanding of a 
substance's uptake into CNS, because the uptake can be measured with or without the 
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influence of blood components. Since the present study was carried out in small, 
delicate, developing animals, a minimal invasive technique was required and therefore 
the single bolus injection method was chosen. Because of the very small size of animals 
it was not possible to give them intravenous injections and the uptake of markers was 
instead measured after a single intraperitoneal injection. 
Animals 
The grey short-tailed South-American opossum (Monodelphis 
domestica) 
The grey short-tailed South American opossum (Monodelphis domestica) was used in 
these experiments. The animals were obtained from the colony established at the 
Central Animal House, University of Tasmania. Monodelphis domestica is a small 
pouchless marsupial native to South-America, from eastern Panama to central 
Argentina. In the wild the animal is nocturnal, terrestrial or semi-arboreal. The adult 
male weighs about 120-150 g and the female slightly less. Animals are housed in 
individual boxes (30x40x16 cm) with a smaller nesting box inside (20x12x10 cm) and 
males and females are kept in separate rooms except for breeding. The box is filled with 
paper pellets for ground cover and shredded paper supplied for nest bedding. The room 
temperature is kept at 25-28°C with a reversed day/night cycle with 14 hours of light. 
The diet consists of cat food (fortified with meat meal, milk powder, high protein cereal, 
peanut oil, and multivitamin mix), dry cat pellets, fresh fruit such as banana or kiwi, and 
live meal worms and crickets. The female reaches sexual maturity at 6 months and the 
male at 8 with a breeding life of approximately 2 years for both sexes. Two days before 
breeding the male and female swap cages in order to pheromonally promote oestrous 
and decrease aggressive behaviour between the pair. The pair remains together for two 
weeks and afterwards the female is monitored for weight gain in order to check if the 
mating was successful. 
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Like all marsupials, this species is born at an earlier stage of brain development than 
any eutherian mammal, after a gestational period of only 14 days (Saunders et al., 
1989). The new born pup weighs approximately 0.1 grams (crown-rump length —10 
mm) and is in terms of general development equivalent of a E13-14 rat, a E35-E40 
sheep or pig, or a 6 week human embryo (Saunders et al., 1989). The main precursor of 
the cortex, the cortical plate appears at around postnatal day 3 in the Monodelphis, 
which in the rat can be first seen on E 16, in sheep at E34, or in the human at E50 
(Saunders et al., 1989). As an animal used for biomedical research it has the advantage 
over other marsupials that it breeds all year around, gives birth to large litters that range 
from 1-14 pups, and can be housed in rather small areas because of its size. It has been 
successfully used in other areas of neurobiological research such as regeneration of 
immature spinal cords (Saunders et al., 1998), and studies of spinal cord, cortex and 
olfactory bulb development (Saunders et al., 1989; Brunjes et al., 1992; Molnar et al., 
1998; Knott et al., 1999; Cabana, 2000). The only disadvantage is that the time of 
mating cannot be exactly established which make developmental studies of embryonic 
opossums difficult. 
Care of pups 
Monodelphis pups are constantly attached to mother's teats until 15-20 days after birth. 
While attached to mother, it is very difficult to make delicate injections into young 
pups. This can be made easier by lightly anaesthetising the mother during injections, 
however, this would have enforced another problem since mothers are known to eat 
their pups when disturbed. Instead in the present experiments, to avoid the risk of 
cannibalism, pups were detached from mother before injections and kept in a 
humidicrib (65-75% relative humidity) until terminally anaesthetised. The mother was 
briefly anaesthetised with isoflurane (see below) while the pups were detached. The 
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maximum time young animals were kept in the humidicrib did not exceed 41/2 hours. 
Newborns were wrapped in a tissue to minimise heat loss. A temperature probe was 
kept with the pups in the humidicrib and the temperature was maintained at 27.5- 
29.5°C. Normal adult body temperature in the opossum is lower (32°C) than in 
eutherians (Kraus and Fadem, 1987). All experiments were conducted in accordance 
with NHMRC guidelines and approval of the University of Tasmania Ethics 
Committee. 
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Figure 2.1 
The grey short-tailed South-American opossum (Monodelphis domestica). A) 
Close-up of a 7-day old opossum pup. B) Female with 1-day old pups attached 
to her teats. The opossum is a pouchless marsupial which makes access to the 
pups easy. It can give birth to up to 14 pups but normal litter sizes range from 5 
to 10 animals. The newborn opossum only weighs approximately 0.1 g with a 
crown-rump length of about 10 mm. C) Female with 6-day old pups attached to 
her teats. The pups weigh approximately 0.3 g at this age. D) 35-day old 
opossum weighing approximately 6-7 g. E) Cage and nesting box. The nesting 
box is filled with shredded paper which the animals use to build a nest. Adults 
are kept in separate boxes except for during mating. F) Adult opossum. The 
adult male weighs 100-120 g and the female weighs slightly less 
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Anaesthesia 
Surgery, such as nephrectomy, was performed under gaseous anaesthesia with 
isoflurane (2.5-3.5%; Abbott). This anaesthetic was chosen because of its superior 
safety margin over other anaesthetics and also its short duration of action, which means 
quick recovery. The depth of anaesthesia was evaluated by tail and toe pinch throughout 
the time of anaesthesia. Before collecting blood, CSF or brain samples animals were 
terminally anaesthetised with inhalation of halothane (Zeneca). 
Nephrectomy 
Some experiments in this thesis involved injections of radioactive markers into the 
intraperitoneal cavity of young opossums in order to measure the uptake from blood 
into the CSF and brain. The model which will be described in detail in Chapter 3 was 
based on uptake measurements determined by steady-state concentration ratios between 
CSF/plasma and brain/plasma several hours after the injections. Samples of plasma 
showed that the plasma concentration increased quickly after the injections, but after an 
initial peak the concentration gradually fell over time, which possibly was a result of 
clearance through the kidneys. Urine samples after the injection showed high 
concentrations of isotopes which confirmed that large amounts of the marker were lost 
from the blood by filtration out of the kidneys. In order to avoid renal clearance of 
markers, opossums at P37 and P65 were bilaterally nephrectomised. This was done on a 
heated operating table under isoflurane anaesthesia. Pups were laid ventrally and the 
skin was cut along the dorsal midline. After a small cut through the back muscles the 
kidneys were located and adipose tissue removed so the kidneys could easily be 
manipulated. The renal artery and vein were then ligated using a suture and the skin was 
sealed with superglue. Pups were left to recover on a heated table until awake and then 
left with their mother before final anaesthesia for sample collection. 
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Injections of radioactive markers 
Radioactive markers were obtained from Amersham International and are listed in 
Table 2.1. All isotopes for injection were prepared in sterile 0.9% NaC1 solution. The 
final activity of each marker was 4.2 - 5.0 KBq 	of 3H and 0.42 - 0.58 KBqp1-1 of 
14C. The activity of injection solution was always measured before the experiment to 
ensure reproducibility between the experiments. Standardised injections (6 pl/g body 
weight) were made into the intraperitoneal cavity with a Hamilton syringe fitted with 
either a 29-gauge needle or a glass micropipette. The intraperitoneal injection avoided 
the possibility of sudden osmotic or volume changes in the blood system. Inulin, 
sucrose and L-glucose were chosen as small lipid insoluble test molecules of 
permeability since they are minimally metabolised in the body (Habgood, 1990) and are 
believed to only distribute in extracellular compartments. As will be discussed in 
Chapter 5 this may be true for the adult animal, however, results presented in this thesis 
suggest that it may not be the case in the developing animal. The use of glycerol was 
restricted to short-time experiments only (less than 25 minutes) to minimise possible 
metabolism. The degree of possible glycerol metabolism in vivo during such an 
experiment was checked 30 minutes after an intraperitoneal injection by thin-layer 
chromatography (see below). 
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Table 2.1 
Radiolabel Marker Code No Molecular Weight 
[U- 14C] Sucrose CFB-146 342 
[3F1] lnulin TRA-324 —5200 
[1-14C] L-glucose CFA-328 180 
[1(3)-3H] Glycerol TRA-244 92 
Radioactive markers used in permeability experiments. All 
markers were either 14C or 3 H radiolabelled. 
Tissue and fluid samples 
Blood samples 
As soon as a deep level of anaesthesia was obtained, blood was immediately sampled 
with a glass micropipette by mouth suction. Each pipette was prepared 1-3 days before 
usage by filling it with heparin and gently blowing out so a film of heparin was formed 
on the inside of the pipette to prevent blood clotting. In older pups (older than P10) the 
rib cage was opened and blood collected from the left ventricle of the heart. In younger 
pups blood was collected by drainage from the left subclavian/axillary artery. The artery 
was carefully dissected out and any fluid around it was removed with a cotton tip. The 
blood vessel was cut and blood collected from the groove after the dissection. This 
artery was chosen since it avoids any possibility of blood mixing with intraperitoneal 
fluid. Blood samples were transferred to a plastic tube and kept on ice until plasma was 
separated by centrifugation (5 minutes, 5000 rpm). 
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CSF and brain samples 
After blood samples were taken the heart was cut to lower the systemic pressure and 
minimise the risk of blood contamination in CSF samples. CSF was taken from the 
cisterna magna of the hindbrain by gentle mouth suction using a glass micropipette. 
The tip of the pipette was carefully pushed to penetrate through the dura mater at an 
angle to avoid damaging small blood vessels. CSF was transferred to a plastic tube and 
spun at 5000 rpm for five minutes. Every tube was inspected for blood contamination 
by examining it under a dissecting microscope over a white background. Blood 
contamination as low as 0.1% can be detected in this manner (Habgood, 1990). Any 
tube with visible blood contamination was discarded. After CSF collection the whole 
brain was dissected out and immediately frozen. 
Radio-scintillation counting 
In liquid scintillation (LS), radioactive compounds are dispersed in a liquid medium, 
which is called scintillation fluid. This fluid converts the radioactive decay particles into 
photons, which can be detected by photomultiplier tubes and a voltage is produced. The 
LS counter can be set to only count voltage pulses within a set lower and upper limit 
and this normally defines a 'counting channel' or 'counting window'. 
Ideally the rate of counts per minute (CPM; counts seen by the LS counter) is 
proportional to the disintegrations per minute (DPM) of the radioactive compound. 
However, quenching can reduce the number of photons produced by the radioactive 
emission. Quenching is commonly an intrinsic property of plant or animal tissue and 
thus can be different from sample to sample. Therefore the correct number of counts 
(DPM) can be calculated by knowing the counting efficiency, which is defined as 
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Counting efficiency — CPM 
DPM 
Quenching of any sample is determined by the LS counter by exposing the sample to a 
standard gamma ray emitting isotope. It is therefore necessary to make a series of 
samples with a standard radioactivity but different quench which will give a standard 
quench-efficiency curve (see Figure 2.2). A quench-efficiency curve has to be 
constructed for each different isotope since the counting efficiency changes with the 
energy of then-decay. At high quenching the counting efficiency is not linearly related 
to quenching and therefore high quenching in samples should be avoided. From the 
quench-efficiency curve the DPM from any sample can be determined from the CPM. It 
is also necessary to determine if the counting efficiency changes with increasing activity 
(DPM) in the sample solution. By measuring a series of samples with the same quench 
but increasing DPM this can be determined. As seen in Figure 2.3 the counting 
efficiency did not change up to at least 700 ICDPM, which is well above the activity in 
any of the sample solutions used in this study. 
Any radioactive material produces decaying particles within a certain energy spectrum 
and the counting channel can be set to only count particles within this spectrum. With 
the right channel settings, two or more radioactive substances can be counted in the 
same medium as long as their energy spectra do not overlap. Even if the spectra do 
overlap to some degree, is it possible to determine the relative activity from each 
radioactive compound. The lower energy 13-decay emittance for 3H overlaps with the 
higher energy emittance of ' 4C (see Figure 2.4A). The amount overlapping can be 
determined as follows. Two counting channels are set so the lower one (channel A) 
includes all the counts from 3H and a small proportion from 14C. The other channel 
(channel B) is set to include all other counts from 14C (See Figure 2.4B). A series with a 
standard amount of ' 4C but different quench is counted with the channels set as above. 
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The ratio of counts falling into channel A and B is calculated with different quench (see 
Figure 2.4B). Quench will reduce the pulse height and shift the energy spectrum to the 
left and a higher A:B ratio is obtained with quench, ie. the portion of counts is smaller 
in channel B (see Figure 2.4). A sample with both 3H and 14C can now be counted since 
the amount of counts produced by 14C in channel A can be estimated from the counts 
seen in channel B. By subtracting the estimated counts from 14C in channel A from the 
total counts, the CPM for 3H is determined. The error of estimating the CPM for 3H by 
this method can be minimised by having 5-10 times more 3H label than 14C. This is 
especially important when a sample is heavily quenched since the efficiency of 3H 
decreases proportionally more than 14C (see Figure 2.2). 
Sample handling for radio-activity measurements 
Aliquots of plasma and CSF were weighed and 5 ml of scintillation fluid (Packard) 
added. Brains were homogenised and aliquots weighed. To each aliquot of brain 0.5 ml 
of tissue solubiliser (Soluene-350, Packard) was added and aliquots were left in a low 
heat oven (40°C) overnight to ensure complete solubility of tissue. 5 ml of scintillation 
fluid was then added. Tubes were counted for five minutes in a liquid scintillation 
counter (Beckman LS3801) with window settings as above to allow determination of 
both 14C and 3H activity. Background counts for CSF and plasma were estimated by 
vials with only scintillation fluid and background for brain samples by tubes with 
scintillation fluid plus 0.5 ml soluene (Soluene-350, Packard). These counts were 
subtracted from all other tubes. The counting-efficiency curve constructed for each 
isotope converted the CPM determined by the counter to DPM. In order to estimate the 
true activity in brain tissue the amount of isotope still trapped within the vascular 
system of the brain was subtracted from the total activity. The residual vascular space 
was estimated from the initial distribution space of inulin (approximately 1-2 min) in 
P15 pups (n=5; used to correct values in animals between P6-P15) and P40 (n=5; used 
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to correct values in animals between P32-P65). Concentration of isotope in each sample 
was calculated as DPM/g. 
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Figure 2.2 
Counting efficiency (y-axis) for 3H and 14C against quench (x-axis). Quench 
reduces the 14C counting efficiency little whereas the 3H counting efficiency 
decreases considerably with increasing quench. Linear regression lines have 
been fitted to the data. These lines were used to determine counting efficiency 
at a given quench. The counting efficiency was necessary to know in order to 
convert the CPM measured by the scintillation counter to DPM. 
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Figure 2.3 
The radioactive concentration (DPM/pl) on the y-axis against the total amount of 
DPM in sample (x-axis). The same solution of 14C was pipetted into scintillation 
vials in increasing volumes (5-180 pl). The measured concentration of 
radioactivity (DPM/pl) was the same in all samples. This experiment showed 
that the counting efficiency did not change with either increasing sample volume 
or total amount of radioactivity. Both the sample volume and total amount of 
radioactivity were greater in these experiments than in any of the samples 
collected from animals. 
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A is a schematic drawing of 14C and 3 H spectra and illustrates changes in 
spectra with (dashed line) or without (solid line) quench. As seen quench will 
shift the energy spectrum to the left and also decrease the counts seen by 
the scintillation counter (reduced counting efficiency). The total energy pulse 
is decreased proportionally more for 3H than 14C with increasing quench (see 
also Figure 2.2). In order to determine the counts produced both by 14C and 
3H in a sample, the scintillation counter was set to count energy within two 
windows, window A (0-400) and window B (400-660). With these settings, in 
a sample with little quench, all counts produced by 3H will fall into window A 
and the counts produced by 14C will mostly fall into window B with a small 
amount in window A. Since quench shifts the energy spectrum for 14C to the 
left this will increase the proportion of counts produced by 14C that falls in 
window A. A series of samples containing the same amount of 14C label but 
different quench were counted with the windows set as above. The results 
are shown in B. This graph shows the ratio between counts in window A and 
B (y-axis) with increasing quench (x-axis) for 14C. A linear regression line was 
fitted to the data. Samples with both 3 H and 14C can be counted since the 
amount of counts produced by 14C in window A can be estimated from the 
counts seen in window B by the regression line. By subtracting the counts 
from 14C in window A from the total counts in that window, the total counts for 
3H is determined 
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Lipid solubility of markers 
As mentioned in Chapter 1, lipid solubility is a principal molecular property 
determining rate of uptake into the CNS. Blood solutes, which are in an aqueous 
environment are believed to enter the CNS by crossing the lipid cell membrane of the 
endothelium, diffusing through the cytosol and crossing the abluminal cell membrane 
into an aqueous medium on the other side of the endothelium. This hypothesis could 
explain the high rate of penetration for lipid soluble blood solutes across the brain 
barriers, since they leave the aqueous phase of plasma more easily and are less restricted 
in crossing lipid cell membranes. A solute's lipid solubility is measured by its 
partitioning in a lipid and in a water phase. A correlation of in vitro measurements of a 
substance's partitioning in hydrocarbon/water phases and brain uptake was found by 
Mayer et al. (1959). More recently the partitioning between octanol/water has been 
measured and found to predict brain uptake more accurately (Rapoport and Levitan, 
1974). The permeability experiments (presented in Chapter 3) showed clear differences 
in brain uptake for inulin, sucrose, L-glucose and glycerol throughout development. 
Measurements of lipid solubility were conducted in order to check if differences in 
permeability of markers could be explained by their lipid solubility. 
Measurement of a substance's lipid/water partitioning is greatly influenced by the 
medium in which the measurement is performed. A molecule can exist in both ionised 
and unionised forms, and the ionised form has much more difficulty leaving an aqueous 
environment because of its polarity. Therefore the ionised form crosses the brain 
barriers at a slower rate. Measurements of a compound's lipid/water partitioning 
coefficient as well as its fractional concentration between altered species in a whole 
range of different pH media will provide information of how lipid solubility changes 
with ionisation of the drug. From this the partitioning coefficient can be calculated for 
the unionised form of the compound and is referred to as Log Plipid. This is quite 
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straightforward as long as it is possible to change the pH to drive the compound into its 
neutral form. Even if a smaller amount of the compound is in a charged form, the true 
Log Plipid can be calculated by knowing the fractional concentration for different 
species. However, if the compound can both give and take protons it becomes more 
difficult, since it will be impossible to change the pH to get large amounts of the neutral 
form of the compound. Instead the measurements can be made under standardised 
conditions (ie. pH 7.4 and 37°C) and the partitioning coefficient is then referred to as 
Log plipid.  It can be expected that the fractional concentration of different species under 
these conditions is similar to what would be found in vivo. 
Radiolabelled markers were made up in 154mM phosphate buffered saline at pH 7.4, 
and 2 ml of each isotope was transferred to 2-5 separate mixing vials. The initial isotope 
concentration in buffer was measured by radio-scintillation counting, and the total 
amount of isotope in each vial ranged between 18.5 GBq — 130 GBq. To each mixing 
vial 2 ml of (2)-Octanol was added, and to assure proper partitioning between buffer 
and octanol phase, tubes were vigorously shaken overnight at room temperature. Vials 
were spun at 3000 rpm for 5 min and left for 30 min on bench. The isotope 
concentration in the two phases was determined by radio-scintillation counting. The 
partitioning coefficient (LogD0ctan0i,25T)  for each marker is presented in Table 2.2. 
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Table 2.2 
Marker LogD ± SD n 
lnulin -3.51 ± 0.02 5 
Sucrose -3.47 ± 0.01 5 
L-glucose -2.68 & -2.68 2 
Log Doctanol, 25°C values for each marker calculated from their 
partitioning between equal volumes of phosphate buffer and 2- 
octanol at 25°C. Values shown are mean ± SD (n=number of 
individual measurements). Since only two measurements were 
made for L-glucose both are listed here. 
Possible metabolites of glycerol 
In order to check possible metabolites or breakdown products of glycerol in vivo, a P30 
opossum was injected intraperitoneally (ip) with 3H-glycerol, and blood and CSF was 
collected 30 minutes after the injection. In comparison, the longest duration of any 
measurement of the in vivo glycerol permeability was 23 minutes. 5 pi samples were 
spotted and run, together with a standard (blood from an uninjected animal mixed with 
3H-glycerol), on 20 cm silica thin layer chromatography (TLC) plates (Merck, G60). 
Plates were run in an ascending fashion in a chloroform:methanol (1:2) mixture until the 
solvent reached up to 3/4 of the plate. A non-radioactive standard was run at the same 
time to identify the glycerol position. At the end of the run, each plate was divided into 
seven equal fractions (approximately 1.5 cm each) and the gel was carefully removed 
into individual scintillation vials. The activity in each vial was determined by liquid 
scintillation counting. Background activity was measured in two vials containing only 
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the gel and was subtracted from sample vials. 
The proportional activity (%) in each fraction to the total amount on each plate was 
calculated (see Table 2.3). Standard sample showed 96% activity in the two fractions 
(fraction 4 and 5) that corresponded to the glycerol spot. The same fractions in blood 
and CSF had 71% and 80% of the activity, respectively. Less than one percent of the 
activity was found in the fraction moving with the solvent front (fraction 7) in all 
samples. The first fraction (including the initial spot) constituted 8% and 2% of activity 
in blood and CSF, respectively. 
Table 2.3 
Fraction 1 2 3 4 5 6 7 
Standard 0.2 1.0 2.5 36.7 59.2 0.4 0 
Blood 8.4 10.8 6.9 20.5 50.3 2.3 0.8 
CSF 1.7 9.2 6.3 16.2 63.4 3.1 0 
TLC analysis of blood and CSF from a P30 opossum 30 minutes after 
intraperitoneal injection of 3H-glycerol. The activity in separate fractions is 
expressed as the proportion (%) to the total on each plate (ie. the total of each 
plate is 100%). Standard was 3H-glycerol mixed with control blood 
immediately prior to chromatography. 
The first fraction corresponds to most hydrophilic substances such as water or glucose, 
the last (7 th) fraction to compounds that are most hydrophobic such as lipids. As seen in 
Table 2.3 small amounts of activity were found in the fractions above the glycerol 
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position, which indicates that little glycerol was converted in to more lipid soluble 
compounds. Instead, some glycerol seemed to have been transformed into more water 
soluble compounds found in fraction one to three. Since conversion products are almost 
uniformly lipid insoluble compounds, which would enter the CNS at a slower rate than 
glycerol, measurements of glycerol permeability should be little affected by these 
compounds. 
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Introduction 
Traditionally the permeability across the brain barriers of slowly penetrating solutes (eg. 
lipid insoluble compounds) has been measured by maintaining a constant blood plasma 
level of test substance until a steady level has been reached in the CSF and brain 
(Ferguson and Woodbury, 1969; Dziegielewska et al., 1979). A constant plasma level 
can be obtained by infusion of test substance until the amount infused equals the 
amount lost from blood (by diffusion into other tissue or renal clearance) (Ueda et al., 
1993). The concentration in brain will also slowly increase until a steady-state is 
reached. Samples of brain and plasma are taken and a ratio between the brain and 
plasma concentration is calculated and expressed as a measure of brain permeability. 
When only a single injection of marker molecule is possible, bilateral nephrectomy 
prevents renal clearance and a steady plasma level is obtained (Habgood et al. 1993). In 
both of these models, preliminary experiments have to be performed to determine the 
time scale of approaching the steady-state between CSF or brain and plasma. Steady-
state ratios between CSF/plasma and brain/plasma are then measured as transfer rates 
across the brain barriers (Habgood et al. 1993). 
For detailed procedures of methods described below such as nephrectomy, injections, 
and tissue sampling see Chapter 2. The experiments described in this Chapter were 
conducted in a sequential manner, where certain parameters in one experiment had to be 
established before the next was commenced. These parameters determined the 
procedures used in the following experiments. The results have therefore been described 
consecutively with respect to development of the underlying methodologies in order to 
understand the reasons for certain experiments and procedures The experimental model 
presented in this Chapter was used in further experiments, which are described in the 
Chapters 4 and 5. 
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Methods 
Litter based model 
Blood and CSF samples were obtained from opossum pups as early as P6. At this age 
the pups weigh 200-250 mg and presuming a similar blood to body weight ratio as in 
older animals, newborn pups would only have a blood volume of about 20-25 ill. This 
makes it impossible to use serial blood sampling from one animal in order to construct a 
plasma concentration curve of markers. This problem can be overcome by using a litter-
based model that was described by Habgood (1990). Instead of taking serial blood and 
CSF samples from one animal, a whole litter is used and only one blood sample is taken 
from each animal at successive time points. This model assumes that every littermate 
behaves in a similar manner, and a sample from one animal can represent all other 
littermates at that time point (Habgood, 1990). 
Newborn opossums model 
The very small size of newborn opossums made it technically impossible to cannulate 
any vessels for infusion or nephrectomise animals in order to maintain a constant 
plasma concentration of markers. In the present study, near to steady-state ratios were 
estimated by dividing the CSF or brain activity by the mean plasma activity throughout 
the experiment following single injection, in non-nephrectomised animals (see 
equations below). 
CSF/Plasma Ratio = CCSF jCp/asma T) 
	
(3.1) 
Brain/Plasma Ratio = Cbrain f Cp/asma T) 
	
(3.2) 
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The accuracy of estimating steady-state ratios with this method was evaluated in older 
postnatal animals by comparing steady-state ratios obtained from nephrectomised 
animals, with ratios from unoperated (intact) animals determined using the above 
equations. Preliminary experiments were necessary to determine the time it takes to 
approach a steady-state in nephrectomised animals. This was investigated in pups at P37 
since it was found impossible to nephrectomise younger animals. It was also necessary 
to determine the plasma concentration curves at several developmental ages in intact 
animals in order to check if the plasma profiles for the markers changed with age. 
Time to approach steady-state in nephrectomised animals 
In order to determine the time it takes to approach steady-state between plasma, CSF 
and brain a group of P37 opossums (n=12) were bilaterally nephrectomised (for surgical 
details see Chapter 2). Animals were injected ip with a mixture of 14C-sucrose and 3H-
inulin and killed with an overdose of halothane inhalation after 1, 2, 3 and 4 hours and 
blood, CSF, and brain samples were collected. Since a litter-based model was used, it 
was necessary to standardise the plasma concentrations between different animals in 
separate experiments. This was obtained by expressing plasma concentrations as a ratio 
between the activity in plasma and injection solution. For each experiment the isotope 
concentration in the injection solution was determined. 
Plasma concentration curves in intact animals 
Opossums at P9-10 (n=15), P15 (n=15), and P37 (n=12) were given a standardised 
injection of a mixture of 14C-sucrose and 3H-inulin. Animals were killed with an 
overdose of Halothane between 1/2  and 4 hours, and blood samples were taken in order 
to determine the plasma concentration curves of markers. The plasma concentration was 
plotted against the time after the injection. The integral of the plasma curve was used to 
-71- 
Chapter 3: Experimental Model 
calculate the mean plasma concentration at any time point throughout the experiment. 
Ratios were calculated between the CSF/mean plasma concentration and brain/mean 
plasma concentration (see Equation 3.1 and 3.2.) 
Results and Conclusions 
Nephrectomised animals 
Plasma concentration curve and time to approach steady-state 
Animals at P37 were bilaterally nephrectomised in order to determine the time it takes 
to reach steady-state and to evaluate the novel model of estimating steady-state ratios in 
intact animals. Figure 3.1 shows the plasma concentration curve in nephrectomised 
animals after a standardised ip injection of sucrose and inulin. After nephrectomy the 
plasma concentration became stable within three hours for both inulin and sucrose. 
Sucrose being a smaller molecule with a faster diffusion rate reaches a steady level 
within one hour. Nephrectomy is therefore a suitable method of achieving steady 
plasma concentration of a substance when constant infusion is not practical. 
CSF/plasma ratios for sucrose and inulin in these animals approached a plateau by three 
hours after the injection (Figure 3.1). The brain/plasma ratios for sucrose also 
approached a plateau after three hours whereas inulin is not illustrated since it did not 
reach detectable levels (<1% of plasma concentration) within 4 hours. 
Non-nephrectomised animals 
Plasma concentration curves 
Groups of opossum pups at P9-10, P15, and P37 were injected with markers without 
prior nephrectomy. As seen in Figure 3.2 the litter based model provides a useful 
method of monitoring plasma concentrations in very small animals, where it is not 
possible to obtain serial blood samples from one animal. The plasma concentrations of 
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inulin and sucrose reached a peak within 1 hour, thereafter they fell throughout the time 
of the experiment because of renal clearance. This was confirmed by finding very high 
isotope activity in urine. The markers were cleared from the blood at a slower rate at 
P9-P15 compared to P37. When possible a polynomial regression line was fitted to the 
plasma concentration time points, and was forced to cross 0 at the origin since at time 0 
all of the isotope should be in the intraperitoneal cavity, and none in the blood. In other 
cases a computer fitted bezier curve was made to fit through the average plasma 
concentration at each time point. According to the litter-based model this was 
representative of the plasma concentration curve for all non-nephrectomised animals 
between 0 to 4 hours and the integral could then be used to estimate the mean plasma 
concentration at any time point. 
Steady-state ratios in intact animals 
In nephrectomised animals the time to approach steady-state had been determined to be 
at least three hours. According to the litter-based model the changes in plasma 
concentration curve from an individual sample could be approximated by the plasma 
concentration curve from the litter-based experiment. Steady-state CSF/plasma and 
brain/plasma ratios in intact animals were calculated using equation 3.1 and 3.2 at three 
hours. The accuracy of these ratios were determined by comparing them with ratios in 
nephrectomised animals at the same time point, which had been shown to approach a 
steady-state (Table 3.1). 
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Table 3.1 
Sucrose 	 Inulin 
CSF/Plasm Brain/plasma CSF/plasma Brain/plasma 
Nephrectomised 15.0 ± 1.8 4.4 ± 0.8 6.9 ± 0.6 3.5 ± 0.9 
Intact 14.2 ± 2.0 4.3 ± 0.5 7.3 ± 0.7 3.4 ± 0.4 
Steady-state CSF/plasma and brain/plasma ratios for 14C-sucrose and 3H-
inulin in nephrectomised (n=4) and intact (non-nephrectomised, n=5) P37 
opossums. CSF concentrations were measured in samples collected from the 
cisterna magna. In nephrectomised animals, the CSF and plasma 
concentrations both approached steady-state by 3 hours after ip injection, 
whereas in intact (non-nephrectomised) animals the plasma concentration 
peaked at 30-60 min after the injection and then gradually fell. In these intact 
animals, the mean plasma concentration was determined from the integral of 
the plasma concentration curve over the entire time course of each 
experiment and ratios calculated as CSF/mean plasma concentration or 
brain/mean plasma concentration (see equation 3.1 and 3.2). These two 
different methods of determining steady-state ratios gave similar results. 
Values are mean ± S.E.M. 
- 74 - 
Figure 3.1 
The left y-axes in A and B show the plasma/injectate (m) and the CSF/injectate 
(•) concentration ratios for sucrose (A) and inulin (B) following a single ip 
injection in nephrectomised opossums at P37. The right y-axes in A and B show 
the CSF/plasma ratios (A). The left y-axes in C show the plasma/injectate (•) 
and the brain/injectate (•) concentration ratios for sucrose in the same animals. 
The right y-axes in C show the brain/plasma ratios (v). The x-axes show the 
time after the ip injection. The concentration in plasma, CSF and brain were 
divided by the original concentration in the injection solution in order to obtain 
normalised data that were comparable between different animals and 
experiments. The plasma/injectate, CSF/injectate and brain/injectate 
concentration ratios are all approaching a steady level by three hours after 
injection for both markers. CSF/plasma ratios for sucrose (A) and inulin (B), and 
brain/plasma (C) for sucrose also approach a steady level by three hours after 
injection. The brain/plasma ratios for inulin were not illustrated because it did 
not reach appreciative levels in brain within three hours. All data points shown 
are means (n=3-4) and the error bars indicate ± SEM. Where no error bars are 
visible, they are contained within the symbol. 
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Figure 3.2 
Plasma/injectate concentration ratios for 14C-sucrose (A), 3H-inulin (B) in 
plasma after a single intraperitoneal injection in non-nephrectomised animals 
determined at P9-P10 (Äo, ), P15 (•), and P37 (p). The x-axes show the time 
after the ip injection. The concentration in plasma, CSF and brain were divided 
by the original concentration in the injection solution in order to obtain 
normalised data that were comparable between different animals and 
experiments. The curves shown are bezier curves computer fitted to data points 
for each age and used to calculate mean plasma concentrations. The 
plasma/injectate concentration ratios in these non-nephrectomised animals all 
reach a peak and then gradually decline over time. The curves at P9-10 and 
P15 animals were very similar for inulin and sucrose, whereas the peak for P37 
animals occurred somewhat later. 
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Validity of model 
The CSF/plasma and brain/plasma ratios of sucrose and inulin at 3 hours were very 
similar for nephrectomised and intact animals (see Table 3.1). Steady-state ratios from 
nephrectomised animals can therefore be accurately estimated from animals without 
prior nephrectomy. Nevertheless, there are a few considerations of the model when 
applying it to younger ages. Firstly, does the time to reach steady-state change with the 
age of the animals? If the equilibrating time is longer in younger animals the ratios 
would be under-estimated since the CSF and brain concentrations are still rising. This 
could not be tested in opossums since it is technically not possible to keep a steady 
plasma concentration at very young ages. However, it is unlikely that it would take a 
longer time in younger animals since lipid insoluble compounds seem to enter the CNS 
faster at younger ages (Ferguson and Woodbury, 1969; Dziegielewska et al., 1979; 
Habgood et al., 1993) and the time to reach steady-state should then be shortened (see 
Chapter 4 for discussion). Secondly, how do the differences in the plasma profile for 
markers at different ages affect the model? By calculating 3-hour steady-state ratios at 
P37 by applying the different plasma concentration curves at P9-10, P15, and P37 this 
could be determined. The data are presented in Table 3.2. By applying the P15 and P9- 
P10 plasma curve to the P37 data, the mean plasma concentration will be 
underestimated, giving higher ratios. The effect is very small on inulin ratios whereas it 
is greater on sucrose ratios especially when using the P15 concentration curve. The 
difference between using the P15 and P9-P10 concentration curves for inulin and 
sucrose is very small. It was therefore assumed that the plasma curve for P9-10 animals 
could also accurately represent the plasma curve for even younger animals. 
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Table 3.2 
P37 	P15 	P9-P10 
Sucrose 14.2 ± 0.9 18.4 ± 1.2 18.6 ± 1.2 
Inulin 7.4 ± 0.3 7.9 ± 0.3 8.3 ± 0.4 
The steady-state 3-hour ratios for inulin (n=5) and sucrose (n=5) in 
P37 opossums by applying P37, P15, and P9-P10 plasma 
concentration curves. The ratios changes for sucrose by using the 
P37 and P15 plasma concentration curves whereas the difference 
is small between P15 and P9-P10 animals. lnulin shows small 
differences in ratios by applying any of the plasma concentration 
curves. Values are means ± SEM. 
- 80 - 
Chapter 4 
* 
Uptake of Low Molecular Weight Markers 
during Development 
- 81 - 
Chapter 4: Uptake of Radiolabelled Markers 
Introduction 
Rapidly penetrating solutes will reach a CSF/plasma concentration ratio of 1 at 
equilibrium. Even slowly penetrating substances should at infinite time (equilibrium) 
reach the same concentration in the CSF as in plasma. Failure to reach a ratio of 1, as 
was reported in Chapter 3 for inulin and sucrose, could result from active transport 
from CSF to blood. However, this is unlikely in the case of substances such as sucrose 
or inulin that are supposed to be biologically inert within the body. A more likely 
explanation is a continuous replacement of CSF in the ventricles (ie. the flow of CSF), 
which could account for slowly penetrating solutes not equilibrating with the plasma 
concentration even after a long exposure in plasma. This is often referred to as the sink 
effect (Oldendorf and Davson, 1967; Davson and Segal, 1969). Slowly penetrating 
solutes will have a lower concentration in the newly formed CSF compared with 
plasma. The slower a substance penetrates the blood-CSF interface, the lower 
CcsF/Coasma ratio will be at steady-state. The steady-state level can therefore be a 
measure of permeability. 
In Chapter 3 a model was described that estimated steady-state CSF/plasma and 
brain/plasma ratios in animals with varying plasma concentrations of marker after a 
single intraperitoneal injection. The model was found to accurately estimate steady-
state ratios and this provided a way to study the penetration of markers with little 
manipulation of the animals. With further use of this model, steady-state ratios were 
estimated in Monodelphis pups at various ages between P6 to P65 for three small lipid 
insoluble markers sucrose, inulin, and L-glucose. The results are presented in this 
Chapter. In the current study, the penetration of lipid insoluble molecules has been 
measured in a quantitative way earlier in development than have previously been 
reported. The results of these experiments are compared with morphological studies 
using tracers presented in Chapter 5. 
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In order to investigate more directly the possible developmental changes that could 
give rise to age related differences in steady-state ratios, short time course uptake 
experiments were carried out (7-24 minutes). As explained in Chapter 2, Kin can be 
determined by the initial uptake into CSF and brain. The slow uptake of sucrose and 
inulin would be difficult to detect and therefore a smaller inert molecule was needed 
with faster penetration but still with hydrophilic characteristics. L-glucose with a 
molecular weight of 182 (about half the size of sucrose), metabolically inert because of 
its L configuration, and a LogDoctanot, 25°C value of —2.68 (see Table 2.2) was used. For 
comparison, the short-term uptake rate of a moderately lipophilic molecule (glycerol, 
LogD —1.94) was studied. Such a molecule should pass the cell membranes of the 
epithelial cells of the choroid plexus and the endothelial cells in the brain blood vessels 
with relative ease. Blood flow and the vascular surface area available for exchange 
would therefore mostly determine the uptake rate into the CNS. A moderately 
lipophilic molecule was chosen because the rate of uptake would be difficult to 
measure for highly lipophilic compound, where the CSF would rapidly equilibrate with 
plasma. Glycerol with a LOgDoctanol, 25°C of —1.94 and which had been shown to be 
relatively stable in vivo during such a short duration (see Chapter 2) was chosen as a 
suitable test molecule. 
Methods 
Steady-state concentration ratios during development 
Opossums at P5-P7 (n=9), P9-P13 (n=15), P15-P17 (n=5), P32-P37 (n=10), and P65 
(n=3) were injected, ip, with a mixture of 14C-sucrose and 3H-inulin. Steady-state ratios 
between CSF/plasma and brain/plasma were estimated by the model described in 
Chapter 3 in animals killed between 3-3V2 hours after the injection. The mean plasma 
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levels for 14C-sucrose and 3H-inulin of animals between P6-P10 were estimated from 
the plasma concentration curves for P9-P10 animals, and for animals aged between 
P13-P17 from the plasma curve for P15 animals; finally for animals aged between P32- 
P37 the plasma concentration curve from P37 animals was used (see Chapter 3 for 
plasma curves). Animals at P65 were nephrectomised prior to injection but were 
otherwise treated in the same manner and ratios were calculated assuming a steady 
plasma level. 
Other groups of opossums were injected, ip, with "C-L-glucose at P18 (n=9) and P38 
(n=10). Samples of CSF, blood and brain were collected approximately every 30 
minutes between % and 4 hours in order to construct a plasma concentration curves at 
both ages. Plasma samples collected for initial uptake rate experiments (see below) 
were included as data points in the plasma concentration curves, however, this resulted 
in many data points between 0 and 30 minutes. For the clarity of presentation, data 
points were grouped within the same 10-minute interval (0-10, 10-20, 20-30 minutes 
etc) and the mean ± SEM was calculated for each group (Figure 4.1). Plasma 
concentration curves were constructed by computer fitting bezier curves to the data 
points. Steady-state ratios between CSF/plasma and brain/plasma were estimated by the 
model described in Chapter 3, in animals killed between 3 and 3% hours (n=4 for both 
ages) after the injection. Differences in steady-state ratios were tested by unpaired t-
test. For more detailed description of procedures used in these experiments see Chapter 
2. Differences in steady-state ratios between P18 and P38 for L-glucose were tested by 
two-way unpaired t-test. 
Short time-course experiments 
Opossum pups at P18 (n=9) and P38 (n=13) were injected ip with a mixture of 3H-
glycerol and "C-L-glucose. The timing of tissue sampling was crucial in these 
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experiments, and therefore the procedure of taking CSF, brain and blood samples was 
modified. After anaesthesia, CSF was collected from the cisterna magna and the 
animal immediately decapitated to stop blood flow to the brain. Blood was then 
collected from the bleeding carotid artery and the brain removed. This procedure 
minimised the time delay between CSF and blood sampling. The starting and ending 
time of the blood collection was recorded and the average time calculated as the blood 
collecting time. The average difference in time between CSF collection and blood 
sampling was 26.3 ± 4.8 (Mean ± SD; n=8) seconds in P18 animals, and 18.5 ± 4.8 
(n=10) seconds in P38 animals. All blood samples were collected between 7 and 24 
minutes after injection. Since there was no blood flow to the brain after decapitation, 
the timing of brain tissue sampling was not considered critical but nevertheless it did 
not exceed one minute after decapitation. The amount of marker molecule entering the 
brain from blood between decapitation and brain tissue sampling will not effect the 
measurements since it will be compensated for by the deduction of the vascular space. 
The time for brain sampling was recorded as the time for decapitation. CSF/plasma and 
brain/plasma ratios were calculated and plotted against the blood collection times. 
Linear regression lines were fitted to data points with least square method. Differences 
in slope of the regression lines were tested with unpaired t-test. For more detailed 
description of procedures such as injections, collection and handling of tissue samples 
used in these experiments see Chapter 2. 
Results 
Steady-state concentration ratios during development 
In order to estimate steady-state ratios for L-glucose with the model described in 
Chapter 3 a plasma concentration curve was first determined after single ip injection in 
non-nephrectomised animals at both P18 and P38. This showed that similar to inulin 
and sucrose (see Figure 3.2), the plasma concentration for L-glucose increased rapidly 
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and then gradually fell over time at both ages (see Figure 4.1). The changes in steady-
state CSF/plasma and brain/plasma ratios for radioactive markers with age are shown in 
Figure 4.2. Ratios for sucrose were consistently higher than for inulin at all ages 
examined. Sucrose CSF/plasma ratios fell from 59.1 ± 2.9% (mean ± SEM) at P6 to 6.2 
± 0.9% at P65 and inulin ratios decreased from 29.7 ± 1.4% at P6 to 1.3 ± 0.2% at P65. 
Brain/plasma ratios for sucrose were reduced from 15.9 ± 0.8% to 4.0 ± 0.2% between 
P6 and P65 whereas inulin ratios declined from 9.5 ± 0.7% to 1.4 ± 0.1% over the same 
time. Ratios for the smaller molecule L-glucose were higher than inulin and sucrose at 
corresponding ages. There was a significant reduction in steady-state CSF/plasma and 
brain/plasma ratios for L-glucose between P18 and P38. The steady-state CSF/plasma 
ratios decreased significantly from 35.5 ± 1.9% at P18 to 14.2 ± 0.3% at P38 (p<0.01). 
In a similar way the brain/plasma ratios at 3 hours were reduced from 13 ± 1.0% at P17 
to 7.1 ± 0.3% at P38 (p<0.01). Brain/plasma ratios were considerably lower than the 
CSF/plasma ratios at every age for all markers. This is probably due to a different 
distribution space in the brain compared to CSF. Both inulin and sucrose are believed 
to be extracellular markers and will therefore have a much smaller distribution volume 
in brain compared to CSF. 
Short-time course experiments 
CSF/plasma and brain/plasma ratios measured in short-time course experiments (7-24 
min) for both glycerol and L-glucose are shown in Figure 4.3. During this short initial 
period (7-24 min) the plasma concentrations were almost stable and therefore changes 
in CSF/plasma and brain/plasma concentration ratios with time were directly related to 
the rate of uptake into CSF and brain (see Figure 4.1). Analysis of the data points 
showed that uptake into CSF and brain was linear over this time period. This suggests a 
unidirectional uptake into the CNS compartments and the slope of fitted linear 
regression lines could be used to represent the initial uptake rate into either CSF or 
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brain (see Fenstermacher et al., 1981). The regression lines' intercept with the x-axis 
could estimate the initial distribution volume in the brain at P18 and P38. The 
radioactivity due to this volume was deducted from all brain samples in order to obtain 
true concentrations in brain tissue. Differences in the slope of the regression lines were 
compared using a student's t-test (unpaired). L-glucose showed a much faster initial 
rate of uptake into CSF and brain at P18 compared to P38 (Figure 4.3). The slope of the 
regression line for CSF uptake of L-glucose in P18 animals was significantly steeper 
than that of P38 (P=0.01). The difference in uptake into brain between the two ages, 
because of the greater scatter of the data, failed to reach statistical significance 
(P=0.07). The rate of uptake of glycerol into both CSF and brain appeared similar at 
both developmental ages (see Figure 4.3). The slopes of the regression lines for CSF 
uptake of glycerol, and for brain uptake of glycerol were not statistically different 
between the two ages (P=0.97 and P=0.33, respectively). 
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Time after injection (min) 
Figure 4.1 
Plasma/injectate concentration ratios for 14C-L-glucose in plasma after a single 
intraperitoneal injection in non-nephrectomised animals determined at P18 (0) 
and P38 (•). The x-axes show the time after the ip injection. The concentration 
in plasma, CSF and brain were divided by the original concentration in the 
injection solution in order to obtain normalised data that were comparable 
between different animals and experiments. The data points were averaged for 
1-5 animals within the same 10-minute interval (0-10, 10-20, 20-30 minutes 
etc). The curves shown are bezier curves computer fitted to data points for 
each age and used to calculate mean plasma concentrations. The 
plasma/injectate concentration ratios reach a peak and then gradually decline 
over time. Note that the plasma concentration appeared to be almost stable 
between 7-25 minutes after the injection. 
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Figure 4.2 
The y-axes show steady-state CSF/plasma (A) and brain/plasma (B) ratios (°/0) 
for 14C-sucrose (•), 3H-inulin (0), and 14C-L-glucose (A) and the x-axes show 
the postnatal age in days. All ratios were measured in non-nephrectomised 
animals, except those at P65 which were measured in animals that had been 
nephrectomised. Both CSF/plasma and brain/plasma ratios declined markedly 
with increasing postnatal age. Brain/plasma ratios were also consistently lower 
than CSF/plasma ratios at all ages. Values shown are means (n=3-8) and the 
error bars indicate ± S.E.M. Where no error bars are visible, they are obscured 
by the symbols. 
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Figure 4.3 
The y-axes show CSF/plasma and brain/plasma concentration ratios (%) for 
L glucose (A and C) and 3H-glycerol (B and D) measured in short time 
course experiments after a single ip injection in P18 (•) and P38 (0) 
opossums. The x-axes show the time after injection at which samples were 
collected. Linear regression lines have been fitted to the data points. The slopes 
of the regression lines (the rate of uptake) between P18 and P38 animals were 
compared using a student's t-test. The rate of uptake of 14C-L-glucose into CSF 
in P18 animals was significantly faster than in P38 animals (P=0.01). The rate 
of uptake of 14C-L-glucose into brain at P18 appeared faster than at P38, but the 
difference was not statistically significant (P=0.07). The rate of uptake of 3H-
glycerol into CSF and brain appeared similar both at P18 and P38 (P=0.33 and 
P=0.97,respectively). 
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Discussion 
Previous studies in rats and sheep have shown that the penetration of lipid insoluble 
molecules into brain and CSF is higher in early development and decreases with age 
(Ferguson and Woodbury, 1969; Dziegielewska et al., 1979; Habgood et al., 1993). The 
present study confirms earlier results, and shows that sucrose and inulin CSF/plasma 
ratios fell approximately tenfold from P6 to P65, and brain/plasma ratios about fivefold 
over the same time span. Ferguson and Woodbury (1969) reported much higher steady-
state ratios in rat embryos than those presented in this study (CSF/plasma ratio for 
sucrose and inulin was 88% and 76% at E17, compared with 59% and 29% at P6 in this 
study). In similar experiments during postnatal development in the rat by Habgood et al. 
(1993), much lower ratios were reported. In both these studies neonates or pregnant 
females were nephrectomised and given an ip injection of markers in order to achieve a 
stable plasma concentration. Ferguson and Woodbury (1969) found that CSF/plasma 
and brain/plasma ratios did not reach a plateau until 16-24 hours after the injection or in 
some cases the ratios were still increasing at 24 hours. Steady-state was defined by little 
change in the ratio and no effort was made to investigate whether the plasma or CSF 
concentrations were stable throughout the whole 24 hours. Habgood et al. (1993) 
showed in neonatal rats that a plateau in plasma concentration was obtained after 2-3 
hours, thereafter the plasma level gradually declined. This gradual decrease in plasma 
concentration probably explains the high steady-state ratios and also the long time until 
steady-state was achieved in the study by Ferguson and Woodbury (1969). The steady-
state experiments for sucrose and inulin showed a large decrease in steady-state ratios 
during development (see Figure 4.2). This has been shown before in other species 
(Ferguson and Woodbury, 1969; Dziegielewska et al., 1979; Habgood et al., 1993) but 
the explanation for this is still debatable. As has been discussed before in Chapter 3, the 
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most likely explanations are: 
a) a decrease in the permeability of exchange surface areas 
b) an increase in CSF turnover rate 
c) a decrease in area of exchange surfaces 
d) a decrease in blood flow to exchange surfaces 
These are discussed separately below. 
Decrease in permeability of the brain barriers 
One possible explanation for falling ratios with age could be a reduced rate of entry 
across the brain barriers during development. One of the distinct structural features of 
the mature brain barriers is the presence of complex tight-junctions in endothelia of the 
brain blood vessels and epithelia of the choroid plexus (Brightman and Reese, 1969). To 
what degree there are changes in the structure of the tight-junctions during development 
is still debatable (for more detailed discussion see Chapter 1). Reports showing complex 
tight-junctions from the first blood vessels that invade the brain (Mollgard and 
Saunders, 1975; Bauer et al., 1993) have been published as well as papers showing a 
more gradual change in the structure of the junctions (Stewart and Hayakawa, 1987). 
Nevertheless, as has been discussed before, there is a clear reduction in the penetration 
of lipid insoluble compounds after birth in the rat (Ferguson and Woodbury, 1969; 
Habgood et al., 1993) when the endothelial tight-junctions already show a mature form 
(Kniesel et al., 1996). This suggests that the development of tight-junctions is not the 
determinant of the changes in penetration of markers with age. Other explanations for 
the decline in permeability with age have been proposed to be due to a decrease in 
transcellular transport in vesicles (Xu and Ling, 1994) or different tubulo-canicular 
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structures (Lossinslcy et al., 1986; Balslev et al., 1997a). Several authors have proposed 
that the penetration of lipid insoluble molecules into CSF is by unrestricted diffusion 
(Felgenhauer, 1974; Dziegielewska et al., 1979; Habgood et al., 1993). This means that 
larger molecules are not more restricted than smaller ones; instead it is the diffusion 
capacity of the molecule which is the deciding factor. A smaller molecule will penetrate 
faster because of its higher diffusion capacity. Habgood et al. (1993) found a parallel 
decrease in CSF/plasma ratios with age for inulin and sucrose and an absence of any 
increase in the slope of curves between diffusion coefficient (D37) and steady-state 
CSF/plasma ratios. It was therefore suggested that there is change in 'pore' numbers 
rather than 'pore' size during development (Habgood et al., 1993). These 'pores' are 
morphologically uncharacterised structures that form an aqueous pathway between 
blood and CSF for water soluble molecules. In contrast, lipid soluble solutes will cross 
the blood-CSF interface rapidly in a non-selective way and newly formed CSF will 
therefore have the same concentration as in the plasma. 
Increase in CSF turnover 
A decrease in CSF/plasma steady-state levels of markers could also be a reflection of an 
increase in CSF sink, which is the process whereby CSF solutes are diluted by the 
continuous production of CSF (Davson and Segal, 1969). CSF is produced mainly by 
the choroid plexus, which is situated in the roof of each ventricle (Johanson, 1988). The 
detailed process of CSF production will not be discussed here but it involves Na+ and 
HCO3" being actively transported by the epithelial cells from blood to CSF (Speake et 
al., 2001). This creates an osmotic force for water molecules to rapidly pass from 
plasma to CSF, whereby CSF is approximately isoosmolal to plasma (Johanson, 1995). 
The CSF production generates a flow through the ventricles, spinal canal and 
subarachnoid space, which results in drainage of CSF through the arachnoid villi in the 
arachnoids (see Figure 1.1). The arachnoid viii are believed to work like pressure 
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valves whereby ventricular pressure is not augmented even if CSF production increases 
(Johanson, 1995). The fluid is formed across a selective choroidal epithelial layer and 
drained out of the system by bulk flow across the non-selective arachnoid villi 
(Johanson, 1989). The newly formed fluid will dilute any substance in the CSF and the 
effect is often referred to as the CSF sink (Saunders and Dziegielewska, 1997). 
Reproducible measurements of the CSF production rate have proven difficult. Most 
methods are quite invasive and have given different estimates of CSF production (Cserr, 
1965; Dudzinski and Cutler, 1974; Nakamura and Hochwald, 1983). The most accurate 
estimations involve determining CSF production by dilution rate of a substance from 
the CSF. The marker substance needs to be as inert as possible without escaping from 
the CSF, therefore molecules such as inulin and larger dextrans have been used 
(Rothman et al., 1961; Johanson and Woodbury, 1974). The production rate is measured 
in gl/minutes, however, when comparing different animal species it is more useful to 
express it as the rate of newly formed fluid to the whole volume of CSF. This is called 
the CSF turnover and in adult humans has been estimated to be around 0.25 % per 
minute (Johanson, 1995). 
Even more of a technical challenge is to estimate the CSF production during 
development due to the small size of the brain. This might be the reason why it has only 
been attempted in neonatal rats and fetal sheep with discrepancies between the reported 
results (Bass and Lundborg, 1973; Evans et al., 1974; Johanson and Woodbury, 1974; 
Fossan et al., 1985). There are, however, similar trends in the results of those papers: 
The CSF volume production clearly does increase during development in both species. 
When this is related to CSF volume and expressed as CSF turnover, there is no 
significant increase during development in sheep (Evans et al., 1974). Studies in 
neonatal rats by Bass and Lundborg (1973) and Johanson and Woodbury (1974) 
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reported an increase in the CSF turnover with age, however, the exact numerical value 
was quite different between the two studies. An increase in the CSF turnover should 
also reduce the time for substances to reach a steady level in the CSF. Habgood et al. 
(1993) noticed no change in the time to reach steady-state in rats between P2 and P20, 
when there was a marked decrease in steady-state ratios for both inulin and sucrose. 
In the adult, brain/plasma ratios will also be affected by an increase in CSF sink since 
there is a free exchange of solutes between the extra cellular fluid (ECF) and CSF, 
however, the situation is more complicated than in the CSF. The brain ECF volume has 
been estimated to be 15-20% of the adult brain, which makes the ECF volume 
approximately the same or slightly larger than the CSF volume (Johanson, 1993). 
Considering this, it is more likely that brain composition influences CSF more than the 
other way round in the adult. Therefore the CSF turnover is only effective in removing 
solutes from the brain when they enter the brain via the blood-brain barrier at a slow 
rate. The effect has been demonstrated by experiments where the CSF production has 
been reduced showing increased steady-state levels in brain (Davson and Segal, 1969). 
The relative importance of CSF turnover on CSF and ECF has been shown using 
dilution rates of protein from CSF and ECF. The clearance rate from CSF is faster than 
from ECF (Johanson, 1993). This might show a physiological role of the CSF turnover 
whereby it constitutes a way for polar substances produced in the brain to be transported 
out from the CNS (Johanson, 1993). The relative importance between CSF and ECF 
may be quite different in the developing compared to the adult brain. In younger 
animals the choroid plexus and CSF volume are proportionally larger to the size of the 
brain (Johanson, 1995). Interestingly, when the CSF turnover is related to brain size 
there is a clear reduction in the CSF 'sink' effect on the brain with age (Saunders, 
1992). If the turnover rate of CSF compared to brain size is lower in older animals this 
should, in contrast to the results of this study, increase the brain ratios during 
development. It therefore seem unlikely that an increase in the CSF sink is responsible 
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for the age related decline in steady-state ratios. 
Decrease in exchange surfaces and blood flow 
As mentioned before it has been suggested that the greater penetration of lipid insoluble 
compounds during development could be a result of a larger number of 'pores' available 
for penetration across the blood-CNS interface. This could be brought about by an 
increased surface area for exchange such as an augmented capillary bed. Morphological 
studies of brain capillaries have shown that capillary density increases during 
development (Caley and Maxwell, 1970; Dambska, 1995). These studies suggest that it 
is unlikely that an increase in exchange surface area could explain higher steady-state 
ratios of lipid insoluble molecules in the developing CNS. One of the factors 
influencing uptake rate is blood flow. The entry of a substance, which has high 
permeability across the brain barriers, is mostly restricted by the delivery (blood flow) 
to the exchange surfaces. However, sucrose and inulin, being lipid insoluble molecules 
(see Table 2.2), enter the CSF and brain at a slow rate and will therefore be affected 
very little by changes in the blood flow. 
Nature of the decrease in steady-state ratios 
The short-term uptake experiments were undertaken in order to more precisely examine 
the factors that could explain changes in steady-state ratios for markers with age. As 
mentioned before, the factors affecting steady-state ratios of small lipid insoluble 
molecules are permeability, CSF turnover rate, blood flow, and vascular surface area. 
The influence of CSF turnover was considered negligible in short-term experiments 
since the uptake rate was measured during a short time space in which the CSF 
production must have been very small. It was necessary to use a marker (L-glucose) that 
behaves passively and which is small enough to penetrate into the brain and CSF to a 
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measurable extent during the short time of the experiments. In addition to L-glucose, the 
uptake was measured of the moderately lipid soluble molecule glycerol (see Table 2.2). 
The radioactive labelling of glycerol in plasma and CSF was checked in samples 30 min 
after injection (see Table 2.3). This showed that 71% in blood and 80% in CSF of 
labelling was still on glycerol. Almost all the rest was on more water soluble 
compounds. Any label on water would have been rapidly and widely distributed 
throughout the whole body water and would therefore influence the CSF/plasma and 
brain/plasma ratios very little. That the proportion of radioactive label still on glycerol 
was higher in CSF than blood indicates that there was little label on compounds that 
penetrate from blood to brain at a higher rate than glycerol. Because glycerol is 
relatively lipid soluble, it could be expected to readily penetrate the cell membranes of 
endothelial and epithelial cells. The uptake rate should therefore not be affected by any 
possible tightening of the brain barriers such as a change in tight-junctional structure. It 
could, however, be expected to be influenced by a change in blood flow or exchange 
surface area. The initial uptake rate into brain and CSF for glycerol did not change 
significantly between P18 and P38. This indicates that there is little change in either 
blood flow or surface area for exchange between P18 and P38. In contrast to glycerol, 
the uptake rate for L-glucose decreased both into the CSF and brain. It can therefore be 
concluded that there is a significant decrease in the permeability of the brain barriers to 
L-glucose with age. This can to a large extent, if not all, explain the decrease in steady-
state ratios between P18 and P38 for L-glucose and probably also the striking decline in 
ratios for inulin and sucrose with age (see Figure 4.2). 
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Introduction 
There has been a lack of low molecular weight tracers available that can be visualised 
both for light and electron microscopy. Markers that have been previously used such as . 
FIRP, ferritin, and cytochrome c are large proteins that are difficult to quantitate in low 
concentrations. The only small molecular sized tracer that has been used in the past is 
lanthanum, however, it is probably not suitable for in vivo experiments because of its 
toxicity (Milhorat et al., 1975). Molecules such as inulin and sucrose, which are easy to 
quantitate because they can be radiolabelled, are water soluble, and will therefore be 
washed out of the material when tissue is processed. The only way to localise these 
molecules would be to quick-freeze the material and visualise them using 
autoradiography. However, this technique does not give high enough resolution to 
determine the intracellular distribution. In order to prevent washing out of molecules 
from the tissue, tracers need to be immobilised. This is achieved by fixation in which 
proteins and lipids crosslink, thereby preserving cell structure. Suitable tracing 
molecules need to be able to react with the fixation agents (eg. aldehydes) and be 
immediately attached to their surroundings. For the present study an inert tracer was 
needed that could be expected to cross the brain barriers in a manner similar to inulin 
and sucrose and be of comparable size. Biotin-dextrans have been extensively used for 
axonal tracing (for review see Kobbert et al., 2000) but their properties also make them 
appropriate low molecular weight tracers across the brain barriers. Dextrans are 
hydrophilic polysaccharides and have favourable characteristics for usage as an external 
tracer such as high water-solubility, they are inert in vivo and can be manufactured in a 
variety of different molecular weights. Their unusual a-1,6-polyglucose linkages are 
resilient to cleavage by most enzymes and they will therefore remain structurally intact 
for a long time. Lysine residues can be incorporated into the dextran and this makes it 
aldehyde fixable, a characteristic that was essential for the present study. Moreover, 
biotin can be conjugated to dextrans and this will make the molecule visible using 
avidin reactions. Therefore, a 3000 molecular weight, lysine fixable, biotin-dextran 
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(BDA-3000, Molecular Probes) was chosen as a small, lipid insoluble tracer. However, 
the molecular weight of the dextran is not uniform, and each sample of BDA-3000 
contains a range of different sized biotin-dextrans with an average molecular weight 
close to 3000 (technical information provided in the Molecular Probes handbook for 
product number D-7135). 
Experiments described in this Chapter were undertaken in order to visualise the route 
for small lipid insoluble molecules across the brain barriers, using BDA-3000, in the 
course of development. It was first necessary to establish whether BDA-3000 was 
crossing the brain barriers in a similar way to other small lipid insoluble molecules of 
comparable sizes. This was achieved by comparing BDA-3000 uptake into CSF with 
that of sucrose, inulin and L-glucose. BDA-3000 seemed to behave in a similar passive 
manner to these compounds (see Figure 5.9) and it was therefore further used in tracer 
experiments where it was visualised both at the light and electron microscopic levels. 
Preliminary experiments suggested that BDA-3000 was transferred across the blood-
CSF barrier (choroid plexus) and then into brain tissue and did not seem to escape out 
of blood vessels inside the brain. In order to compare morphological aspects of the 
choroid plexus with the transfer of radioactive markers and BDA-3000, the structure of 
the choroid plexus was examined during development using both the light and electron 
microscope. As has been described in Chapter 1 the choroid plexus is the site for blood-
CSF barrier mechanisms (see Figure 1.1). The structural basis of this barrier is believed 
to be tight-junctions present between adjacent epithelial cells that have been shown to 
stop the paracellular movement of tracers from blood into the CSF in adult animals 
(Becker et al., 1967; Brightman, 1968; Milhorat et al., 1973; van Deurs, 1978). Several 
studies have proposed that structural changes of tight-junctions are responsible for the 
decrease in brain barrier permeability during development (Stewart and Hayakawa, 
1987; Kniesel et al., 1996), however, there are also studies showing that tight-junctions 
with mature appearance are present both at the blood-brain and the blood-CSF barrier 
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early in development (Tennyson and Appas, 1968; Mollgard and Saunders, 1975; 
Mollgard et al., 1979; Bauer et al., 1993; Xu and Ling, 1994). Other studies have 
suggested that the permeability change is caused by a decrease of transfer in vesicular 
structures or other subcellular organelles (Mollgard and Saunders, 1977; Lossinslcy et 
al., 1986; Xu and Ling, 1994). These studies have been reviewed in detail in Chapter 1 
and possible explanations for the somewhat contradictory results of these investigations 
have also been given. The electron microscopic study in this thesis focused on 
investigating the presence and appearance of tight-junctions, vesicles and other 
subcellular structures that have been proposed to be of importance for the transfer of 
molecules from the blood into CSF in the choroid plexus. The more general 
ultrastructural development of the choroid plexus was also examined in order to assess 
the opossum as a model to study the mammalian choroid plexus. This was important to 
assess since the opossum has been reported to show a difference in choroid plexus 
development from other mammals in that it does not seem to have a stage when the 
choroid plexus epithelial cells store large amounts of glycogen (Dziegielewska et al., 
2001). 
Methods 
Validation of BDA-3000 as a tracer for small lipid insoluble 
molecules 
To confirm that BDA-3000 is a suitable marker for small lipid insoluble molecules, 
CSF/plasma ratios were measured for a structurally similar lysine fixable 3000 
molecular weight rhodamine dextran (D-3308, Molecular Probes). D-3308 was used 
instead of BDA-3000 since it is fluorescent and can therefore be measured 
quantitatively. A group of opossums pups aged P16 (n=9) were injected ip with D-3308 
(0.7 mg g body weight in sterile 0.9% NaCl solution) and samples of plasma and CSF 
were collected after three hours. For more detailed description of methods such as the 
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collection of CSF and plasma see Chapter 2. The amount of fluorescence in each sample 
was measured with an Olympus BX50 fluorescence microscope attached with a PM30 
photomicrograph unit. Samples of plasma and CSF were transferred to 5 pi glass 
capillaries and mounted on glass slides. At x10 magnification the exposure time (ET) 
was recorded for the centre of the glass capillary. CSF/plasma ratios were calculated as 
ETplasmaiETcsF (the ET is inversely related to the concentration in the sample, see Figure 
5.1). The accuracy of measuring ratios this way was confirmed by comparison with 
ratios obtained using absorbance spectrophotometry. The absorbance of serial dilutions 
of D-3308 in saline was determined by a spectrophotometer at 518 nm and ET was 
recorded for the same solutions. Ratios calculated using absorbance spectrophotometry 
between the different solutions were almost identical to ratios calculated from the ET 
readings (Table 5.1). The influence of media on ET readings was also examined; similar 
concentrations of D-3308 in saline, CSF or plasma all gave similar ET readings. That 
this was a reliable method for determining concentrations in samples was further 
confirmed by serial dilutions of D-3308 in saline; this showed a linear relationship 
(R=0.996) between ET and the concentration of D-3308 (Figure 5.1). The major 
advantage of measuring ratios with a fluorescence microscope is that very small sample 
volumes can be measured (1-2 gl) undiluted in a glass capillary. This was critical in 
young pups where only small volumes of CSF could be obtained (<10 pi); this would 
have been undetectable using conventional absorbance spectrophotometry. 
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Table 5.1 
Measurements of solutions Concentration ratios 
Solution 
Absorbance 
at 518 nm 
Exposure 
time (sec) 
Ratios 
Absorbance 
Spectrophotometry 
Exposure 
time 
A 
B 
C 
0.304 
0.090 
0.025 
4.85 
15.3 
54.7 
B:A 
C:A 
C:B 
0.296 
0.082 
0.278 
0.317 
0.089 
0.280 
On the left are measurements of absorbance and ET on three dilutions of D-
3308. On the right are concentration ratios calculated between these solutions. 
Note that the ET for a sample is inversely related to its concentration and the 
concentration ratio between sample B and A is calculated by dividing the ET of 
sample A by B. Both methods gave similar ratios, which shows that exposure 
time readings is an accurate way of determining the concentration of D-3308 in 
a sample. 
In order to check that the brain uptake of D-3308 and BDA-3000 were similar, their 
distribution in brain sections was compared. A P7 opossum was injected simultaneously 
with both D-3308 and BDA-3000 at the same dose (0.7 mg g -1 body weight) into the 
intraperitoneal cavity, and the brain fixed in Bouin's fixative after 30 min. D-3308 was 
detected directly using filters for rhodamine and BDA-3000 was visualised with the 
diaminobenzidine tetrahydrochloride (DAB) reaction (see below and Appendix A and B 
for more detailed description of histochemical methods and reagents used). 
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Figure 5.1 
Standard curve for D-3308. The x-axis is the concentration (mg/ml) of D-3308 
and the y-axis is ET-1 (note that the ET reading is inversely related to the 
concentration). A linear regression line was fitted to the data with a R-value of 
0.996. 
Light Microscopy 
Tissue preparation 
Litters of opossum pups at PO (n=4), P5 (n=2), P8-P9 (n=6), P13 (n=2), and P30 (n=2) 
were detached from the mother and then injected ip with the BDA-3000 (0.7 mg g -1 
body weight in a sterile 0.9% NaC1 solution). Five to 90 minutes after the injection, 
0.2 - 
0.1 - 
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animals were killed with an overdose of inhaled halothane (Zeneca) and brains 
immediately fixed. For technical reasons it was not possible to fix all brains in the same 
manner. For animals aged between PO and P13 brains were dissected out and 
submerged in Bouin's fixative. Animals at P30 were first perfuse-fixed with 
paraformaldehyde and then the brains were dissected out and submerged in Bouin's 
fixative. Paraformaldehyde was made up freshly as a 4 % solution in 0.15M phosphate 
buffered saline (PBS; pH 7.4) and kept at 4°C until just prior to perfusion. The right 
atrium was cut open and the fixative was delivered through propylene tubing into the 
left heart ventricle by a motor driven syringe pump. The delivery rate was set at half the 
animal's predicted total blood volume per minute and perfusion stopped after 10 
minutes. The total blood volume was estimated as 10% of the weight of the animal. In 
order to clear blood from the vasculature, a PBS solution containing heparin (10 
units/m1) was perfused for the first minute before switching to the fixative. After 24 
hours in Bouin's fixative, brains were dehydrated in serial solutions of ethanol (70% to 
100%) and cleared in chloroform. After embedding in paraffin wax, serial sagittal or 
coronal sections of brain tissue (5 p,m) were cut and transferred to glass slides. 
Detection of BDA-3000 in paraffin sections 
Sections were dewaxed in xylene and rehydrated in serial ethanol solutions (100% to 
70%). This was followed by incubation in peroxidase blocker (Dako) followed by 
protein blocker (Dako) for 30 min each at room temperature. An avidin-horseradish 
peroxidase complex was used to detect biotin using a Vectastain Elite ABC kit (Vector). 
Sections were then processed with the diaminobenzidine tetrahydrochloride (DAB Kit, 
Dako) reaction for about 5-10 min. After a 10 min rinse in tap water the sections were 
dehydrated in serial ethanol solutions (70% to 100%), cleared in xylene and mounted in 
DPX and left to dry overnight in a low heat oven (40°C). Control staining was 
performed on sections obtained from animals not given a BDA-3000 injection. For 
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detailed protocol see Appendix A and B. 
Transmission electron microscopy 
General morphology of choroid plexus 
Choroid plexus tissue from opossums at PO-P1 (n=4), P13 (n=4) and P64 (n=2) was 
prepared for conventional electron microscopy in order to investigate its ultrastructure 
during development. Fresh 2.5 % glutaraldehyde solution in 0.1M sodium-cacodylate 
(Sigma) buffer adjusted to pH 7.3 was used as the primary fixative. Animals were killed 
by an overdose of halothane and the whole brain was carefully removed and submerged 
in fixative in a new dish for further dissection. Care was taken not to expose tissue to 
air. Holes through the cortex into the lateral ventricles were immediately cut in order to 
fix the choroid plexus as quickly as possible. The choroid plexuses in the 4th and lateral 
ventricles were removed with a small piece of brain tissue connected to it in order to 
facilitate the orientation and handling of the tissue. Larger pieces of the choroid plexus 
were sometimes cut into several smaller fragments so they would be of an appropriate 
size. Tissue was post-fixed in the same fixative for 2-3 hours at 4°C. Tissue was rinsed 
in cacodylate buffer for 30 min and postfixed in a 1:1 mixture of 4% osmium tetroxide 
solution and 0.05 M potassium ferrocyanide in cacodylate buffer for 45 minutes. After 
rinsing in cacodylate buffer for 30 minutes, tissue was stained en bloc in an aqueous 1% 
uranyl acetate solution for 30 minutes. Tissue was then dehydrated in serial ethanol 
solutions (50 to 100%), cleared in propylene oxide and embedded in Epon 812. Detailed 
procedure of protocol can be found in Appendix C. 
BDA-3000 localisation in choroid plexus 
Opossum pups at P1 (n=3) and P13 (n=3) were injected ip with BDA-3000 (0.7 mg/g 
body weight) and choroid plexus tissue was fixed 30-40 minutes after the injection for 
electron microscopy. A 2.5 % glutaraldehyde solution in phosphate buffered saline (0.1 
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M) adjusted to pH 7.3 was made up freshly and used as the primary fixative. Animals 
were killed by an overdose of halothane and choroid plexus tissue was dissected out in 
the same manner as described above. The tissue was post-fixed in the same fixative for 
2-3 hours at 4°C. The tissue was washed in buffer for 30 min and permeabilised in a 
50% Ethanol PBS solution for 30 min. After rinsing in buffer for 30 min, the tissue was 
incubated in an avidin-horseradish peroxidase complex (Vectastain Elite ABC kit, 
Vector) for 60 min. The tissue was washed in buffer and processed with the DAB 
reaction (DAB kit, Dako) for 2-3 min. The reaction time was kept as short as possible to 
minimise precipitation. Tissue was rinsed in PBS and postfixed in a 1:1 mixture of 4% 
osmium tetroxide solution and 0.05 M potassium ferrocyanide in PBS buffer for 45 
minutes. After rinsing in PBS for 30 minutes, the tissue was stained en bloc in a 1% 
uranyl acetate solution for 30 minutes. The tissue was then dehydrated in serial ethanol 
solutions (50 to 100%), cleared in propylene oxide and embedded in Epon 812. Control 
tissue was obtained from animals not given an injection but otherwise treated in the 
same way. Detailed procedure of protocol can be found in Appendix D. 
Sectioning 
Semi-thin sections (0.5-1 gm) were cut and stained with toluidine blue and examined 
under the light microscope. Ultrathin sections were cut with an Ultratome LKB Nova 
and transferred to 200, 300 mesh grids, or butvar coated single slot grids. The 
interference colour of the thin-sections ranged from silver to pale gold. Thin-sections 
for general morphology were contrasted in 4-5% aqueous solution of uranyl acetate (30 
min) followed by lead citrate (5-10 min), whereas thin-sections that were stained for 
BDA-3000 were not contrasted. Sections were examined with a CM 100 Phillips 
electron microscope at 60 or 80 KY. 
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Results 
Structural development of the choroid plexus 
For the interpretation of BDA-3000 distribution, the morphological study of the choroid 
plexus is presented first. The light and electron microscope were used to study the 
structure of the lateral and 4th ventricular choroid plexuses at P1 and P13, and in young 
adults at P64. The main aim of the investigation was to study structures that may be 
relevant for the permeability of the blood-CSF barrier that is situated in the choroid 
plexus. Structures such as junctional complexes between cells that are believed to be 
determinants of the paracellular movement of molecules, and vesicles that may be 
significant for trancytosis of exogenous material were therefore studied in detail. 
A general description of the choroid plexus structure in the opossum will be presented 
first. The choroid plexus can be divided into the stroma, which is the core of the choroid 
plexus and the epithelial cells that form a single layer of cells outside the stroma. The 
electron microscopic study showed that the stroma contained blood vessels that were 
fenestrated and that outside of these, between the blood vessels and the epithelial cells, 
connective tissue and few interspersed fibroblast cells were present. The fenestrations 
had a width of about 50 nm which is similar to what has been reported in other species 
(Brightman and Kaya, 2000). The fibroblast cells formed finger-like projections within 
the extracellular matrix. The epithelial cells, which rested on a basement membrane, had 
a centrally located nucleus and a brush border at the ventricular surface with microvilli 
and also with occasional tufts of cilia. The microvilli had the appearance of club-like or 
clavate projections, and the cilia had 9 peripheral doublets and 2 centrally located 
microtubules (Figure 5.5), which is consistent with what has been described in other 
mammals (Dohrmann and Bucy, 1970; Dohrmann and Herdson, 1970; Davis et al., 
1973). Resting on the microvilli were occasional cells resembling the so-called 
epiplexus cells (also referred to as Kolmer cells) that have been reported in other 
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species (Sturrock, 1979; Zaki, 1981; Peters et al., 1991; Lu et al., 1993 and others). 
These cells had abundant projections, mostly in close contact with the microvilli and 
numerous vacuoles. The cytoplasm of the epithelial cells contained mitochondria, 
vesicles, rough and smooth endoplasmic reticulum, Golgi apparatus and a few dense 
bodies, which presumably contained lipids that stained dark because of osmium. A 
minority of the epithelial cells appeared to have darker cytoplasm, however, the shape 
and organelle organisation of these darker cells appeared similar compared to other 
cells. Similar "dark and light cells" have been reported in other mammalian species (see 
Discussion for references) 
The choroid plexuses appear in the ventricles in the following order: 4th ventricular 
choroid plexus appears first, followed by that in the lateral ventricles; both these 
choroid plexuses are present at birth in the opossum, although the lateral ventricular 
plexuses are only rudimentary. The 3rd ventricular choroid plexus appears around P3- 
P4. In all the ventricles, the epithelial cells of the choroid plexuses show a similar 
morphological development that can be divided into three stages. The choroid plexus 
cells first have an elongated shape forming a pseudostratified layer. In the second stage 
they have a columnar form and in the third stage a more cuboidal shape. Under the light 
microscope the epithelial cells of the 4th and lateral ventricular choroid plexus appeared 
to be in different stages of development even in the same animal (see Figure 5.2). This 
was confirmed in the electron microscope which showed that a majority of the epithelial 
cells in the lateral ventricle had a pseudostratified appearance whereas the epithelial 
cells in the outer most parts of the choroid plexus villi had a columnar shape at birth 
(see Figure 5.4). In the 4th ventricle most of the epithelial cells had a columnar shape 
except for those closer to the root of the choroid plexus. However, the cell organelle 
structures were similar in all cells with few interspersed organelles throughout the 
cytoplasma and many nuclear invaginations. Figure 5.4 shows the comparison of a 
pseudostratified epithelium from the root of the 4th ventricular choroid plexus with a 
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columnar-shaped epithelia from the outer parts of the same choroid plexus. At P13 the 
epithelial cell at the root of the choroid plexuses in both ventricles still had a somewhat 
pseudostratified appearance. At P13 and P64, the epithelia appeared very similar in both 
the lateral and 4th ventricular choroid plexus (see Figure 5.4). 
There were several ultrastructural changes of the choroid plexus during development. In 
the stroma, the endothelial wall consisted of wider segments with numerous vesicles 
and other cell organelles, and thinner sections with fenestrations. In animals at PO, 
normally only a small part of the endothelial wall contained thin segments exhibiting 
fenestrations whereas at P64 most of the endothelial wall was thin with a more uniform 
diameter exhibiting numerous fenestrations (see Figure 5.6). The individual 
fenestrations had a similar length (around 50 nm) and thickness in all animals (see 
Figure 5.6). In the endothelial wall many vesicles were present at all ages. At the 
luminal side of the intercellular cleft of the endothelial cells, zonulae occludent es-like 
junctions were present at all ages studied. Outside the blood vessels, the extracellular 
matrix became richer in connective tissue with age. As has been described above, the 
epithelial cells in the choroid plexus change in shape during development. As seen in 
Figure 5.3 the epithelial cells at PO formed a pseudostratified layer with elongated 
epithelial cells, sometimes with bulbous structures. The pseudostratified epithelium at 
PO formed a very uneven surface at the ventricular side, which changed into a layer with 
more uniform columnar cells with convex ventricular surface at P13, and changed 
further into a layer of almost cuboidal cells with flat or somewhat curved apical cell 
surface at P64. A prominent characteristic of the epithelial cells at PO was the deep 
invaginations of the nuclei. In some sections this gave the appearance that the nuclei 
consisted of several lobes. At P13 the nuclei still had numerous invaginations, although 
each individual invagination was smaller than at PO, and at P64 the nuclei appeared 
spherical with only occasional invaginations. At PO most epithelial cells had thin 
microvilli that formed short projections into the ventricle and a minority of cells lacked 
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microvilli and had a smooth ventricular cell surface. The microvilli progressively 
formed longer and more uniform projections between P13 and P64 so that the microvilli 
had a length of 2-3 gm at P64 (see Figure 5.5). Interspersed tufts of cilia were common 
at the epithelial surface at all ages. It was difficult to conclude whether the number of 
cilia changed during development in thin-sections since it is not easy to know from 
which epithelial cell individual cilia originated. It would require a very large amount of 
serial sectioning in order to estimate the true number of cilia. It is also difficult to judge 
whether the length of cilia changed with age, however, the cilia exhibited the normal 
9+2 microtubular arrangement at all ages (see Figure 5.5). During development, the 
cytoplasma became more packed with different cell organelles, which also became 
more polarised mainly to the apical side. The most noticeable change was the increase 
in mitochondrial content of the cytoplasm; this increase was less prominent between 
birth and P13 than between P13 and P64. The mitochondria were distributed throughout 
the cell but were more common in the apical part (see Figures 5.3-5.5). Not only did the 
number of mitochondria increase with age but also the size of individual mitochondria 
became bigger (see Figure 5.5). The shape of the Mitochondria changed from small, 
with a round or oval shape at PO, to large with an elongated or crescent shape in the 
young adults (P64). As cells became more polarised there was also an increase in other 
organelles such as rough endoplasmic reticulum, which tended to be mostly numerous 
towards the apical side of the cells. Small and large vesicles were present in the 
epithelial cells at all ages. The larger vesicles were especially abundant in the region 
towards the apical and intercellular surfaces. No apparent difference in the number of 
vesicles was found between the three ages. Large clear vacuole like structures (up to 2 
gm) could be found in a minority the epithelial cells at PO (see Figure 5.4). These 
structures were large enough to be visible under the light microscope in semi-thin 
sections. In the electron microscope it was revealed that a single membrane 
encapsulated the structures and it can therefore be assumed that they are intracellular 
structures. These structures were more abundant in the epithelial cells in the 4th 
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ventricle compared with those of the lateral ventricle. Similar structures could be found 
at P13, however, they were less frequent and with a smaller diameter. The large size of 
these vacuoles is probably an artefact. 
In all sections studied, a junctional complex was always present towards the apical side 
between epithelial cells. Within the junctional complex, the cell membranes of 
neighbouring cells were in close contact with each other at certain points. Using the 
goniometric tilting device (up to 20 0  tilting) it appeared that these contact points were 
similar to tight-junctions described in the choroidal epithelium of other species 
(Tennyson and Appas, 1968). The tilting device helps to orientate the membranes in 
parallel to the electron beam resulting in a sharper view of the apposing membranes. 
The interepithelial cleft was often convoluted and it was therefore not always possible 
to view the junctional complex along its whole length in one section (see Figure 5.7). In 
sections where the cell membranes were visible below the apical surface it was found 
that several tight-junctions were present within the junctional complex. There was no 
noticeable difference in the appearance of the tight-junctions or the number of tight-
junctions within the junctional complex between the three ages studied. Below the 
junctional complex, cisternal structures could often be seen that were in close contact 
with the cell membranes in adjacent cells. These cisterns were positioned in parallel to 
the cell membranes. At PO several cisterns often formed a row below the apical 
junctional complex whereas only single cisterns were found interspersed along the cell 
membranes at older ages (see Figure 5.8). 
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Figure 5.2 
H&E stained paraffin sections of the fourth ventricular choroid plexus at PO (A), 
and lateral ventricular choroid plexus at PO (B), P13 (C) and P65 (D) in the 
opossum. Note the difference in the morphology of the epithelial layer in the 
lateral and fourth choroid plexus at birth (A and B). Most of the epithelium in the 
lateral ventricles forms a pseudostratified epithelium at birth whereas most of 
the epithelial cells in the fourth ventricle have a columnar form except for those 
close to the root of the choroid plexus (insert in A). At P13 the epithelial cells 
are simple columnar and at P65 the epithelial cells have a more cuboidal shape 
which is characteristic of the mature choroid plexus. 
Scale bar is 50 pm in A, and 30 pm in B-C and insert in A. 
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Electron micrographs of the epithelial layer in the lateral ventricular choroid 
plexus at PO (A), P13 (B) and P64 (C). The epithelial cells change in shape 
during development from being elongated (cell height 15-20 pm) at birth to short 
(cell height 8-12 pm) and wide in the mature choroid plexus. The epithelial cells 
at P1 formed great protrusions into the ventricles whereas the apical surface of 
the cells was round at P13 and more or less flat at P64. Note that at birth and at 
P13 there were few organelles in the cytoplasm. In contrast, the cytoplasm at 
P64 was very rich in organelles, especially abundant were mitochondria, which 
were concentrated towards the apical side of the cells. The nucleus shape also 
changed from being very lobulated at PO (arrowheads in A), to having small 
invaginations at P13 (arrowhead in B) and changed further to almost spherical 
at P64. 
Scale bar is 5 pm. 
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Figure 5.4 
Electron micrographs of the choroidal epithelium in different parts of the choroid 
plexus at birth (A and B) and at P13 (C and D). A and B show the fourth 
ventricular choroid plexus from the root (A) and from the outer parts of the 
plexus villi (B). A and B highlights the heterogeneity of this tissue at birth when 
some parts formed a pseudostratified layer and others already have formed a 
simple columnar layer. Also compare B with the choroid plexus in the lateral 
ventricle at birth in Figure 5.3. Arrow in A points to an epiplexus cell; these cells 
were commonly observed at all ages. Note the numerous lysosomes in the 
epiplexus cell which suggests it has a phagocytic function. Arrowhead in A 
points to a large vacuole (between 1-3 pm); these were infrequently observed in 
animals at P1 and seemed to be more common in the 4th than the lateral 
ventricular choroid plexus. The enormous size of these vacuoles is possibly an 
artefact. The vacuoles always appeared empty, however, this may be a result of 
tissue processing. C and D show the choroid plexuses from the lateral (C) and 
4th (D) ventricle at P13. These two choroid plexuses appeared similar at this 
age. 
Scale bar is 7 pm in A and B, and 5 pm in C and D. 
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Figure 5.5 
Electron micrographs of the apical side of epithelial cells at PO (A), P13 (B) and 
P64 (C). Several changes in the cell organelles were seen during development. 
The most noticeable difference was the increase in microvilli and mitochondrial 
content with age. The microvilli became longer and more abundant, and the 
mitochondria became more numerous and increased in size during 
development. The endoplasmic reticulum was mostly smooth at PO whereas 
ribosomes were often associated with the ER in the more mature epithelial 
cells. Note also the difference in nuclear shape at different ages. Tufts of cilia 
were situated interspersed on the surface of the epithelia at all ages. To the 
right hand side in B one such tuft can be seen that has been sectioned 
perpendicular to the tuft so that the cilia appear in cross section. Insert in A and 
B show high magnification of cross sections of cilia. At all ages the cilia showed 
the normal 9+2 microtubular organisation. Arrowheads point to vacuole-like 
structures (100-500 nm) that were common at all ages. As seen in B these 
structures sometimes contained vesicles and they therefore have some 
phagocytic function. 
Scale bar is 2 pm in A-C, and 350 nm in insert in A, and 300 nm in insert in B. 
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Figure 5.6 
Electron micrographs of different parts of blood vessels in the choroid plexus at 
P1 (A, C and E) and P64 (B, D and F). The wall of the blood vessels was 
composed of thicker segments with numerous cell organelles, such as 
mitochondria, vesicles and endoplasmic reticulum, and thinner segments with 
numerous fenestrations. The fenestrations appeared as segments of the wall 
without cytoplasm but only thin membrane. At birth, the endothelial cell only had 
a small part of the wall exhibiting fenestrations whereas at P64 almost the 
whole wall was thin with numerous fenestrations. A and B shows the difference 
in the thickness of the blood vessel wall between P1 and P64. The appearance 
of individual fenestrations was similar at all ages with a width of about 50 nm (C 
and D). At the luminal side of the interendothelial cleft a single tight-junctional 
structure was present (arrows in E and F). 
Scale bar is 2 pm in A and B, 250 nm in C and D, 125 nm in E, and 80 nm in F. 
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Figure 5.7 
High-power electron micrograph showing the structural identification of a tight-
junctional strand (arrow). The membranes of adjacent epithelial cells in the 
choroid plexus came together at certain point to form these junctions. The 
arrowheads show two other possible strands. The goniometric tilting device was 
used to obtain a sharper view of the cell membranes and improve the 
identification of such junctional structures. Compare also with Figures 5.6E-F 
which show tight-junctions in endothelial cells of the choroid plexus. 
Scale bar is 100 nm. 
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Figure 5.8 
Electron micrographs showing the interepithelial cleft at P1 (A) and P64 (B), and 
high power electron micrographs of the junctional complexes at P1 (C-D), P13 
(E) and P64 (F). All electron micrographs are from the lateral ventricular choroid 
plexus except for A and C that are from the 4th choroid plexus. A junctional 
complex (zo) was always present at the apical side of the interepithelial cleft at 
all ages studied. Below this complex cisternal structures were often seen in 
close association with the intercellular cleft. These cisternal structures often 
formed a whole row at P1 whereas they were less frequent at P64. The 
structural significance of this difference is unknown. The zonulae occludentes in 
A is shown in high power in D. No noticeable difference could be seen between 
the junctional complexes at different ages (compare C-F). Up to five tight-
junctions were often identified within the junctional complex (arrows). 
Scale bar is 500 nm in A and B, and 125 nm in C-F. 
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Uptake of D-3308 into the CSF and localisation in brain tissue 
The CSF/plasma ratios for D-3308 were compared to ratios obtained for inulin, sucrose 
and L-glucose in order to assess whether D-3308 behaved in a similar passive manner 
across the brain barriers to other lipid insoluble markers. As has been mentioned before, 
several authors have proposed that the penetration of lipid insoluble molecules is by 
unrestricted diffusion (Felgenhauer, 1974; Dziegielewska et al., 1979; Habgood et al., 
1993). Dziegielewska et al. (1979) showed that the concentration in CSF of several lipid 
insoluble markers was related to their diffusion coefficient (D), which can be calculated 
from the Einstein-Stokes radii. Values of D for inulin, sucrose and L-glucose were taken 
from Normand et al. (1971) and were multiplied by a factor of 1.1924 in order to 
transform values from 25°C to 32°C (D32), which is the body temperature in the 
Monodelphis (Saunders et al., 1992). The D value for D-3308 was estimated from its 
molecular weight. The D25 values for a range of molecules given by Normand et al. 
(1971) were plotted against MW-I/2 and a linear regression line fitted to the data 
(r=0.997, least squares regression). From this regression line, the D25 value could be 
estimated for D-3308 and corrected to 32°C as described above. Figure 5.9 shows the 
three-hour CSF/plasma ratios for D-3308 and other markers plotted against D32 
obtained from experimental data in animals of similar ages (P15-P16 for inulin and 
sucrose, P16 for D-3308, and P17-P18 for L-glucose). The D-3308 reaches a ratio of 
approximately 16% which is similar to the ratio for inulin (15%), but substantially less 
than those for the smaller molecules sucrose (51%) and L-glucose (60%). Details of 
inulin, sucrose and L-glucose can be found in Chapter 4. 
In order to validate D-3308 as a quantifiable replacement for BDA-3000, the 
distribution of both markers was compared in brain sections from a P7 opossum. The 
markers showed matching distribution patterns with staining in a small proportion of the 
choroidal epithelial cells and intracellular staining in some cells in the ventricular zone 
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and in the hippocampal area of the brain (Figure 5.10). The rest of the brain seemed to 
lack any staining except for the blood vessels, which were strongly stained. 
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Figure 5.9 
CSF/plasma ratios (y-axis), three hours after an intraperitoneal injection of 
markers against the diffusion coefficients D32 (x-axis) in opossums at P15-P16 
for inulin and sucrose, P16 for D-3308, and P17-P18 for L-glucose. Data for 
inulin, sucrose and L-glucose are taken from experiments presented in Chapter 
4. A linear regression line was fitted to the data points. This plot should be a 
straight line if the penetration of molecules is by unrestricted diffusion. D-3308 
falls close to the regression line, confirming that its entry into CSF is consistent 
with diffusion. 
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Figure 5.10 
Localisation of D-3308 (A and C) and BDA-3000 (B and D) in brain sections 30 
minutes after an ip injection of both tracers into a P7 opossum. 0-3308 was 
viewed directly using filter for rhodamine and BDA-3000 detected using a 
Vectastain Elite ABC kit followed by the diaminobenzidine tetrahydrochloride 
(DAB) reaction. D-3308 and BDA-3000 showed identical intracellular staining in 
a small proportion of the ependymal cells in the ventricular zone (compare A 
and B) and in epithelial cells of the choroids plexus (compare C and D). 
Scale bar is 30 pm. 
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BDA-3000 in the opossum brain at the light microscopic level 
Examination of brain sections processed for BDA-3000 revealed that in the brain at all 
ages most of the reaction product was within the lumen of the blood vessels (see Figure 
5.11). The endothelial cells also appeared positive for BDA-3000. This was most 
prominent in P30 animals in which the lumen was empty with no reaction product since 
the contents of the blood vessels had been washed out when animals were perfuse-fixed 
(see Figure 5.11). Many cells in the ventricular zone of the lateral ventricle showed 
intracellular staining in animals between PO and P9. The number of cells with 
intracellular staining in the ependymal or subependymal layer in the ventricles 
decreased with development so that at P30 none of these cells appeared to be positive 
for BDA-3000. Occasional cells in the hippocampal area showed intracellular staining 
at all ages. Little or no staining was detectable outside the blood vessel wall or in the 
brain parenchyma. The surfaces of both the ventricular neuroependyma and of the 
choroid plexuses were positive where CSF had precipitated on the surface (see Figures 
5.12 and 5.13). In general, the staining was more prominent in the brains of younger 
animals where intracellular staining in the basal forebrain and diencephalon was also 
found. At P30 the whole brain appeared devoid of reaction product except for 
endothelial cells in the brain and the perivascular space of the choroid plexus. Control 
sections showed no staining. 
Uptake of BDA-3000 in choroid plexus 
Light microscope 
The uptake of BDA-3000 in the choroid plexus was studied under the light microscope 
at various ages between PO and P30, and under the electron microscope at P1 and P13 
after single intraperitoneal injection. In the light microscope the choroid plexuses blood 
vessels and surrounding connective tissue were strongly stained along with a small 
number of the epithelial cells. Staining was visible on the surface of the choroid plexus 
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and inside the ventricular system (see Figures 5.11-5.13). The staining was particularly 
abundant within the ventricular system at younger ages. In paraffin sections, the 
reaction product had a granular appearance and seemed to be absent from the nuclei of 
stained epithelial cells. The number of BDA-3000 positive cells in the choroid plexuses 
from all four ventricles decreased progressively with age. At the time of birth (PO) a 
proportionally higher number of epithelial cells was positive in the choroid plexuses in 
the lateral ventricles (Figure 5.12 and Table 5.2), whereas the 4th ventricular plexus 
contained only occasional stained epithelial cells. At this age the choroid plexus cells in 
the lateral ventricles have an elongated shape, whereas the 4th ventricular choroid 
plexus cells have a more mature columnar form (see Figure 5.2). At P8 and later only 
very occasional stained epithelial cells were found in the 4th ventricular choroid plexus 
and the proportion of stained epithelial cells in the lateral ventricles was substantially 
less than at PO (Figure 5.12). In contrast, at P8 the choroid plexus in the 3rd ventricle 
had a high proportion of stained epithelial cells (Figure 5.13). At P30 all choroid 
plexuses showed only very occasional stained epithelial cells with rather faint 
intracellular staining (Figure 5.12). The choroidal epithelial cells at this age have a 
cuboidal shape which is characteristic of the adult choroid plexus. In paraffin sections, 
from P8-P9 and in older animals, there appeared to be no staining in the upper most 
apical parts in between epithelial cells. This is the region where the tight-junctions are 
present (see Figure 5.8). At earlier ages it was difficult to determine the extent of 
intercellular staining since the epithelium at these ages have a tightly packed 
pseudostratified appearance. 
In order to quantitate the number of stained epithelial cells at different ages and in each 
separate choroid plexus, the proportion of epithelial cells with intracellular reaction 
product was determined at PO, P8 and at P30. In random coronal or sagittal sections, 
which contained choroid plexus tissue from one or all the ventricles, all epithelial cells 
were counted and the proportion of BDA-3000 positive epithelial cells was calculated. 
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A minimum of ten sections containing choroid plexus tissue from each ventricle was 
counted. The results are presented below in Table 5.2. 
Table 5.2 
n Lateral 3rd 4th 
PO 10 15.1 ± 1 .0 5.5 ± 0.2 
P8 12 4.3 ± 0.6 11.4 ± 3.1 4.8 ± 1.1 
P30 11 1.4 ± 0.3 1.9± 0.1 1.9 ± 0.1 
Proportion (%) of epithelial cells with intercellular staining of BDA-3000 in the 
lateral, 3rd and 4th ventricular choroid plexus at PO, P8 and P30. The number 
for the 3rd ventricular choroid plexus at birth is missing because this choroid 
plexus has not formed yet at this age. The proportion of BDA-3000 positive cells 
dropped in all three different choroid plexuses during development. Values as 
means ± SEM 
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Figure 5.11 
Localisation of BDA-3000 in the developing opossum brain 30-45 min after an 
intraperitoneal injection. Figures show coronal sections of the opossum 
forebrain at PO (A, D and E), P8 (B and F) and P30 (C and G). Because of the 
increase in the size of the brain with age, C only shows half the brain at P30 in 
order to illustrate the brains at different ages at comparable sizes. BDA-3000 
was detected using a Vectastain Elite ABC kit followed by the diaminobenzidine 
tetrahydrochloride (DAB) reaction. D shows a magnified area of the developing 
cortex (boxed area in A) and E is a high power micrograph of a blood vessel 
(arrow in D) from a PO animal. Note that at P30 (C) only blood vessels stained 
positive and there was no staining in the rest of the brain. Strong staining could 
be seen in precipitated CSF at PO (A and D). As shown in D it appeared that 
some cells in the ventricular zone had taken up BDA-3000 from the CSF. The 
low power view of a P8 opossum brain (B) showed strong staining in the stroma 
of the choroid plexus and in blood vessels throughout the brain. A few cells in 
the hippocampal area also seemed to have taken up BDA-3000. Note the larger 
number of blood vessels in the brain compared to PO (A). F is a high power 
micrograph of a blood vessel at P8. At all ages no noticeable difference could 
be seen in the staining around the blood vessels compared to other areas of 
brain tissue (see E, F and G). In the younger animals, brains were immersed 
fixed and thus the lumen of the blood vessels were positively stained (E and F). 
At P30 the brains were perfuse fixed resulting in the lumen of blood vessels 
appearing empty, but the endothelial cells of the blood vessels contained 
reaction product (G). At this age no staining could be seen in the brain except 
for the endothelial cells. 
Scale bar is 400 pm in A and B, 500 pm in C, 60 pm in D, 12 pm in E and F, 
and 60 pm in G. 
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Figure 5.12 
Localisation of BDA-3000 in the developing choroid plexus of the lateral 
ventricles approximately 45 min after intraperitoneal injection at PO (A), P8 (B) 
and P30 (C). BDA-3000 was detected using a Vectastain Elite ABC kit followed 
by the diaminobenzidine tetrahydrochloride (DAB) reaction. The proportion of 
choroidal epithelial cells positive for BDA-3000 in the lateral ventricle 
decreased with age (A-C). Note the developmental change in choroid plexus 
morphology from a pseudostratified layer of epithelial cells (A) to the mature 
stage with cuboidal plexus cells exhibiting large apical surface area (C). In the 
younger animals brains were immersed fixed and thus the stroma of the 
choroid plexus was positively stained (A and B). At P30 the brains were 
perfuse fixed resulting in the lumen of blood vessels appearing empty (C). 
Scale bar is 25 pm. 
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Figure 5.13 
Localisation of BDA-3000 in the lateral (A and B), 3rd (C and D) and 4th (E and 
F) ventricular choroid plexuses at P8 30-40 min after intraperitoneal injection. 
On the right are higher power micrographs of the same choroid plexus which is 
shown on the left. BDA-3000 was detected using a Vectastain Elite ABC kit 
followed by the diaminobenzidine tetrahydrochloride (DAB) reaction. The 
proportion of epithelial cells with intracellular staining of BDA-3000 was higher 
in the 3rd ventricular choroid plexus (C and D) than in the other choroid 
plexuses at this age. 
Scale bar is 60 pm in A and C and E, and 30 pm in B, D and F. 
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Transmission electron microscope 
BDA-3000 was visualised in choroid plexus tissue from the lateral and 4th ventricle at 
P1 and P13. The uptake of BDA-3000 was visualised with avidin reactions followed by 
the DAB reaction, which gives an electron dense granular reaction product visible both 
under the light and electron microscope. The staining of BDA-3000 in this section is 
referred to as the reaction product. Only selected areas of semi-thin Epon sections of the 
choroid plexus, in which reaction product was visible either in the lumen of blood 
vessels or the perivascular space when examined under the light microscope, were 
further processed for thin-section electron microscopy. 
A similar distribution of the reaction product in the choroid plexus was observed in 
ultrathin sections as in paraffin sections. Different parts of the choroid plexus exhibited 
similar staining patterns. As can be seen in Figure 5.14 the reaction product was 
abundant in the lumen of blood vessels but appeared to be most plentiful in the 
perivascular space between the blood vessels and the epithelial cells. The electron 
micrograph in Figure 5.14 is of the lateral choroid plexus at P13, however, a similar 
distribution of reaction product was seen in the lateral and 4th ventricular choroid 
plexuses at both P1 and P13. The reaction product was also abundant around the 
fenestrations of the endothelial wall. The intercellular cleft between the epithelial cells 
was often filled with the reaction product except for the most apical part. Reaction 
product was, especially at Pl, abundant on the surface of the epithelial cells, between 
and around the apical microvilli. Many vesicles in the endothelial cells often filled with 
the reaction product at both ages. The reaction product was sometimes seen in small 
vesicles, multivesicular bodies or associated to cisternal structures in the epithelial cells 
at both ages (see Figure 5.15). Large vesicular structures in the epithelial cells were 
common and were often heavily labelled with reaction product at both PI and P13 (see 
Figures 5.14 and 5.15). These vesicles were common throughout the epithelial cells, 
however, none were found to fuse with either the apical or basolateral cell membrane. 
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There was no noticeable difference in the number of these large vesicles containing the 
reaction product between the two ages. Both at P1 and P13, the outer most apical part of 
the interepithelial cleft lacked the reaction product in the area where the junctional 
complex was present. Sections of the apical side of the intercellular cleft showed that 
the reaction product was only present on the basal side of certain points of the 
intercellular cleft where the cell membranes of adjacent cells seemed to be fused (see 
Figure 5.17). Similar to the staining in paraffin sections, some of the epithelial cells 
contained large amounts of the reaction product. The proportion of these epithelial cells 
was much higher at P1 than at P13 in both choroid plexuses. Under the light microscope 
it appeared as these epithelial cells did not contain the reaction product in the nucleus. 
In contrast, under the electron microscope it was revealed that reaction product was 
present in the nucleus of these cells but in lesser quantities than in other parts of the 
cells (see Figure 5.16). The large amount of reaction product and rather diffuse 
intracellular staining of these epithelial cells made it difficult to resolve which 
organelles contained the reaction product (see Figure 5.16). The reaction product was 
especially plentiful in small vesicles and it also appeared to be associated with cell 
membranes of some cisternal-like structures (see Figure 5.16). These cisternal structures 
could be part of the endoplasmic reticulum. The mitochondria in these cells did not 
seem to contain the reaction product. Apart from having large amounts of intracellular 
reaction product the intracellular organisation of these cells was not different from other 
epithelial cells. 
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•Figure 5.14 
Electron micrograph showing the localisation of BDA-3000 in the lateral 
ventricular choroid plexus at P13. Large amounts of tracer have leaked out of 
the blood vessels and accumulated in the perivascular space. Similar 
localisation of reaction product was seen at P1. Large arrows point to large 
vacuolar structures that contained the reaction product (see also Figure 5.15). 
Note that there is reaction product in the intercellular space between adjacent 
epithelial cells but it does not appear to penetrate the zonulae occludentes at 
the most apical side of the intercellular cleft (small arrows). 
Scale bar is 10 pm. 
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Figure 5.15 
Electron micrograph showing the staining of BDA-3000 in epithelial cells of the 
lateral ventricular choroid plexus at P13. Note that the large amounts of tracer 
escaped the blood vessels and accumulated in the interstitial space between 
the blood vessels and the epithelial cells and in the intraepithelial cleft. The 
dextran could also be seen in some small and large vesicular structures (see 
arrows in A). The dark structures around the microvilli may be artefacts of the 
staining technique or a result of precipitation of CSF during fixation. Arrowhead 
in A points to a vacuolar structure that often contained large amounts of the 
reaction product. One of these vacuoles is shown in higher power in B (large 
arrow). Small arrow in B points to the upper most apical part of the intercellular 
cleft that lacked the reaction product (see also Figure 5.17). 
Scale bar is 2 pm in A and 500 nm in B. 
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Figure 5.16 
Electron micrograph showing intracellular staining of BDA-3000 in the lateral 
ventricular choroid plexus at P1. Some epithelial cells contained large amounts 
of reaction product, similar to what was observed in paraffin sections (see 
Figure 5.12). The reaction product was visible interspersed throughout the 
whole cytoplasm and also in the nucleus although less than in the cytoplasm. 
The reaction product was especially abundant in association with cisternal 
structures which may be part of the endoplasmic reticulum (arrows in B). The 
mitochondria in these cells seemed to lack the reaction product (arrowhead). 
Scale bar is 2 pm in A and 500 nm in B. 
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Figure 5.17 
Electron micrographs showing the localisation of reaction product in the 
interepithelial cleft towards the ventricular surface (on the right side of the 
micrographs) at P1 (A and B) and P13 (C and D). The reaction product was 
absent from the most apical part of the interepithelial cleft. It seems that the 
zonulae occludentes restricts the paracellular movement of BDA-3000 at both 
ages. Arrows point to possible tight-junctions that appear to impede the 
penetration of BDA-3000, however, the contrast and resolution in these 
sections did not allow for definite identification. 
Scale bar is 100 nm in A and 200 nm in B-D. 
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Discussion 
The current study was undertaken in order to examine the route of penetration across 
the blood-brain barrier and blood-CSF barrier for small molecular size, lipid insoluble 
molecules. This was made in the opossum in parallel with uptake studies using 
radiolabelled markers such as inulin and sucrose, which were presented in Chapter 4. 
Ideally, the same marker that is used for permeability studies should also be used for 
tracer studies. However, this is not possible since molecules such as inulin and sucrose 
are water soluble, difficult to fix in tissue and cannot be readily visualised in the 
electron microscope. Instead, a lysine fixable biotin-dextran was used that had a 
molecular weight of 3000 Daltons which is slightly smaller than inulin but larger than 
sucrose (see Table 2.1). In order to assess the suitability of BDA-3000 as a lipid 
insoluble tracer molecule, CSF/plasma ratio was measured at three hours for a 
fluorescent dextran (D-3308) that is structurally similar to BDA-3000 and compared to 
ratios for inulin, sucrose and L-glucose at the same time points. The dextran reached a 
ratio similar to that of inulin, but much lower than sucrose and L-glucose as would be 
expected from its molecular size (Figure 5.9). Under the light microscope, D-3308 and 
BDA-3000 co-localised in the brain indicating that both markers behave in a similar 
manner across the brain barriers and also inside the brain (see Figure 5.10). It was 
necessary to use the fluorescently labelled dextran in order to be able to quantify CSF 
and plasma concentrations in very small samples and to calculate CSF/plasma ratios. 
BDA-3000 was preferred for morphological studies because histochemical methods 
give much better resolution and it can also be made visible for ultrastructural studies. 
Thus BDA-3000 appeared to be a suitable tracer in order to visualise the pathways from 
blood to CSF and brain for small lipid insoluble molecules. 
Previous studies using electron dense markers have generally been restricted to 
morphology and lacked parallel physiological experiments, which are essential for 
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proper understanding of the functional mechanisms involved in brain barriers. These 
studies have used markers such as HRP (van Deurs et al., 1978; Tauc et al., 1984) and 
MP (van Deurs, 1978), but the physiological interpretation of these studies is difficult 
because it is not known whether the cerebral endothelial and choroid plexus epithelial 
cells handle these tracers similarly to quantitative markers such as inulin and sucrose 
used in physiological experiments (Ferguson and Woodbury, 1969; Habgood et al., 
1993). 
Route of penetration of BDA-3000 from plasma into the brain 
BDA-3000 was visualised under the light microscope in the brain after intraperitoneal 
injection in opossums aged between PO and P30.This showed that BDA-3000 appeared 
to penetrate into the brain to a lesser extent in older brains compared to younger brains 
(see Figure 5.11) suggesting a change in brain barrier permeability with age. At all ages 
cerebral endothelial cells appeared to contain BDA-3000, but there was little staining 
visible in the extracellular space surrounding blood vessels. This indicates that even as 
early as birth in the neocortex of the opossum, when blood vessels are only just 
beginning to appear, the blood-brain barrier to small molecular compounds is already 
present. It could be argued that the lack of staining around the extracellular space of the 
blood vessels could be due to dilution of the tracer to an extent that it could not be 
visualised with the present staining techniques although present. However, this seems 
unlikely since the staining techniques are very sensitive and would have been able to 
detect at least a 100-fold dilution of levels in CSF which were clearly visible. Many 
cells in close association of the ventricular system, in the ventricular zone and sub-
ventricular zone, and on the outer surface of the brain were stained in young pups. 
There was also strong staining of precipitated CSF in the ventricles on the surfaces of 
the choroid plexus and the neuropendyma. In paraffin sections it was also noted that the 
strong staining was found in the choroid plexus tissue including a small proportion of 
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choroid plexus epithelial cells. Furthermore, the proportion of choroid plexus epithelial 
cells that was positive for BDA-3000 also declined during development. The highest 
proportion of BDA-3000 positive cells in the lateral ventricular choroid plexus was in 
the newborn animal and in the 3rd ventricular choroid plexus shortly after it appears at 
around P5 (see Table 5.2). The proportion of positive cells fell subsequently (earlier in 
the lateral ventricular choroid plexus) corresponding to the decline in permeability to 
small lipid insoluble markers (compare Figures 4.2, 5.12 and Table 5.2). The light 
microscopic study of BDA-3000 localisation in the brain therefore suggests that the 
route of penetration for lipid insoluble molecules into the early developing brain is 
across the blood-CSF interface in the choroid plexus and not directly across the blood 
vessels inside the brain. The intracellular staining of some of the epithelial cells in the 
choroid plexus suggested that there was an intracellular pathway in the epithelium of the 
choroid plexus. 
The intracellular staining pattern for BDA-3000, that showed a small proportion of 
stained choroidal epithelial cells was similar to that reported for endogenous albumin by 
Balslev et al. (1997a) and Knott et al. (1997), in the same species. Balslev et al. (1997a) 
and Knott et al. (1997) suggested that these albumin positive cells may transfer albumin 
from the blood into the CSF in early development. The localisation of BDA-3000 and 
albumin was therefore compared using double labelling immunocytochemistry (see 
Appendix B for methods). Similar to DAB staining, localisation for BDA-3000 using 
streptavidin Texas-Red showed that the highest proportion of positive epithelial cells 
was found in the youngest animals. In all sections studied, choroidal epithelial cells 
were either double labelled for both BDA-3000 and albumin, or single labelled for 
BDA-3000 only. Even at P8 when the highest proportion of epithelial cells were found 
to be positive for albumin in the lateral and 4th ventricular choroid plexus by Knott et 
al. (1997), the number of BDA-3000 positive cells was higher than albumin positive 
cells in these choroid plexuses. In no sections were there any epithelial cells single 
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labelled for albumin (see Figure 5.18). The transfer of native albumin into the CSF 
during early development is by a specific mechanism that can distinguish between 
native albumin and other species of albumin (Dziegielewska et al., 1991; Habgood et 
al., 1992; Knott et al., 1997). The uptake of native albumin into the CSF seems to be the 
result of a contribution of specific transport and diffusion. Knott et al. (1997) suggested 
that both the specific transfer of native proteins such as albumin and the passive transfer 
of other proteins into the brain, are intracellular through a subset of the choroidal 
epithelial cells. Similar to the study of Knott et al. (1997) the transfer of BDA-3000 also 
seems to be intracellular since there was a good correlation between BDA-3000 positive 
choroidal epithelial cells and the decline in steady-state ratios of markers such as inulin 
and sucrose. In order to resolve in more detail possible routes of entry across the blood-
CSF barrier of small lipid insoluble molecules, both the ultrastructure of the choroid 
plexus and the localisation of BDA-3000 in the choroid plexus were studied during 
development using the electron microscope. 
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Figure 5.18 
Double labelling of BDA-3000 (A) and albumin (B) in the lateral ventricular 
choroid plexus of a P8 opossum. Albumin was detected using antibodies to 
human albumin and FITC coupled secondary antibodies, and BDA-3000 was 
detected using streptavidin conjugated with Texas-red. Arrows indicate a 
double-labelled cell and the arrowhead indicate a single labelled cell for BDA-
3000. The number of cells positive for BDA-3000 was higher than for albumin. 
No cells were found to be labelled only for albumin. 
Scale bar is 30 pm. 
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Transfer of BDA-3000 across the choroid plexus 
BDA-3000 was visualised under the electron microscope after intraperitoneal injection 
in opossums aged P1 and P13. Ultrathin sections of the choroid plexus revealed that 
large amounts of reaction product were present within the perivascular space. This 
shows that there is little or no barrier function of the blood vessels in the choroid plexus 
since the dextran easily leaked out of them (see Figure 5.14). This is in agreement with 
previous studies using other tracers such as HRP (Balin and Broadwell, 1988), MP (van 
Deurs, 1978), and cytochrome c (Milhorat et al., 1973), which all easily leaked out of 
the blood vessels in the choroid plexus. The dextran may have crossed the endothelial 
cells in several ways: firstly, the dextran may have passed through the intercellular cleft. 
Conventional electron microscopy showed that at least a single tight-junctional structure 
always seemed to be present at the luminal side of the intercellular cleft (see Figure 
5.6), which might seem to render this pathway unlikely. However, in thin sections it is 
difficult to judge whether these junctions are continuous and freeze-etch studies have 
shown that the tight-junctions in the choroidal endothelial cells are discontinuous 
(Dermietzel, 1975a). Even if the intercellular clefts were filled with reaction product it 
is difficult to evaluate whether these tight-junctions were penetrated by the dextran 
since it was possible that the dextran may have reached the upper part of the 
intercellular cleft through some other pathway, circumventing the junctions. Secondly, 
it was noted that endothelial vesicles often contained the dextran and these may have 
transferred substantial amounts of dextran from the lumen to the perivascular space. 
Thirdly, the dextran may have crossed directly through the endothelial fenestrations (see 
Figure 5.6). It is not possible to resolve whether the fenestrations were leaky to the 
dextran, however, fenestrations have been related to higher permeability in vessels 
(Dermietzel, 1975a; Brightman and Kaya, 2000). Cells in the extracellular matrix, 
between the endothelial and epithelial cells, also seem to have little barrier functions 
since large amounts of reaction product were present in the interepithelial cleft. Under 
the light microscope it appeared that the dextran was not present in the upper most 
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apical part of the interepithelial cleft from around P8 and in older animals, however, in 
the resolution of the light microscope it was not possible to reveal whether this was the 
case for younger animals as well, because of the pseudostratified appearance of the 
epithelium. That dextran was not present in the apical intercellular cleft was confirmed 
by electron microscopy as it seemed to be stopped by junctional structures between 
epithelial cells at P1 and also in pups at P13 (see Figure 5.17). The contrast and 
resolution of the thin-sections did not allow for definite identification of these junctional 
structures, however, the appearance and localisation of these structures strongly suggest 
that they are tight-junctions (compare Figures 5.8 and 5.17). With conventional electron 
microscopy it was found that at birth a junctional complex was always present at the 
most apical part of the interepithelial cleft and that several tight-junctions could be seen 
within the complex (see Figure 5.8). The tight-junctions in the pups at PO were not 
noticeably different from junctions found in older opossums (see below for more 
discussion). Studies of the movement of other tracers across the blood-CSF barrier in 
developing animals have been reviewed in Chapter 1 and will therefore only briefly be 
discussed here. Whether the epithelial tight-junctions prevent the movement of HRP in 
early development has been a matter of some controversy. Wakai and Hirokawa (1978, 
1981) and Bertossi et al. (1988) reported that in the chick the tight-junctions are leaky to 
HRP during early development (before incubation day 10-11). In contrast, Tauc et al. 
(1984) showed that the junctions stop HRP as early as E14 in the rat and Dziegielewska 
et al. (1988) reported that tight-junctions prevent the intercellular movement of HRP at 
birth in an Australian marsupial, the tamar wallaby. These differences may be species 
related, however, as has been discussed before in Chapter 1, all the studies in chicks 
used large amounts of HRP which may have affected the integrity of the brain barriers. 
Since this could have particularly affected younger fetuses it may have resulted in false 
appearances indicating that the barriers were not tight early in development. BDA-3000 
has a molecular weight less than a tenth of HRP. The present experiments show that the 
structural barrier to a low molecular weight lipid insoluble tracer, that was shown to 
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behave in a similar manner to other lipid insoluble molecules across the barrier, appears 
to be present early in development. The opossum at birth can be compared to a E13-14 
rat embryo or a 6-7 week human embryo in regard to brain development (Saunders et 
al., 1989). 
Other structures that have been proposed to be responsible for the higher permeability 
during development have been vesicles (Tauc et al., 1984). Vesicles were occasionally 
found that contained the dextran (see Figure 5.15). However, there was no indication 
whether these vesicles transferred the dextran across the epithelium since none were 
found to fuse with the cell membranes. Even if these vesicles do transfer molecules 
from the blood into the CSF it is unlikely that they are responsible for the change in 
permeability for small lipid insoluble markers during development since there was no 
difference in the number of vesicles that were labelled with dextran at P1 and P13. Most 
epithelial cells also contained vacuole-like structures that were found at both P1 and 
P13 and these seemed to be filled with the dextran (see Figure 5.15). These structures 
were infrequently seen close to the cell membranes but were never found to fuse with 
the cell membrane. It is therefore unlikely that they have transporting functions but may 
have some phagocytic role. Furthermore, these vacuole-like structures were also 
identified with conventional electron microscopy, yet again, there was no noticeable 
difference in the number of vacuoles between birth and 64-day old opossums. 
Similar to the light microscopic study, the electron microscopic investigation showed 
that a small proportion of the epithelial cells had large amounts of BDA-3000 
intracellularly. The proportion of these cells was much higher at P1 than at P13. The 
subcellular staining in these cells appeared diffuse which made the interpretation of the 
results difficult. The diffuse staining may be a consequence of the staining methods. 
The labelling technique of BDA-3000 using an avidin-peroxidase complex followed by 
- 156 - 
Chapter 5: Morphological and Tracer Studies 
the DAB reaction is based on an electron dense enzymatic reaction product. The 
deposition of the reaction product may extend to areas around where the peroxidase 
complex is present. That the reaction product tended to spread was apparent around 
heavily stained areas such as the intercellular cleft (see Figure 5.17B). This made it 
difficult to identify the subcellular presence of the dextran in these cells. Nevertheless, 
the reaction product was particularly associated with cisternal structures that may be 
part of the endoplasmic reticulum and was also present in small vesicles in these cells. 
As has been discussed before, the transfer of albumin has been suggested to be through 
certain epithelial cells in the choroid plexus (Knott et al., 1997). The double label 
experiments with albumin and BDA-3000 showed that these co-localised to a high 
degree (Figure 5.18). Balslev (1997a) studied the uptake of albumin in the choroid 
plexus using the electron microscope and found that it was present in a system of 
tubulo-cisternal endoplasmic reticulum. The authors suggested that this system is the 
route for albumin into the CSF. Whether stained cisternal structures in the present study 
are the same as the tubulo-cisternal endoplasmic reticulum described by Mollgard and 
Saunders (1977) and Balslev (1997a) is difficult to conclude because of the diffuse 
staining. In order to test whether the diffuse staining in the present study is an artefact, 
another technique has to be applied. Nano-gold labelling could possibly give more 
specific staining of BDA-3000, however, this technique is also associated with other 
problems such as penetration limitations of the gold particles. 
It cannot be ruled out that the BDA-3000 positive cells may have taken up the dextran 
from the CSF and not from the blood. The dextran may have gained access to the CSF 
through some other route and then have been taken up by these cells. This could be 
tested by localising BDA-3000 in the choroid plexus after administering it directly into 
the CSF. However, such experiments would be technically very difficult because of the 
small size of the newborn opossum. The CSF volume of an opossum at birth is only a 
few microlitres. 
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Fine structure and function of the choroid plexus during 
development 
The fine structure of the choroid plexus was examined at three developmental ages (PO, 
P13 and P64) corresponding to ages studied in permeability experiments (see Chapter 
4). The different choroid plexuses from each separate ventricle have been reported to 
have almost matching light microscopic and ultrastructural appearances in late 
developing and adult animals (Davis et al., 1973; Gomez and Potts, 1981). This may be 
the reason why the choroid plexus is often referred to as one tissue and results from 
studies of one choroid plexus are often generalised for all choroid plexuses. As pointed 
out by Dziegielewska et al. (2001) some authors do not even mention which of the 
choroid plexuses is used in their studies. Ultrastructural studies of choroid plexus 
development have mostly used choroid plexus tissue from the lateral ventricles and 
some from the fourth ventricle, however, comparative studies of all the different 
choroid plexuses are lacking. To the author's knowledge only very few studies have 
made comparative investigations of the different choroid plexuses during development 
using the transmission electron microscope and none seem to have examined the 
diencephalic (3rd ventricular) choroid plexus. Keep et al. (1986) and Keep and Jones 
(1990) made quantitative measurements of some morphological features of the 
developing lateral and 4th ventricular choroid plexuses in the rat. They stated that the 
development of the two choroid plexuses appeared similar although the timing of 
morphogenesis was different. Tennyson (1971) studied the same two choroid plexuses 
of the rabbit, and at some stages of man during development. This study reported 
several ultrastructural differences of the two choroid plexuses with the most striking 
being that the epithelial cells of the lateral choroid plexus go through a glycogen rich 
stage which was much less prominent in the myelencephalic (4th ventricular) choroid 
plexus. The only other comparative studies of the developing choroid plexuses have 
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been presented by el-Gamma! (1981, 1983) who studied the surface changes of the 
lateral and third ventricular choroid plexus in embryonic chicks using the scanning 
electron microscope. These studies showed that the morphogenesis of lateral choroid 
plexuses was distinct in regard to proximal to distal differentiation whereas the cells in 
the 3rd choroid plexus appeared to differentiate from several unrelated sites of the 
choroid plexus. 
Kappers (1958) distinguished three stages in the development of the choroid plexus, 
however, later Shuangshoti and Netslcy (1966) and Tennyson and Appas (1968) 
characterised four stages. The difference in classification is that Shuangshoti and 
Netsky (1966) and Tennyson and Appas (1968) divided the last stage (stage III) into 
two separate stages based on stages when the epithelium is poor or rich in glycogen and 
also on reposition of the nucleus. The opossum follows a similar development to 
eutherians with the exception that the choroid plexuses seem to be lacking the large 
amounts of glycogen stored in the epithelial cells as has been observed in eutherians 
(Dziegielewska et al., 2001). This observation was confirmed in the present study, 
which did not reveal any glycogen in the epithelial cells at any age. The glycogen has 
been postulated to be serving as an energy source for the developing brain (Shuangshoti 
and Netsky, 1966). The reason for the lack of glycogen in the opossum is not clear, 
however, Dziegielewska et al. (2001) suggested that the explanation may be related to 
the higher oxygen tension in a species developing outside the uterus compared to in 
utero. As the opossum seems to lack glycogen, its choroid plexus can be divided into 
three stages of development, starting with a single columnar pseudostratified layer of 
epithelial cells, changing into a columnar layer and then further flattens into a cuboidal 
layer (see Figures 5.2 and 5.3). In the course of development, the choroid plexuses in 
each ventricle seem to exhibit similar microscopic changes. At birth in the opossum, 
most parts of the fourth ventricular choroid plexus were in stage II and some in stage I, 
whereas most of the lateral ventricular choroid plexus was in stage I. At P13, almost all 
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of the choroid plexuses were in stage II, except for a small part in the root of the choroid 
plexus that still had a somewhat pseudostratified appearance. At P64 the choroid plexus 
epithelium formed a uniform layer in stage III. Not only does it seem that each 
individual choroid plexus goes through similar developmental changes but also within 
each choroid plexus the maturation process is repeated. The choroid plexus shows distal 
to proximal differentiation of cells. The cells at the root of the choroid plexus are less 
mature than the ones in the more distal parts of the choroid plexus villi. This is in 
agreement with the belief that the choroid plexus grows from the proximal parts where 
the cells show a pseudostratified appearance until later in development. At P64 when 
the choroid plexuses can be expected to have stopped growing, the whole choroid 
plexus appears to form a uniform layer. 
The three stages of choroid plexus development were associated with several 
ultrastructural changes in both the core of the choroid plexus but more noticeably in the 
epithelial cells. The choroid plexus of the opossum showed similar ultrastructural 
changes during development that have been reported in other mammalian species such 
as rats (Cancilla et al., 1966; Keep et al., 1986; Keep and Jones, 1990), mice (Sturrock, 
1979; Zaki, 1981) and rabbits (Tennyson and Appas, 1968) with one noticeable 
difference in that no glycogen was found in the developing opossum choroid plexus. 
Several of these changes are probably a reflection of progressive specialisation of the 
choroid plexus as a highly secreting epithelium during development. That the choroid 
plexus CSF production rate increases with development has been demonstrated by Bass 
and Lundborg (1973), Evans et al. (1974), and Johanson and Woodbury (1974). This is 
not just due to an increase in overall mass of the choroid plexus but also to an increase 
in production per weight of choroid plexus tissue (Johanson and Woodbury, 1974). That 
one of the main functions of the choroid plexus is to produce CSF is today 
unquestioned. During development there was an increase in mitochondrial content 
mainly as a result of an increase in the number of mitochondria but also due to an 
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increase in the size of individual mitochondria. The increase in mitochondrial content of 
the epithelial cells is probably a reflection of an increase in CSF production of the 
choroid plexus. The production of CSF is a secretory process and therefore is dependant 
on energy. The production of CSF is dependant on fluid transfer between the blood 
vessels and into the epithelial cells. The increase in fenestrations of the blood vessels 
and basal infolding of the epithelial cells may be a reflection of this increase in fluid 
transfer. As well as producing CSF, the choroid plexus is also responsible for a constant 
regulation of the composition of the CSF. Several studies have shown that the 
regulation and transfer of ions by the choroid plexus is greatly increased during 
development (Jones and Keep, 1987; Parmelee and Johanson, 1989; Parmelee et al., 
1991; Preston et al., 1993). Structures such as microvilli and cilia on the apical surface, 
and numerous pinocytotic vesicles are probably an indication of an increase in exchange 
between the apical cell surface and the ventricular CSF. The opossum also showed a 
distinct change in the structure of the nucleus of the epithelial cells during development 
from being irregular in shape with great invaginations to almost spherical with a smooth 
membrane. Similar developmental changes in nuclear structure of the epithelial cells 
have been described before in mice by Dohrmann and Herdson (1969). These authors 
suggested that the lobulated nucleus along with a high abundance of rough endoplasmic 
reticulum and polyribosomes in the interlobulated cytoplasm were a reflection of greater 
interaction between the nucleus and cytoplasm in younger animals. More evidence that 
the changes in the ultrastructure of the choroid plexus presented in this study is a 
reflection of its functional development comes from studies of the aging choroid plexus. 
In rats, both morphological and functional changes during development appears to be 
reversed with aging; for instance, there is a decrease in the number of microvilli with 
age (Serot et al., 2001), while there is a reduction in the CSF secretion in older rats 
(Preston, 2001). 
One of the main aims of the present ultrastructural study was to investigate the presence 
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of tight-junctions between adjacent epithelial cells. Using the goniometric tilting device, 
several tight-junctions were often found within the junctional complex. The tight-
junctions appeared as points along the intercellular cleft where the two cell membranes 
of neighbouring epithelial cells were touching each other; this is similar to tight-
junctions that have been described between epithelial and endothelial cells of other 
mammals (Tennyson and Appas, 1968; Bouchaud and Bouvier, 1978; Stewart and 
Hayakawa, 1987; Peters et al., 1991; Schulze and Firth, 1992; Sedlakova et al., 1999). 
These tight-junctional structures appeared similar at all ages showing that the structural 
basis for the brain barriers is formed early in development. Other studies have reported 
differences in endothelial tight-junctions using the goniometric tilting device (Stewart 
and Hayakawa, 1987). It therefore does not seem that structural changes in the tight-
junctions can explain the changes in permeability to low molecular weight markers with 
age. The tight-junctions form a complex network at the apical part of the intercellular 
cleft. Serial sectioning can follow a junction a shorter distance but it has to be 
mentioned that establishing whether there are gaps in the junctional network is difficult 
using this technique. In order to determine whether there are openings in the tight-
junctional network a freeze-fracture study is needed. In freeze-fracture, the cell 
membrane is cleaved and junctions appear as ridges or grooves depending which side of 
the fractured membrane is visualised. This technique enables visualisation of the whole 
network of junctions between two adjacent cells in one preparation and is therefore a 
more practical technique of determining whether there are gaps in the junctions. This 
technique can also determine the complexity of the overall junctional network. Thin-
section electron microscopy and freeze-fracture studies of epithelial tight-junctions 
during development have been discussed in Chapter 1 and will therefore not be 
discussed in detail in this Chapter. Briefly, studies have not found any significant 
differences in either tight-junctional appearance in thin-sections or the complexity of the 
junctional network in freeze-fracture preparations of choroid plexus epithelial cells 
between developing and adults animals (Tennyson and Appas, 1968; Dermietzel et al., 
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1977; Mollgard et al., 1979; Tauc et al., 1984). 
Under the electron microscope the epithelial cells showed differences in their overall 
density, ranging from a light to dark appearance, but otherwise there was no difference 
in structure observed. These variations have also been reported in other species 
(Dohrmann, 1970; van Deurs et al., 1978; Sturrock, 1979). Dohrmann (1970) suggested 
that these differences in appearance of cells may represent different states of cell 
hydration but others have considered them as artefacts of fixation. Sturrock (1979) 
quantitated the dark and light cells in mice and found that the dark cells first appeared at 
E14, constituted around 12% of all the epithelial cells, and that this fraction remained 
almost constant up to 90 days after birth. Similar to Dohrmann (1970), the authors 
postulated that the dark cells may be dehydrated and reduced in size based on the fact 
that these cells had thinner microvilli than surrounding cells. In the present study, it 
seems unlikely that these differences can be explained by timing of fixation since the 
choroid plexus was dissected out and fixed by immersion immediately after animals 
were killed. The single layer of epithelial cells would have been exposed to the fixative 
instantly and was therefore presumably rapidly and uniformly fixed. There was no 
obvious pattern in the distribution of light and dark cells and dark cells were often found 
interspersed in the epithelium. It is still not known whether these morphological 
differences in cell density are of functional importance. 
Summary 
The uptake of a fluorescently labelled dextran (D-3308) showed that dextrans are 
suitable tracers for lipid insoluble molecules across the brain barriers. The lack of 
staining for BDA-3000 around blood vessels and in the extracellular space of the brain 
demonstrates that the blood-brain barrier is formed at birth in the opossum. The reaction 
product was particularly abundant in cells of the ventricular zone, precipitated CSF and 
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in the choroid plexus suggesting that the route for BDA-3000 into the brain could be via 
the choroid plexus and not across the brain blood vessels. Tight-junctional structures 
between adjacent epithelial cells seemed to impede the extracellular movement of BDA-
3000. This suggests that the dextran reached the CSF through an intracellular pathway 
in the choroid plexus. This intracellular pathway may be through some of the epithelial 
cells of the choroid plexus since the proportion of epithelial cells with intracellular 
staining of BDA-3000 declined in a similar manner to the reduction in steady-state 
ratios for inulin and sucrose. The very few blood vessels found early in development 
supports the hypothesis that these do not constitute a major route of entry for lipid 
insoluble molecules into the brain at this early age. This study could only suggest that 
this possible intracellular route at the subcellular level is associated with the 
endoplasmic reticulum. Experiments using some other labelling technique may be able 
to answer this question. 
Two main conclusions can be drawn from the ultrastructural study of the opossum 
choroid plexus. Firstly, at birth in the opossum, which can be compared to an E13-E14 
rat embryo regarding general brain development, the ultrastructural basis for the blood-
CSF barrier is already present in that tight-junctions with a mature appearance were 
visible between epithelial cells. Secondly, apart from the lack of glycogen, the 
morphogenesis of the choroid plexus in the opossum is similar to what has been 
described in other mammals both at immature and mature stages. This shows that the 
opossum choroid plexus seems to be a good model to study the functional development 
of the choroid plexus. 
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The experiments presented in this thesis measured the uptake and visualised the route of 
entry for low molecular weight, lipid insoluble molecules from the blood into the CNS 
from early development stages until young adulthood. The main strength of these 
experiments was that permeability, tracer and morphological studies have been carried 
out in the same species over a similar developmental period. These experiments are 
therefore directly comparable with respect to developmental stages and also 
uncertainties about species variations are avoided. The present experiments together 
with previous studies (Dziegielewska et al., 1989; Knott et al., 1997; Li et al., 1997) 
mean that the grey short-tailed South-American opossum is now one of most studied 
mammalian models of transfer mechanisms into the developing brain. 
Transfer of small lipid insoluble molecules into the developing brain 
In order to study the uptake of radiolabelled markers into the brain and CSF of newborn 
opossums, a new experimental model had to be developed since previously used 
methods in other species were not suitable due to the small size of the animals. The 
model, which is described in Chapter 3, estimated steady-state concentration ratios 
between blood and CSF or brain in animals after a single ip injection without invasive 
surgery. The accuracy of determining steady-state ratios in this way was determined by 
comparing ratios obtained from intact animals with ratios from nephrectomised animals 
that had been shown to approach steady-states between plasma, CSF and brain. It was 
shown that the model could accurately estimate steady-state concentration ratios. The 
new model therefore can be used to study the uptake of molecules from blood to 
different body compartments with minimal manipulation of animals. It was further used 
to study the uptake of several radiolabelled markers of various sizes into the brain and 
CSF during development. These experiments, presented in Chapter 4 showed that the 
steady-state concentration ratios for low molecular weight, lipid insoluble molecules 
were high in early development and that they declined with age, particularly in youngest 
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animals. This is the earliest stage of brain development that such studies have been 
carried out. The decrease in steady-state ratios during development was shown to be due 
to a reduction in permeability of the interfaces between the blood-brain and blood-CSF. 
A plot of steady-state ratios and diffusion coefficient for radioactive markers in the 
opossum, and including data on succinylated albumin from Knott et al. (1997) is 
illustrated in Figure 6.1. This shows that in the opossum, at early stages of brain 
development, there is an inverse correlation between diffusion coefficient and steady-
state CSF/plasma ratios. Furthermore, with increasing developmental age there is a 
parallel decline in these curves. This suggests that the penetration of lipid insoluble 
molecules into CSF is probably by unrestricted diffusion through some water filled 
'pore' (see Dziegielewska et al., 1979). Moreover, it implies that there is a decrease in 
the number of such pores with age rather than a decrease in pore diameter, which would 
have been expected to alter the slope of curves between steady-state CSF/plasma ratios 
and diffusion coefficient (Dziegielewska et al., 1979; Habgood et al., 1993). However, 
the experiments in Chapter 4 could not determine which of the blood-CNS interfaces 
were avenues of entry for these molecules. With the use of a small dextran tracer the 
experiments presented in Chapter 5 showed that the major route into the brain for small 
lipid insoluble molecules appears to be from the blood vessels of the choroid plexus, 
across the choroidal epithelial cells, and then into brain tissue via the CSF. There was 
little evidence that the dextran crossed the endothelial cells of cerebral blood vessels 
directly into brain tissue. Although the cerebral endothelial cells stained for BDA-3000, 
none could be detected in the extracellular space around the blood vessels. This was in 
contrast to the strong staining for BDA-3000 in the CSF. 
The possible routes of entry for lipid insoluble molecules through the cells of the brain 
barriers are shown in Figure 1.2. Several of these pathways can most certainly be ruled 
out as major contributors to the transfer of lipid insoluble molecules across the barriers 
such as receptor- and carrier-mediated trancytosis and absorptive-mediated transfer. 
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These transfer mechanisms can only be used by molecules of certain configuration and 
charge. Moreover, the quantitative permeability experiments showed that these 
molecules are transferred in a passive manner and not by a facilitated mechanism. 
Another possible route for small lipid insoluble molecules into the brain could be 
through the intercellular cleft including the zonulae occludentes. Structural changes of 
the tight-junctions producing increased restrictions on the movement of molecules 
through the intercellular cleft during development, could then explain the decrease in 
permeability with age. However, the present studies using BDA-3000 do not support 
this theory. The dextran seemed to be impeded by tight-junctional structures in the 
choroid plexus already at birth whereas there was a significant decrease in the brain 
barrier permeability of radiolabelled markers after birth. Furthermore, the ultrastructural 
investigation did not reveal any differences in the appearance of the tight-junctions in 
the CNS between newborn opossums and young adults. This would have been expected 
if structural changes of these junctions were responsible for the decline in permeability 
with age. The postulated pore could be a water-filled intracellular pathway through the 
cells as was suggested by Balslev et al. (1997a). Both the light and electron microscopic 
study demonstrated an intracellular distribution of BDA-3000 in the choroidal epithelial 
cells suggesting that the dextran may have an intracellular pathway through a small 
proportion of the epithelial cells of the choroid plexus. Moreover, this intracellular 
pathway appeared to diminish during brain maturation which would fit with the 
hypothesis that this pathway is responsible for the higher permeability in young 
animals. The particular electron microscopic method used did not localise this possible 
intracellular pathway precisely because of uncertainties about reaction product 
diffusion. This problem can be further studied by the use of immunogold labelling. 
The present study demonstrated that brain barriers are certainly present at early stages 
of development, although their properties are different from those of the adult animal. 
The strength of the current studies is that physiological and morphological approaches 
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have been combined in the same preparation, so that it is possible to draw conclusions 
about the structural basis for the permeability changes observed. Without the 
morphological studies in these experiments, one could interpret the observed high 
permeability of the brain barriers in young animals to be due to the barriers simply not 
being properly developed at early stages of development. However, the morphological 
studies showed that the ultrastructural basis for the blood-CSF barrier (tight-junctions) 
is present very early in development. Subsequently, if the transfer of molecules into the 
CSF is higher in development because of a developmentally regulated intracellular 
pathway, this can be regarded as a specialisation of the transfer mechanism across the 
brain barriers in early development rather than a reflection of poorly developed barriers. 
It is difficult to hypothesise about the exact physiological importance for such transfer 
mechanisms. However, they may be important for the provision of a suitable 
environment for the growing brain. There is a high concentration of protein in the CSF 
in early development which at least for albumin has been shown to be due to specialised 
transporting mechanisms across choroid plexus cells that is only present in the 
developing brain (Habgood, 1990; Dziegielewska et al., 1991; Knott et al. 1997). The 
high levels of proteins in the CSF have been postulated to be a driving force for normal 
brain enlargement and also to provide nutrients for the growing brain (Dziegielewska et 
al., 2001). The transfer mechanisms at the choroid plexus for low molecular weight, 
lipid insoluble molecules in the CSF may have similar functions. 
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Figure 6.1 
Steady-state CSF/plasma ratios (y-axis, note logarithmic scale) against the 
diffusion coefficients (D32) for molecules of various molecular sizes (x-axis) in 
P5-P7 (•), P10-P13 (0), P15-P17 (•), P32-P37 (0), and P65 (A) opossums. 
Diffusion coefficients were calculated for 32°C, as this is the normal body 
temperature for opossums. Data for succinylated albumin (s-Albumin) are from 
Knott et al. (1997). Values shown are means (n=3-10) and the error bars are ± 
SEM. Where no error bars are visible, they are obscured by the symbols. There 
was a parallel decrease in the curves between CSF/plasma ratios and diffusion 
coefficients with increasing postnatal age 
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Further studies 
The model and techniques described in this thesis could be used for several further 
studies of transfer mechanisms into the brain. Under the light microscope it appeared 
that BDA-3000 was taken up by endothelial cells within the brain but did not appear to 
escape from these into the surrounding brain tissue. It would be interesting to determine 
the subcellular distribution of BDA-3000 in endothelial cells. This could also determine 
whether there is a paracellular pathway of the tracer in the developing blood vessels. 
Since BDA-3000 did not appear to escape the blood vessels in the brain it could be 
expected that intercellular movement of BDA-3000 between endothelial cells is already 
restricted by tight-junctions at early stages of brain development, as has been 
demonstrated in this thesis for the zonulae occludentes between choroidal epithelial 
cells. BDA-3000 could also be used to study the barriers situated within the meninges 
and the pial surface of the brain which are fluid interfaces of the brain have been almost 
forgotten in studies of exchange between blood, brain and CSF. Several species have 
been found to have developmentally regulated intercellular junctions (strap-junctions) 
of the ependymal lining of the brain ventricles. Whether such junctions exist in the 
opossum is not known but would be of interest to examine. 
This thesis presents quantitative data on the uptake of several markers (L-glucose, 
sucrose and inulin) from blood to brain and CSF along with a visualisable tracer BDA-
3000, that is of similar size to inulin. There are now several other small tracers that 
could be used to study transfer mechanisms into the brain. It will, however, be essential 
to check whether each tracer behaves in a comparable manner across the brain barriers 
to other small lipid insoluble molecules before they should be used as tracers. This has 
been overlooked in previous studies with other tracers. Biotin-dextrans are only 
available in sizes larger then BDA-3000. However, several other neuronal tracers are 
derivates of biotin and may be suitable as low molecular weight tracers. Biocytin, 
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neurobiotin and biotin cadaverine are all water soluble low molecular weight tracers 
(molecular weight range of about 250-800 Daltons) that all have amine residues and can 
therefore be fixed using aldehydes. They can be visualised with similar techniques to 
biotin-dextrans and are also available with flourophore conjugates. This means they 
could easily be quantitated using the same methods as in this thesis in order to test 
whether their transfer mechanisms into the brain can be expected to be similar to biotin-
dextrans and other lipid insoluble compounds. 
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Appendix A 
Fixation and processing tissue for paraffin sections 
1) Perfuse with PBS solution containing 5000 units heparin /100m1 PBS for 
approximately 1-2 min. In smaller pups that cannot be perfused fixed, the tissue is 
processed from step 3. 
2) Perfuse fix with fresh cool 4% paraformaldehyde solution. 
3) Immerse tissue in Bouin's fixative for 24 hours. 
4) 3xlhour changes in 70% ethanol. 
5) 3x1 hour changes in 95% ethanol. 
6) 3x1 hour changes 100% ethanol. 
7) Leave tissue in chloroform overnight. 
8) Leave in paraffin for 1 hour. 
9) Transfer tissue to fresh paraffin and leave under —10 inches of mercury for 1-2 
hours. 
10) Decrease pressure to —20 inches of mercury and leave for 1-2 hours. 
11) Embed in fresh paraffin and leave cool to harden. 
Dewaxing and rehydrating paraffin sections 
1) Melt paraffin in 60°C oven for 30 min. 
2) 10 min in xylene. 
3) 5 min in xylene. 
4) 5 min in xylene. 
5) 5 min 100% ethanol. 
6) 5 min 100% ethanol. 
7) 5 min 95% ethanol. 
8) 5 min 70% ethanol. 
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Rehydrating and mounting paraffin sections 
1) 5 min 70% ethanol. 
2) 5 min 95% ethanol. 
3) 5 min 100% ethanol. 
4) 5 min 100% ethanol. 
5) 5 min in xylene. 
6) 5 min in xylene. 
7) Mount slides. 
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Appendix B 
Processing paraffin sections for BDA-3000 histochemistry 
1) Dewax and rehydrate sections according to appendix A. 
2) 3x5 min wash in 0.2% Tween20 PBS. 
3) Incubate in peroxidase blocker (Dako) for 30 min. 
4) 3x5 min wash in 0.2% Tween20 PBS. 
5) Incubate in protein blocker (Dako) for 30 min. 
6) 3x5 min wash in 0.2% Tween20 PBS. 
7) Apply avidin-horseradish peroxidase complex using a Vectastain Elite ABC kit 
(Vector). Solution A and B must be mixed 30 min before incubation. 
8) 3x10 min wash in Tween20 PBS. 
9) Process sections with the diaminobenzidine tetrahydrochloride reaction (DAB Kit, 
Dako) for about 3-10 min. 
10) Rinse briefly in distilled water. 
11) Wash 10 min in tap water. 
12) Dehydrate sections according to appendix A. 
13) Mount slides with DPX. 
Processing paraffin sections for BDA-3000 and endogenous 
albumin double labelling 
1) Dewax and rehydrate sections according to appendix A. 
2) 3x5 min wash in 0.2% Tween20 PBS. 
3) Incubated in rabbit antibodies against human albumin (Dako) diluted 1:100 
overnight in fridge. 
4) 3x10 min wash in 0.2% Tween20 PBS. 
5) Incubate in a mixture of 1:30 dilution of swine anti-rabbit fluorescein conjugated 
antiserum (FITC) antibodies (Dako) and 1:70 dilution of streptavidin Texas-Red 
(Vector) overnight in fridge. 
6) 3x10 min wash in 0.2% Tween20 PBS. 
7) Mount sections in an aqueous mounting medium (Dako). 
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Appendix C 
Processing of choroid plexus for standard electron microscopy 
1) Choroid plexus fixed in 2.5% glutaraldehyde cacodylate buffer (0.1 M, pH 7.3) and 
left in fixative for 2-3 hours at 4 C. 
2) 3x10 min washes of tissue in buffer. 
3) Osmicate in 50/50 mixture of osmium tetroxide (4%) and 0.05 M potassium 
ferrocyanide 0.2 M PBS solution for 45 min. 
4) 3x10 min washes of sections in buffer. 
5) Leave tissue in a 1% uranyl acetate solution for 30 min. 
6) 10 min in 50% Ethanol. 
7) 10 min in 75% Ethanol. 
8) 10 min in 95% Ethanol. 
9) 2x15 min in 100% Ethanol. 
10) Rinse tissue 2x15 min in Propylene oxide. 
11) Transfer to a 50/50 mixture of Procure 812/Propylene oxide for at least 1 hours. 
12) Transfer to a 75/25 mixture of Procure 812/Propylene oxide for at least 1 hours. 
13) Transfer to 100% Procure and leave overnight. 
14) Transfer to fresh Procure and leave for 6-7 hours. 
15) Embed in fresh procure and leave in 37°C for 12 hours. 
16) Increase heat to 60°C and leave for 48 hours. 
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Appendix D 
Biotin-dextran labelling of choroid plexus for electron microscopy 
Injection: Intraperitoneal injection of BDA-3000 (0.7 mg/g body weight) and wait 30- 
45 min. Choroid plexuses dissected out and fixed in 2.5% glutaraldehyde 
phosphate buffered saline (0.1M, pH 7.3). Leave tissue in fridge for 2-3 
hours. 
1) 3x10 min washes of sections in large amounts of PBS. 
2) Leave sections in 50% ethanol PBS solution for 30 min. 
3) 3x10 min washes of sections in PBS. 
4) Apply avidin peroxidase complex using an ABC kit (Vector). Leave A and B 
solution for 30 min in room temperature before incubation. Incubate for 30-60 min. 
5) 3x10 min washes of sections in PBS. 
6) Carry out DAB reaction. Try keeping the reaction time as short as possible to 
minimise precipitation. 
7) 3x10 min washes of sections in PBS. 
8) Osmicate in a 50/50 mixture of osmium tetroxide (4%) and 0.05 M potassium 
ferrocyanide 0.2 M PBS solution for 45 min : 
9) 3x10 min washes of sections in PBS. 
10) Leave tissue in a 1% uranyl acetate solution for 30 min. 
11) 10 min in 50% Ethanol 
12) 10 min in 75% Ethanol. 
13) 10 min in 95% Ethanol. 
14) 2x15 min in 100% Ethanol. 
15) Rinse tissue in 2x15 min in Propylene oxide (for Procure 812). 
16) Transfer to a 50/50 mixture of Procure 812/Propylene oxide for at least 1 hours. 
17) Transfer to a 75/25 mixture of Procure 812/Propylene oxide for at least 1 hours. 
18) Transfer to 100% Procure and leave overnight. 
19) Transfer to fresh Procure and leave for 6-7 hours. 
20) Embed in fresh procure and leave in 37°C for 12 hours. 
21) Increase heat to 60°C and leave for 48 hours. 
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